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ABSTRACT 
 
There is considerable interest in the beneficial role of dietary polyunsaturated fatty 
acids (PUFA) on reproduction in ruminants. Detailed information regarding the 
mechanisms behind this beneficial effect is limited. The main objective of this thesis 
was to test the effects of dietary supplementation with omega-3 (n-3) or -6 (n-6) 
PUFA on gene expression, fatty acid (FA) composition and steroidogenesis in 
granulosa and theca cells and pre-implantation embryo development. 
 
A previous study in our laboratory reported increased follicular-fluid progesterone 
concentrations in ewes fed an n-3 compared to an n-6 PUFA-enriched diet, but 
detected no differential effect of n-3 and n-6 PUFA enriched high-density 
lipoproteins (HDL) on granulosa cell steroidogenesis in vitro. Also, n-6 PUFA 
enriched HDL reduced early embryo development, but in the absence of a net uptake 
of FA. In view of these observations it was hypothesised that (i) effects of n-3 PUFA 
on ovarian steroidogenesis are mediated by theca rather than granulosa cells and (ii) 
during embryo culture lipids are acquired solely from the albumin fraction of serum, 
so that albumin delivered n- 3 and n-6 PUFA would exert a greater differential effect 
on embryo development than either LDL or HDL delivered PUFA.  
 
Initial investigations into granulosa cell gene expression profiles using an ovine 
gonad-targeted cDNA macroarray were unsuccessful, highlighted by subsequent 
qRTPCR analysis. A thorough investigation confirmed that inconsistencies were due 
to poor array hybridisation. In vitro data confirmed that n-3 PUFA, via delivery by 
HDL, increase progesterone production solely in theca cells and that this is 
associated with an increase in STAR transcript expression. We also demonstrate that 
albumin is the only serum fraction that leads to a net uptake of FA during embryo 
culture. PUFA enriched serum and albumin accelerated the development of embryos 
and increased the yield of morphologically poorer quality blastocysts with increased 
transcript expression for the antioxidant enzyme SOD1. Important differential effects 
of n-3 and n-6 PUFA on ovarian steroidogenesis acting solely on theca cells are 
identified, but differentially effects of PUFA on embryo development are less 
apparent. 
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CHAPTER 1 
 
Literature Review 
 
1.1 Introduction 
 
Low reproduction rate in ruminants is a major restriction in the production of these 
species (Sinclair and Webb, 2005). Declining fertility in cattle, especially dairy cows, 
has become an international problem, despite variations in breed and management 
systems (Beam and Butler, 1999; Harris and Kolver, 2001; Lucy, 2003; Chagas et 
al., 2007). Reproductive performance has declined with genetic selection for high 
milk yield (Berry et al., 2003; Chagas et al., 2007). It is thought that this process 
selects for metabolic processes that are beneficial for milk production but detrimental 
to reproduction (Butler and Smith, 1989; Gutierrez et al., 2006). Additional to 
genetic variation, nutrition has been recognised as a major factor affecting fertility, 
with nutritional status varying greatly between herds (Beever, 2006). There have 
been a multitude of varied nutritional studies focussing on improving reproductive 
function in cattle. For example correlations have been observed between negative 
energy balance (NEB) and reduced reproductive performance (Butler and Smith, 
1989), high dietary protein levels and decreased reproductive efficiency (Ferguson 
and Chalupa, 1989) and vitamin supplementation and improved reproductive 
function (Hemingway, 2003). One of the major constraints in dairy cow fertility is 
the problem of NEB brought on by high milk production and food intake too low to 
compensate for the energy expended by these high production animals (Pryce et al. 
2001). NEB can affect many factors such as follicle growth, oocyte maturation and 
changes in follicular fluid composition including fatty acid composition (Leroy et al., 
2005; Llewellyn et al., 2007; Leroy et al., 2008). An increase in dietary fat in high 
energy diets seems to have abated the severity of NEB (Andersen et al. 2008) and 
there is recent evidence which supports supplemental fat having a positive effect on 
cow fertility (Wathes et al., 2007). Protecting fats against rumen biohydrogenation 
have shown beneficial effects on energy metabolism and ovarian function (Mattos et 
al., 2000; Adamiak et al., 2006). In addition to increasing energy stores, fatty acids 
(FA) are known to affect reproduction by moderating prostaglandin production, 
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steroidogenesis, maintenance of cell membrane properties and cholesterol 
metabolism (Worgall et al., 1998; Abayasekara and Wathes, 1999; Jump and Clarke, 
1999; Elmes et al., 2004; Vanholder et al., 2005). Therefore, the positive effects seen 
by additional fat in the diet of these animals could be due to specific FA acting via 
these complex mechanisms as opposed to increased energy availability. Many studies 
to date that have reported effects of polyunsaturated fatty acids (PUFA) on fertility 
have been inconsistent and have varied between species (Wathes et al. 2007).  Due to 
the vast number of pathways PUFAs are able to affect, studies are only able to focus 
on a few of these aspects and the larger picture of the interactions of PUFA in the 
ovary remains unclear. 
 
1.2 Reproductive physiology 
 
1.2.1 The oestrous cycle 
 
The oestrous cycle consists of a series of physiological events that begin and end 
with the onset of oestrus (heat). These reproductive events continue throughout the 
life of the female in a cyclical manner and are interrupted only by pregnancy, 
anoestrous (in seasonal breeders and during lactation), poor nutrition and some 
pathological conditions. The oestrous cycle can be divided into two parts; the 
follicular and luteal phases. The follicular phase refers to the point after luteolysis 
when progesterone levels begin to fall and oestradiol secretion increases due to 
follicular growth, ending with ovulation. The luteal phase begins as the ruptured, 
ovulated follicle transforms into a functioning corpus luteum (CL) (luteinisation) 
along with an increase in progesterone, ending with luteolysis. 
 
1.2.2 Hormonal control of the oestrous cycle 
 
The oestrous cycle is regulated by many inter-relationships between the 
hypothalamus-pituitary-ovarian axis, and the various hormonal and chemical 
signalling messages between them. The oestrous cycle is controlled mainly by 
hypothalamic gonadotrophin releasing hormone (GnRH) which stimulates the 
secretion of gonadotrophins from the anterior pituitary gland and initiates the 
follicular phase (Figure 1.1). GnRH is released into the portal blood in a pulsatile 
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fashion (Scaramuzzi et al., 1993) which then stimulates the synthesis and release of 
the gonadotrophins, luteinising hormone (LH) and follicle stimulating hormone 
(FSH), thereby promoting follicle development (McNeilly, 1991). Despite the initial 
stages of follicle development occurring independently of gonadotropic hormones, 
FSH is necessary for follicular emergence, whereby antral follicles become 
responsive to and then ultimately dependant on gonadotrophins (Roche, 1996). As 
follicles develop the production of oestradiol increases, synthesised by the increasing 
population of granulosa cells. At the same time, inhibin and activin are synthesised 
by granulosa cells which inhibit and stimulate the synthesis and secretion of FSH, 
respectively, maintaining correct levels. Inhibin and activin are two closely related 
glycoprotein complexes which appear to have multiple endocrine and paracrine 
functions in follicle development (Klein et al., 2000). LH receptors begin to be 
expressed by fully differentiated granulosa cells of large preovulatory follicles 
(Baird, 1991) and, along with maximal levels of oestradiol and low levels of           
 
 
Figure 1.1. Endocrine feedback mechanisms and relationship between the 
hypothalamus, pituitary and ovaries. LH = luteinising hormone; FSH = follicle 
stimulating hormone; GnRH = gonadotrophin releasing hormone. 
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progesterone, a positive feedback effect of elevated oestradiol stimulates GnRH to 
induce the release of surge levels of LH from the pituitary.  This surge in LH triggers 
a cascade of events which ends in ovulation and the formation of a CL. 
 
1.2.3 Folliculogenesis 
 
Folliculogenesis is an established pattern of follicle growth whereby follicles 
undergo stages of development termed recruitment, selection and dominance. 
Quiescent primordial follicles contain an oocyte that has no zona pellucida but is 
surrounded by a layer of flattened granulosa cells contained within a basal lamina 
(Scaramuzzi, 1993). The entire pool of primordial follicles develops in ruminants 
during foetal life (Fortune, 1994), and once committed to growth the follicles grow 
until they become atretic or they become dominant and ovulate. Once this pool of 
growing follicles has been established, a cohort is recruited by mechanisms that still 
remain unclear and become irreversibly committed to growth (recruitment). Studies 
indicate that these initial stages are not controlled by gonadotrophins (McNatty et al., 
1999; Abel et al., 2000; Campbell et al., 2000), but follicular growth probably 
depends on the presence of oocyte/granulosa cell interactions and the secretion of a 
range of local factors (e.g., growth differentiating factor (GDF), bone morphogenetic 
proteins (BMP), activins, inhibins, fibroblast growth factor (FGF), and epidermal 
growth factor (EGF); (McNatty et al., 1999; Knight and Glister, 2001; Webb et al., 
2003). As these committed follicles become primary follicles (Figure 1.2), several 
changes are detected; oocyte enlargement, development of flattened to cuboidal 
granulosa cells, formation of the zona pellucida, mitotic activity and RNA synthesis 
by the oocyte. Theca cells begin to differentiate from the surrounding stromal tissue 
as the granulosa cells become 2-3 layers thick (Scaramuzzi, 1993). The developing 
follicles become gondatropin-responsive once the granulosa and theca cells begin to 
express FSH and LH receptors, respectively (Erickson and Magoffin, 1983; McNatty 
et al., 1999). Evidence indicates that follicles act in a hierarchical pattern, dependant 
on their individual responses to FSH and their synthesis of androgens and related 
enzyme activity (McNatty, 1992; Scarramuzzi, 1993). Those that do not fit the 
profile, and have a lower expression of receptors and enzymes, become atretic 
(selection). As the follicles become gonadotrophin-dependant the antrum steadily 
grows from fluid-filled cavities, 40µm in diameter that aggregate together (Gougeon, 
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1996). These follicles have a greater requirement for FSH and theca cells begin to 
express LH receptors, which further stimulate the differentiation of theca layers, 
including increased capacity to secrete androgens (Fortune, 1994). LH is released in 
a pulsatile fashion from the pituitary, it binds to receptors on theca cells inducing 
testosterone synthesis, which in turn diffuses into the granulosa cells where it is 
converted to oestradiol (Filicori, 1999) (Figure 1.3). The aromatization of androgens 
in granulosa cells greatly increases oestradiol production which is crucial for further 
differentiation of granulosa cells. A follicle becomes dominant as the signals that 
continue its development are no longer strong enough to maintain the development 
of other, subordinate, large antral follicles. Zeleznik and Kubik (1986) showed that 
levels of FSH which are insufficient to recruit follicles are sufficient to maintain 
growth once it has been initiated. Also, the expression of granulosa cell LH receptors 
allows larger follicles to continue growing and become dominant over smaller 
follicles whose granulosa cells are lacking LH receptors (Campbell et al., 1999).   
 
 
Figure 1.2 Schematic representation of the stages of follicle growth, ovulation and 
corpus luteum development. 
   
 
 
 
Table 1.1. Comparison between cattle, sheep and human of reproductive cycles, follicular waves and ovulatory follicles. (Data adapted 
from Fortune, 1994; Adams, 1999; Hunter et al., 2004 and Johnson, 2007). 
  
  Reproductive Cycles       Follicular waves and ovulation     
 
    
  
     
Species 
Length of 
cycle Length of follicular 
Length of 
luteal  Type of    Number Length of Max follicle diameter (mm) Ovulation 
 
(days) phase (days) phase (days) cycle   of waves folliculogenesis non-ovulatory ovulatory rate 
 
                    
 
    
  
     Cattle 20-21 2-3 18-19 Polyoestrous   2 or 3 4-6 months 10-15 12-20 1 
 
    
  
     Sheep 16-17 1-2 14-15 Seasonal   2-4 4-6 months 5-7 6-7 1-3 
 
   
polyoestrous   
     Human 24-32 10-14 12-15 Menstrual   2 or 3 11 months 10-20 23 1 
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1.2.4 Follicle waves 
 
Ultrasound imaging has allowed the investigation of patterns of development of large 
antral follicles in domestic animals. These studies have shown that recruitment, 
selection and dominance of follicles occurs throughout the oestrous cycle (Lussier et 
al., 1987; Sirois and Fortune, 1988), but only the dominant follicle that is present at 
the time of luteal regression ovulates (Fortune, 2004). This is due to persistent high 
levels of progesterone synthesised by the corpus luteum which prevents the 
development of follicles past a certain stage (Figure 1.3). Typically two or three 
successive waves are observed during ruminant oestrous cycles, however in other 
species, such as primates, pigs and rats, the dominance of follicles is suppressed 
except during the follicular phase of the cycle (Fortune, 1994) (Table 1.1).  
 
1.2.5 Ovulation and luteinisation 
 
The LH surge is the physiological trigger that stimulates ovulation of preovulatory 
follicles, and the expulsion of the cumulus-oocyte-complex from the ruptured follicle 
(Richards et al., 2002). The transition of a follicle to one that can ovulate is a 
complex multi-step process involving a wide array of mechanisms (Richards, 1994) 
including; an increase in angiogenesis, cytokine signalling, synthesis of collagenase, 
inflammatory mediator interactions and extracellular matrix remodelling. A fine 
network of capillaries develops within the thecal layer of the preovulatory follicle 
(Yamada et al., 1994) which increases the supply of hormones and other controlling 
factors to the immediate area. Connective tissue lysis is dependent on proteolytic 
enzymes which are released and activated by FSH and LH. LH induces the 
production of prostaglandins by theca cells which, in turn, stimulate collagenase and 
proteoglycanase secretion by granulosa cells (Franchimont et al., 1988). Immediately 
following ovulation, luteinisation is a tissue remodelling process by which the 
follicle loses its defined concentric structure and granulosa and thecal cells 
differentiate, culminating in the irreversible transition into a corpus luteum (Richards 
et al., 1998). Granulosa cells begin differentiation into luteal cells within 7 hours of 
the LH surge and are reprogrammed to express luteal-specific pattern of genes 
(Richards, 1994).   
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Figure 1.3 Phases of the bovine oestrous cycle and corresponding relative levels of 
progesterone, oestradiol, FSH and LH detected in serum. Adapted from Roche, 1996. 
 
1.2.6 Oocyte maturation 
 
Mammalian oocytes are formed during foetal life and are arrested at prophase of the 
first meiotic division until around the time of ovulation. Resumption of meiosis is 
brought about by the action of gonadotropic hormones which causes ovarian follicle 
cells to produce progesterone which acts directly on the oocyte to initiate oocyte 
maturation (Smith, 1989). This hormonal stimulation leads to germinal vesicle 
breakdown (GVBD) and chromosomal condensation, then progression through 
metaphase of the first meiosis, release of the first polar body then arrest at metaphase 
of the second meiosis (Wu et al., 1997). The induction of oocyte maturation is 
known to involve an initial action of agonists at the oocyte surface, which in turn 
leads to the activation of a cytoplasmic maturation or meiosis promoting factor 
(MPF) (Smith, 1989). MPF is a factor that is capable of inducing the M-phase of cell 
cycle without protein synthesis (Parrish et al., 1992). MPF induces chromosomal 
condensation, nuclear envelope breakdown and cytoplasmic reorganisation (Nurse, 
1990; Parrish et al., 1992). GVBD is one of the events routinely used to score that 
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maturation is underway (Smith, 1989). GVBD is accompanied by expansion of the 
cumulus cell layer surrounding the oocyte, and in cattle occurs within hours of the 
ovulatory LH surge or after removal from the follicle (Sirard and First, 1988). 
Cumulus expansion is a more visible sign of oocyte maturation and is often been 
considered a reliable index to asses the quality of a mature oocyte and indirectly its 
developmental competence (Mattioli and Barboni, 2000). Cultured bovine oocytes 
will undergo spontaneous maturation 80% of the time, but gonadotropins are added 
to culture to ensure cytoplasmic maturation and cumulus expansion and to improve 
embryonic development (Sirard et al., 1988). Studies have shown that a greater 
proportion of in vivo matured oocytes reach the embryo stage compared to those 
produced in vitro (Leibfried-Rutledge et al., 1987), with the intrinsic quality of the 
oocyte being a key factor in this.  It has been reported that oocytes derived from large 
follicles are more competent than those derived from small follicles (Pavlok et al., 
1992, Lonergan et al., 1994; Blondin and Sirard, 1995). It seems that whilst still in 
the follicle the oocyte undergoes a series of significant changes that enable it to 
become developmentally competent, including a number of ultrastructural and 
molecular alterations (Rizos et al., 2002). As most oocytes collected for in vitro 
fertilization are from subordinate follicles, the majority of these will not develop to 
the blastocyst stage. 
 
1.2.7 Fertilization and embryo development 
 
At the point of ovulation, the oocyte is gathered by the fimbriated ositum of the 
oviduct and is transported down the oviduct by cilia. This transport can be severely 
affected if cumulus cells are lacking and/or if the oviductal cilia are malfunctioning 
(Johnson, 2007). When the spermatozoa encounter the oocyte in the first third of the 
oviduct (ampula) they undergo a series of reactions. They firstly bind to the zona 
pellucida by specific proteins overlying the acrosome. This binding then initiates the 
acrosome reaction (Breitbart et al., 2006), where the two membranes fuse and the 
acrosomal contents are dispersed into the oocyte (Senger, 2005). Following 
fertilisation, the zygote is transported towards the uterus during which time it 
undergoes a series of mitotic cleavage divisions. Each cleavage division doubles the 
number of cells (blastomeres) without increasing the total size of the zygote or 
cytoplasmic content, which is maintained by the fixed size of the zona pellucida. In 
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cattle and sheep, after 3-4 cleavage divisions, control of development is taken over 
by the expression of genes from the embryonic genome as maternally-derived 
transcripts become degraded (Hyttel et al., 2000). At around the 16 cell stage, the 
embryo undergoes compaction and becomes a morula, where the number of 
blastomeres can no longer be counted accurately. Gap junctions begin to form 
between the cells causing permeability changes. Fluid accumulates between the cells 
due to an increase in ions.  A distinct cavity called the blastocoele is formed by 
which time the embryo is now called a blastocyst. Two distinct cell groups are 
formed; the inner cell mass (ICM) which gives rise to the body of the embryo, and 
the outer trophoblast which forms the extra embryonic membranes such as the 
amnion and placental tissues. Due to the increased pressure and growth, the zona 
pellucida VSOLWV DQG WKH EODVWRF\VW ³KDWFKHV´ 7KH VXUYLYDO RI WKH HPEU\R LV QRZ
dependant on luteal progesterone synthesis and the responsiveness of the uterus to 
progesterone (Senger, 2005).  
 
1.3 Lipids 
 
1.3.1 Structure and function 
 
Lipids comprise a broad group of naturally-occurring molecules which includes fats, 
waxes, sterols, monoglycerides, triglycerides, phospholipids, glycolipids amongst 
RWKHUV  7KH\ FDQ EH GHILQHG DV µIDWW\ DFLGV DQG WKHLU GHULYDWLYHV DQG VXEVWDQFHV
relDWHGELRV\QWKHWLFDOO\RUIXQFWLRQDOO\WRWKHVHFRPSRXQGV¶&KULVWLH/LSLGV
have many roles within the body including; constituents of cellular membranes, 
energy storage, regulation of gene transcription, metabolic pathways and cell 
signalling (Gurr et al., 2002, Hames and Hooper, 2004).  There are four major groups 
of lipids found in the blood; phospholipids, triglycerides, free fatty acids and 
cholesterol (McDonald et al., 2002). 
 
1.3.2 Phospholipids 
 
Phospholipids consist of a hydrophobic tail of long fatty acid carbon chains, and a 
hydrophilic head containing a negatively charged phosphate group. The majority of 
phospholipids are synthesised in the liver, on the membrane of the endoplasmic 
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reticulum (ER) (Vance and Vance, 1996). The roles of phospholipids are primarily as 
constituents of biological membranes. Most phospholipids contain a diglyceride, a 
phosphate group, and a simple organic molecule such as choline. As part of cell 
membranes, phospholipids are a constant source of fatty acids for the synthesis of a 
variety of effector molecules such as the eicosanoids (Mattos et al., 2000). 
 
1.3.3 Triglycerides 
 
Triglycerides (or triacylglycerols) are a major fuel store and comprise of three fatty 
acid chains esterified to a glycerol backbone. The FA molecules can vary in length 
and saturation and can be removed from the glycerol backbone by the action of 
OLSDVHV 7KH IUHH IDWW\ DFLGV ))$ FDQ WKHQ EH XWLOLVHG WR SURGXFH HQHUJ\ E\ ȕ-
oxidation which is controlled mainly by the concentration of FFA in the blood which 
is in turn controlled by the hydrolysis rate of triglycerides in adipose tissue by 
hormone sensitive triacylglycerol lipase (Hames and Hooper, 2004). 
 
1.3.4 Fatty acids 
 
A fatty acid comprises of a hydrocarbon chain of varying length, a methyl group and 
a terminal carboxylic acid group.  Most naturally occurring fatty acids have an even 
number of carbon atoms arranged in an unbranched chain. This chain can vary in 
length, but usually ranges between 14 to 24 carbon atoms, the most common FA 
containing 16 or 18 carbon atoms. FA differ in the number of carbon atoms and the 
number and position of unsaturated carbon-carbon double bonds. Saturated fatty 
acids contain no double bonds as all carbon atoms are saturated with hydrogen 
atoms. This gives the general formula of CH3(CH2)nCOOH where n is an even 
number. Monounsaturated fatty acids (MUFA) contain one carbon-carbon double 
bond and polyunsaturated fatty acids (PUFA) contain two or more.  These double 
bonds have two configurations, cis and trans, however the vast majority of naturally 
occurring FA arise in the cis form. Trans FA occur as intermediates in the 
biohydrogenation of FA in the rumen and in some plant lipids (Christie, 2003).  
Some common naturally occurring fatty acids are shown in Table 1.2. PUFA are 
grouped depending on the position of the first carbon double bond from the methyl 
end or omega carbon atom, giving the nomenclature omega-3, -6 and -9 (or n-3, -6 or 
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-9). Linoleic acid (C18:2, n- DQG Į-linolenic acid (C18:3, n-3) are classed as 
essential fatty acids (EFA) in mammals. These fatty acids cannot be synthesised by 
WKHERG\DQGPXVWEHLQFOXGHGLQWKHGLHW 7KLV LVGXHWRDODFNRIWKHǻ12 DQGǻ15 
desaturase enzymes and the inability to synthesise fatty acids with double bonds 
closer than carbon number 9 from the methyl terminus.  EFA deficiency can lead to 
growth retardation, dermatosis, impaired reproduction and impairment of function in 
most organs throughout the body (Gurr et al., 2002).  
 
1.3.5 Cholesterol 
 
Cholesterol is a 27 carbon steroid molecule and has several important functions; a 
constituent of cell membranes, a precursor for the five major classes of steroid 
hormones (prostagens, oestrogens, androgens, glucocorticoids and 
mineralcorticoids), and a precursor of bile salts and vitamin D.  It can be synthesised 
de novo, mainly in the liver or be obtained in the diet. Most cholesterol in the blood 
is in the form of cholesterol esters, formed by the addition of a fatty acid to the C3 
hydroxyl group. This makes the cholesterol more hydrophobic enabling it to be 
stored and transported more easily (Lim and Roach, 2007). Cholesterol is transported 
around the body in lipoprotein particles and imported into cells utilising their 
corresponding receptors, although the preference for high- or low-density 
lipoproteins differs between species (Grummer and Carroll, 1988). 
 
1.3.6 Lipoproteins 
 
Lipoproteins are globular particles containing a hydrophobic core consisting of 
triacylglycerols and cholesterol esters, and a surrounding amphipathic coat of 
proteins (apolipoproteins), phospholipids and cholesterol. The apolipoproteins 
present in the structure help to solubilise the lipids in biological fluids. The ratio of 
lipids, proteins, size and specific proteins and lipids within the particles differ and 
can be classed into 5 types (see below). Differences in density and size allow 
lipoproteins to be isolated and characterized by sequential ultracentrifugation, 
electrophoresis or immunoelectrophoresis (Bauchart, 1993).   
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Table 1.2. Some naturally occurring and common fatty acids (Adapted from Gurr et 
al., 2002) 
 
Molecular Common name Systemic name Occurrence 
name 
   
    
C16:0 Palmitic Hexadecanoic 
Most common saturated FA in 
animals and plants 
C18:0 Stearic Octadecanoic 
Major component of animals and 
fungi 
C18:1 n-9 Oleic 9-octadecadienoic 
Most common MUFA in plants 
and animals 
C18:2 n-6 Linoleic 9,12-octadecatrienoic 
Major component of plant lipid. In 
mammals only derived from 
dietary plants and marine oils 
C18:3 n-3 ɲ-Linolenic 9,12,15-octadecatrienoic Component of plant and seed oils 
C20:4 n-6 Arachidonic 5,8,11,14-Eicosatetraenoic 
Major component of animal 
phospholipid 
C20:5 n-3 Eicosapentanoic 5,8,11,14,17-Eicosapentaenoic 
Major component of marine 
animals and oils 
 
 
1) High density lipoprotein (HDL). Highest in density (1.063-1.24g.ml) due to high 
protein-to-lipid ratio. HDL are the major lipoprotein in plasma (>80%) in 
ruminants. They are synthesized in the liver and remove excess cholesterol from 
cells and transport it to the liver (Bauchart, 1993). 
2) Low density lipoprotein (LDL). End product of the degradation of (very low 
density lipoproteins) VLDL. Density 1.019-1.063g/ml.  LDL represents <10% of 
total lipoproteins in plasma in ruminants but contains highest cholesterol ester 
content as a proportion of weight. They carry cholesterol from the liver to cells of 
the body. LDL contains only apoB-100 apolipoproteins which is recognised by 
LDL receptor allowing uptake of LDL into cells. 
3) Intermediate density lipoproteins (IDL). Intermediate between VLDL and LDL 
and are generated during lipolysis (density 1.006-1.019g/ml). This is not 
generally detectable in blood. 
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4) Very low density lipoproteins (VLDL). The second largest and dense 
(<1.006g/ml) lipoprotein in ruminants. Synthesized in the liver, VLDL transports 
triglycerides, cholesterol and phospholipids to other tissues. The VLDL remnants 
remain in the blood first as IDL then as LDL where the cholesterol esters become 
esterified in the transformation. 
5) Chylomicrons: Largest and least dense (<0.95g/ml) due to high lipid-to-protein 
ratio. They transport triglycerides from the intestines to skeletal muscle and 
adipose tissue and cholesterol to the liver. 
Steroid-producing cells require cholesterol for the initial steps of the steroidogenic 
pathway and it seems that both LDL and HDL lipoproteins effectively support 
androgen production in these cells (Dyer and Curtiss, 1988; Magoffin and Erickson, 
1988). The uptake of LDL-derived cholesterol involves specific binding to cell 
surface LDL receptors (LDLR) followed by internalization and lysosomal hydrolysis 
to release cholesterol esters (Brown and Goldstein, 1986).  The HDL receptor 
SCARB1 (scavenger receptor, class B, type 1) preferentially uptakes cholesterol 
esters without the parallel uptake and degradation of the entire lipoprotein particle 
(Pittman et al., 1987). Both LDLR and SCARB1 are found to be localised in theca 
and luteinised granulosa cells (Li et al., 1998) and expression is reported to be 
increased in vitro with insulin (Li et al., 2001).  Moreover, the addition of HDL and 
insulin to in vitro cultured theca-interstitial cells increases LH-stimulated 
androsterone production in a synergistic manner (Magoffin and Erickson, 1988), 
suggesting that lipoproteins are important physiological stimulators of ovarian 
androgen biosynthesis. 
 
1.3.7 Albumin as a fatty acid carrier 
 
The ability of serum albumin to bind fatty acids was discovered in the 1940s 
(Kendall, 1941). Since then extensive investigations have been carried out which 
have mapped the presence of seven albumin FA-binding domains which vary in 
affinity (Curry et al., 1998). Fatty acid binding affinity increases with increasing 
carbon chain length, however, FA binding diminishes when a chain length of 20 
carbons is reached (Spector, 1975). Studies have shown that signalling events that 
have been mediated by unbound FFA have been abolished by the addition of FA-free 
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bovine serum albumin (BSA) to culture which reduced the unbound FFA without 
reducing total FFA concentration (Huber et al., 2006). Albumin is able to deliver FA 
to a wide range of cell and tissue types (van der Vusse, 2009), however its role in 
reproductive processes remains unknown. 
 
1.4 Fatty acid metabolism and biosynthesis 
 
Fatty acid biosynthesis consists of a series of reactions in which a fatty acid molecule 
is sequentially lengthened by the addition of two carbon units to give rise to 16C and 
18C products. Once long-chain fatty acids have been synthesised various 
modifications can then take place, the most important being elongation and 
desaturation (Figure 1.4). 
 
1.4.1 Elongation 
 
In mammals, FA consisting up to 16 carbons in length (palmitate) are synthesised by 
fatty acid synthase (FAS). FAS functions as a homodimeric and multifunctional 
complex of around 250 kDa found in the cytoplasm (Jakobsson et al., 2006). FAS 
contains all the catalytic components required to direct a series of 37 sequential 
reactions leading to the formation of palmitic acid from acetyl and malonyl-CoA 
(Smith, 1994). However, most tissues contain longer-chain fatty acids in their 
membrane lipids. The formation of these very long-chain fatty acids (VLCFA) is 
catalysed by a group of enzymes termed elongases due to their ability to lengthen 
pre-formed fatty acids (Gurr et al., 2002). Elongases are present in the endoplasmic 
reticulum and their functions are principally the same as FAS, but each step is 
performed by individual proteins (Jakobsson et al., 2006).  The enzymes which 
catalyse the elongation of very long chain fatty acids (ELOVL) are expressed 
throughout the body, with ELOVL1, 5 and 6 being expressed ubiquitously and 
ELOVL2, 3, 4 and 7 displaying tissue-specific level of expression, including the 
ovary (see below).  ELOVL3, 6 and 7 have a preference for saturated and MUFA as 
substrates whereas ELOVL2, 4 and 5 are selective for PUFA (Guillou et al., 2010). 
&RQVHTXHQWO\ WKH SURILOH RI (/29/¶V SUHVHQW LQ FHOOV ZLOO PDUNHGO\ LPSDFW RQ
synthetic capacity and overall cellular function. 
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1.4.2 Desaturation 
 
Desaturation is a reaction where a double bond is inserted between two carbon atoms 
of a fatty acid molecule. The enzymes responsible for these desaturation reactions are 
the ǻ, ǻ6 and ǻ desaturases, coded for by the FADS1, FADS2 and SCD genes, 
respectively. They are membrane-bound enzymes of the endoplasmic reticulum that 
require an electron transport chain for NADH which is catalyzed by the NADH 
cytochrome b5 reductase and cytochrome b5 (de Alaniz and Marra, 2003). SCD 
mediates a rate limiting reaction catalysing the conversion of saturated fats 
(preferably palmitic acid (16:0) and stearic acid (18:0)) to MUFA by inserting a cis 
double bond between the two carbon atoms at the ǻ9 position. 
 
Desaturases and elongases have been found to be expressed in cumulus cells in the 
rat (Moreau et al., 2006) and human (Feuerstein et al., 2007) and seem to play a role 
in follicular development and oocyte quality. Mouse studies have shown that mutant 
FADS2 -/- knockout mice have impaired gap junction networks between granulosa 
cells leading ultimately to sterility (Stoffel et al., 2008) with all tissues and fluids 
being devoid of PUFA. ELOVL5 -/- transgenic mice also display infertility in 
females (Moon et al., 2009), however the mechanism for this remains unknown. 
Although these studies suggest that ovarian function depends on the presence of both 
elongase and desaturase enzymes, there have been few studies characterising the 
profile of these factors and relating altered expression to ovarian function. The 
relative positions of the enzymes in the n-3 and n-6 metabolic pathways are 
illustrated in Figure 1.4. 
 
1.4.3 Eicosanoids 
 
The 20-carbon fatty acids arachidonic acid (AA) (20:4, n-6) and eicosapentanoic acid 
(EPA) (20:5, n-3) are precursors for eicosanoids (Figure 1.5), which include the 
prostaglandins, leukotrienes and thromboxanes. These factors are produced through 
the prostaglandin synthase and lipoxygenase pathways. Prostaglandin 
endoperoxidase synthase 2 (PTGS2, also known as cyclo-oxygenase-2 or COX-2) is 
not only responsible for the production of inflammatory eicosanoids from PUFAs, 
but the expression of PTGS2 can be directly altered by PUFAs in vivo 
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Figure 1.4 Summary of dietary PUFA modifications of the n-3 and n-6 families 
through desaturase (FADS) and elongase (ELOVL) reactions. 
 
and in vitro. For example, it has been reported that n-3 PUFA down regulate, 
whereas n-6 PUFA up regulate the expression of the gene. AA (n-6) increased 
PTGS2 expression in cultured mouse bone marrow stromal cells (Shen et al., 2008) 
and EPA and docosahexanoic acid (DHA) (both n-3) caused a dose-dependent 
reduction in PTGS2 expression in cultured bovine chondrocytes (Curtis et al., 2000). 
Also, the fat-1 transgenic mouse which is able to convert n-6 to n-3 PUFA expresses 
approximately 25% reduction in PTGS2 transcript compared with the wild type 
mouse concomitantly with a 200% increase in tissue levels of n-3 PUFA (Boudrault 
et al., 2010). Eicosanoids derived from n-6 PUFAs are pro-inflammatory and those 
derived from n-3 PUFAs are anti-inflammatory and/or reduced pro-inflammatory. 
Due to AA being the major 20-carbon PUFA present in cells and their membranes, it 
tends to be the preferred substrate for eicosanoid synthesis. By changing the n-3:n-6 
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dietary ratio, the composition of the phospholipid membrane can change thus altering 
the proportion of available n-3 and n-6 PUFAs for eicosanoid production 
(Simopoulos, 2006). 
 
PGF2Į is a key prostaglandin in reproduction. Produced by the uterus (also the ovary 
in the human), PGFĮ causes luteolysis and in domestic animals can be used 
pharmacologically to shorten the luteal phase if given during the mid or late stages. It 
has been reported that n-3 PUFAs can inhibit PGF2Į production in cultured bovine 
endometrial cells (Mattos et al., 2003), therefore n-3 PUFAs could inhibit luteolysis, 
thus impacting on subsequent follicular development. PGE2 has been shown to be 
expressed in maturing oocytes (Neal et al., 1975) and developing follicles and seems 
to coordinate oocyte meiotic maturation and cumulus cell expansion (Takahashi et 
al., 2006).  
 
The process of ovulation has been compared to a controlled inflammatory process 
(Espey, 1980), with marked changes seen in the ovarian vasculature and extracellular 
matrix after the LH surge; vasodilatation and increased vasculature, infiltration of 
immune cells, increased synthesis of inflammatory mediators, proteolytic activity 
leading to tissue damage and the subsequent healing. Some of these changes are 
thought to be attributable, at least partly, to mediation by eicosanoids. In a study by 
Matousek (2001), a leukotreine B4 (LTB4) receptor agonist inhibited ovulation 
through inhibition of matrix metalloproteinase (MMP)-2, which degrades collagen in 
basement membranes. A similar study using a lipoxygenase inhibitor also saw 
inhibition of ovulation which was reversed through administration of an exogenous 
LTB4 (Mikuni et al., 1998). Prostaglandins are also essential for ovulation to take 
place. The preovulatory LH surge stimulates granulosa cells to express PTGS2 and 
phospholipase A2, the enzymes needed for prostaglandin synthesis. PGE2 levels 
increase in follicles during the first several hours of ovulation and reach a peak at the 
time the follicles begin to rupture (Espey, 1994). Follicle rupture is prevented by 
PTGS2 inhibitors (Pall et al., 2001, Salhab et al., 2001), and can be restored by 
injection of PGE2 (Duffy and Stouffer, 2002). Progesterone enhances the activity of 
the enzyme responsible for converting PGE2 to PGF2Į (PGE2-9- ketoreductase). 
PGF2Į has been shown to increase the collagenolytic activity within follicles 
(Murdoch et al., 1986), as well as increasing the contraction of ovarian smooth                          
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Figure 1.5 Structure of arachidonic acid (n-6) and eicosapentanoic acid (n-3) and the 
metabolites PGE2, PGFĮ, PGE3 and PGFĮ synthesised through the PTGS2 pathway. 
 
 
muscle (increasing follicular pressure) and stimulating the increase of lysosomal 
enzymes in the immediate area (Senger, 2003), showing it to be an integral factor of 
successful ovulation. Thromboxanes also increase in synthesis before ovulation takes 
place, but specific agonists to block TXB2 do not prevent follicle rupture (Wilken et 
al., 1990), however detailed information about their role in the ovary is limited. 
 
1.4.4 Steroidogenesis 
 
In terms of reproduction, cholesterol is vital as it is a precursor for the synthesis of all 
steroid hormones (Figure 1.6).  This process is initiated by the rate limiting transfer 
of cholesterol from the outer to the inner mitochondrial membrane by steroidogenic 
acute regulatory protein (STAR) (Stocco and Clark, 1996). Once in the mitochondria 
the synthesis of steroid hormones begins by the removal of a six carbon unit from the 
cholesterol side chain by cholesterol side chain cleavage enzyme (P450scc or 
CYP11A1) to form pregnenelone. Steroidogenesis in ovarian theca and granulosa 
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cells is regulated by the interaction of the gonadotrophins LH and FSH with their 
receptors. The STAR gene is expressed in theca cells under the influence of LH but 
not in granulosa cells until the preovulatory LH surge, where the expression 
increases and continues to be strongly expressed throughout luteinisation (Bao and 
Garverick, 1998). As granulosa cells do not synthesise the STAR protein, the 
androgens produced by the theca cells via LH stimulation diffuse into the FSH-
exposed granulosa cells where they are aromatized into oestradiol. This mechanism 
of oestrogen production is termed the two-cell two-gonadotrophin model for 
steroidogenesis (Fortune and Quirk 1988) (Figure 1.7). 
 
It is well documented that hormones such as LH induce AA release in steroidogenic 
cells and that this release is essential for steroid biosynthesis (Wang et al., 2000), as 
metabolic derivatives of AA regulate STAR gene expression (Wang et al., 2006). 
However little is known about the consequences on steroidogenesis of reducing the 
amount of AA availability through dietary modification. One group has investigated 
plasma progesterone and oestradiol concentrations in n-3 and n-6 PUFA fed dairy 
cows. Cows were fed either a high linolenic acid (LNA) (n-3) or high linoleic acid 
(LA) (n-6) diet and serum samples were taken throughout the oestrous cycle. They 
saw increased oestradiol concentrations in the n-3 group and an increase in 
progesterone concentration in the late luteal phase of the n-6 group (Robinson et al., 
2002). However the underlying mechanisms or steroid regulation through dietary 
PUFA supplementation remain unclear. Another study investigated the role of HDL 
and LDL on steroidogenesis in cultured bovine theca cells (Bao et al., 1995). They 
found that HDL significantly increased progesterone synthesis at 96 hours. This 
study focussed on the effects of cholesterol and each lipoprotein treatment was 
equilibrated to deliver equal cholesterol levels. This shows that together with the type 
of FA present, the type of vehicle (i.e. HDL, LDL) in which cholesterol is delivered 
to these steroidogenic cells is important for optimal steroidogenesis. 
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Figure 1.6 Steroidogenic pathways in the ovary. CYP11A1 = cholesterol side chain 
cleavage, CYP17$   Į ± K\GUR[\ODVH +6'%   ȕ - hydroxysteroid 
dehydrogenase, HSD17B = ȕ - hydroxysteroid dehydrogenase, CYP19A = 
aromatase. 
 
 
1.4.5 Metabolism of fatty acids in ruminants 
 
Lipids in animal diets can affect productive efficiency through caloric and regulatory 
effects and any attempt to improve productive efficiency of ruminants by modifying 
dietary lipids must take into account ruminal metabolism of lipids (Jenkins, 1994). In 
non-ruminant species, the fatty acid composition of circulatory lipids are influenced 
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Figure 1.7 Schematic representation of the two-cell two-gonadotropin model for 
ovarian steroidogenesis (Adapted from Senthilkumaran et al., 2004). 
 
 
by the fatty acid composition of the diet, but this is not true of ruminant animals.  
Unsaturated fatty acids, including LNA (n-3) and LA (n-6), are abundant in grass and 
certain other ruminant feedstuffs, yet are present at low concentrations in meat and 
milk. Ruminants have evolved a system of digestion that involves microbial 
fermentation of food prior to exposure to their own digestive enzymes.  Bacteria 
number 109-1010 per ml of rumen contents, protozoa number 106 per ml and at least 
12 species of anaerobic fungi have been identified (McDonald et al., 2002). As this 
microbial mass synthesises about 20% of nutrients absorbed by the host animal the 
composition of these microorganisms is important. Two major processes occur 
within the rumen which influences the composition and distribution of lipids and 
their subsequent metabolism within the intestine, these are hydrolysis and 
biohydrogenation. 
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1.4.6 Hydrolysis 
 
Microbial lipases catalyse hydrolysis reactions whereby phospholipids, di- and 
triglycerides are broken down into glycerol and FFA molecules. Glycerol molecules 
are fermented rapidly, producing propionic acid as a major end product (Jenkins, 
1992) and FA enter the small intestine as FFA. Hydrolysis is a prerequisite for 
biohydrogenation as it provides a free carboxyl group for isomerisation. 
 
1.4.7 Biohydrogenation 
 
After hydrolysis, unsaturated FFA are hydrogenated into more a saturated end point 
by ruminal microbes. The rates of hydrolysis and biohydrogenation are dependent on 
the type and amount of fat delivered to the rumen (Beam et al., 2000) and ruminal 
pH (Van Nevel and Demeyer, 1996). The initial step of biohydrogenation is an 
isomerisation reaction that converts cis-12 double bond to a trans-11 isomer followed 
by hydrogenation of the double bonds from an unsaturated to a saturated bond. The 
major substrates for biohydrogenation are linoleic and linolenic acids. They convert 
C18 unsaturated fatty acids to stearic acid (SA), via a number of intermediates. The 
main intermediates of linoleic acid biohydrogenation are cis-9, trans-11 conjugated 
linoleic acid (CLA) and vaccenic acid (VA). The main intermediates of a-linolenic 
acid biohydrogenation are cis-9, trans-11, cis-15 CLA, trans-11, cis-15 LA and VA 
(Nam and Garnsworthy, 2007).  Despite the dramatic alteration of dietary fatty acids, 
ruminants do not appear to suffer from EFA deficiency.  It seems the amount of 
unchanged EFA passing through the rumen (up to 4% of dietary intake) is sufficient 
for the needs of the animal (Gurr et al., 2002). 
 
1.5 Metabolic hormones 
 
1.5.1 Insulin  
 
Insulin is a hormone V\QWKHVLVHG E\ WKH ȕ-cells of the pancreas and is central to 
regulating energy and glucose metabolism. Both in humans and in animal models, 
insulin receptors are widely distributed throughout all ovarian compartments, 
including granulosa, thecal, and stromal tissues (Poretsky et al., 1999). There is 
 24 
evidence that insulin may support the growth and maturation of preovulatory follicles 
(Shimizu et al., 2008), with reported effects on steroid hormone production (Barbieri, 
1994), steroidogenic enzyme synthesis (McGee et al., 1995; Nestler and Jakubowicz, 
1996) and the regulation of LH receptors (Adashi et al., 1985). Negative energy 
balance and dietary restriction have been shown to reduce levels of insulin in the 
body (Sinclair et al., 2000). In vivo experiments in cattle have also shown an 
improvement in reproductive function with increased circulating levels of insulin 
(Armstrong et al, 2002; Gong, 2002).  Any alterations in the synthesis and regulation 
of insulin have strong links with ovarian dysfunction observed in a number of human 
disorders such as diabetes mellitus, obesity and polycystic ovarian syndrome (PCOS) 
(Poretsky et al., 1999).  
 
1.5.2 Insulin-like growth factors 
 
The insulin like growth factor (IGF) family consist of two single chain polypeptide 
ligands (IGF-1 and -2), two cell surface receptor types (types I and II IGF-R), and at 
least six IGF-binding proteins (IGFBP), which appear to adapt the actions of the 
ligands. The presence of the components of the IGF family seems to be tissue and 
species specific but have been detected in the bovine and ovine ovary (Campbell et 
al., 1995; Spicer et al., 1993). Hastie and Haresign (2006) have identified, in great 
detail, mRNA expression for all components of the IGF system in the ovine ovary 
with respect to follicle size and health status, and a recent study has shown that FSH 
is a potent inducer of IGF-R expression in granulosa cells of bovine ovaries (Sudo et 
al., 2007). In all mammalian species IGF-1 stimulates granulosa cell proliferation 
and steroidogenesis (Monget et al., 2002) and the presence of certain IGFBP are 
characteristic of follicle growth and atresia (Monget et al., 1996). 
 
1.5.3 Leptin 
 
Leptin is the 16kDa protein product of the obese (ob) gene.  It is highly conserved 
between species, is secreted predominantly by adipocytes and plays a key role in 
energy intake and expenditure by controlling appetite and metabolism. It has been 
demonstrated that PUFA intake influences adipose tissue expression of leptin, and of 
several lipogenic enzymes and transcription factors. In addition, leptin stimulates 
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triglyceride depletion in white adipose tissue without increasing free fatty acid 
release, thus favouring fatty acids as a fuel source (Hynes and Jones, 2001). In most 
domestic animals, reproductive function is dramatically influenced by nutrition. 
Leptin receptors have been found in the brain and hypothalamus, where it has a 
direct action on GnRH secretion, inhibiting or stimulating release in a dose-
dependant manner (Spicer, 2001).  Receptors for leptin have also been found in the 
ovary (Cioffi et al., 1996), and more specifically in ruminant granulosa (Spicer and 
Francisco, 1997) and theca cells (Spicer and Francisco, 1998).  The role of leptin in 
reproduction was first highlighted in homozygous (ob/ob) genetically obese mice 
which lack endogenous leptin.  These mice were sterile but reproductive function 
resumed when given exogenous leptin (Chehab et al., 1996).  In the bovine ovary, 
OHSWLQ GLUHFWO\ DQWDJRQL]HV LQVXOLQ¶V VWLPXODWRU\ HIIHFW RQ JUDQXORsa cell 
steroidogenesis, and in the absence of insulin, had little effect on granulosa cells 
steroidogenesis (Spicer and Francisco, 1997; Spicer et al., 2000).  Muñoz-Gutiérrez 
and colleagues (2005) indicated that the actions of leptin in ovarian follicles are 
mediated by the IGF system, and that reduced oestradiol production by leptin-treated 
granulosa cells is due to a decrease in bioavailablity of IGF-1. The leptin receptor has 
also been detected in oocytes and pre-implantation embryos, implying the role of 
leptin in oocyte development, maturation and cleavage of embryos (Brannian and 
Hansen, 2002; Herrid et al., 2006).   
 
1.6 Polyunsaturated fatty acids and gene expression 
 
It was previously thought that PUFAs regulated gene expression by altering the 
make-up of phospholipid membranes or through eicosanoid production. However the 
existence of nuclear receptors capable of binding fatty acids which therefore affected 
gene transcription was discovered by Gottlicher and colleagues in 1992. Since then, 
other transcription factors that utilise fatty acids to control gene expression have been 
discovered, and it seems that these factors are involved in a complex interplay to 
maintain tissue-specific biological functions throughout the body. Within the context 
of reproductive function very few studies have investigated the role of dietary 
PUFAs on gene expression (Childs et al., 2008; Coyne et al., 2008), but PUFAs are 
known to regulate a wide range of genes which are expressed within the ovary, 
oocyte and embryo. Indeed, the examination of gene expression is now 
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acknowledged as a valuable tool to assess the viability of cultured embryos (Childs et 
al., 2008), and could be used to a much greater extent to investigate the role of PUFA 
on the multitude of genes they can affect throughout reproductive tissues. 
 
1.6.1 Peroxisome proliferator-activated receptors (PPAR) 
 
PUFAs are one subset of a wide range of ligands and activators for PPARs, others 
include; hypolipidemic drugs (clofibrate, bezafibrate), thiazolinediones (ciglitazone, 
troglitazone), eicosanoids (PGJ2, LTB4), and steroids (DHEA) (Jump and Clarke, 
1999; Moraes et al., 2006). PPARs were discovered in 1990 (Issemann and Green, 
1990), and belong to a family of steroid nuclear receptors, which act as ligand 
activated transcription factors. When bound to its ligand, PPARs form heterodimers 
with retinoid X receptors (RXRs) which then in turn regulate transcription and gene 
expression. There are 3 isoforms in the PPAR family; PPARĮ33$5ȕ Ȗ 
each being expressed at varying levels in different tissues, and each having specific 
physiological functions which are attributable to the specific genes they modulate 
(Desvergne and Wahli, 1999). PPARs contain two zinc-finger motifs in their DNA 
binding domain which allow them to bind to peroxisome proliferator response 
elements (PPREs) upstream from responsive genes (IJpenberg et al., 1997) (Figure 
1.8). 
 
PPARĮ is an important factor in regulating fatty acid metabolism and has been 
detected at high levels in liver, heart, kidney and brown adipose tissue (Escher and 
Wahli, 2000). PPARȕ is ubiquitously expressed with higher amounts found in brain, 
adipose tissue and skin (Braissant et al., 1996). PPARȖ is found in most tissues, with 
higher expression found in adipose tissue, skeletal muscle, liver, heart and colonic 
epithelium (Braissant et al., 1996). In the context of ovarian expression PPARĮ and ȕ 
have been detected in ovarian stroma and theca cells, whereas PPARȖ has been 
found to a much greater extent in granulosa cells of developing follicles (Komar et 
al. 2001; Froment et al. 2003) ,Q DGGLWLRQ JUDQXORVD FHOO 33$5Ȗ H[SUHVVLRQ 
increases with follicular development until the large antral stage and then rapidly 
declines after the luteinising hormone (LH) surge (Komar et al., 2001), but only in 
follicles that have responded to the LH surge (Komar and Curry, 2003). Some genes 
which are important for normal ovarian follicle development are directly regulated  
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Table 1.3. A selection of genes involved in ovarian function regulated by PUFA-
sensitive transcription factors; peroxisome proliferator activated receptors (PPARs), 
sterol regulatory element binding protein (SREBPs) and nuclear factor kappa-B 
(1)ț%). 
Type of molecule/ Gene Transcription Factor  Reference 
Pathway 
 
Family 
 Inflammatory/ IL-1, 2, 6, 8, 12 1)ț%33$5 McKay and Cidlowski 
1999 
Immune TNF-Į 1)ț%33$5 Minge et al. 2006 
 
IFN-Ȗ-ȕ 1)ț% McKay and Cidlowski 1999 
 
PTGS2 PPAR Froment et al. 2006 
 
iNOS 1)ț% Wahle et al 2003 
    Lipid metabolism FAS  SREBP Xu et al 1999 
 
SCD SREBP Ntambi et al 2002 
 
Acyl CoA synthetase PPAR Schoonjans et al 1995 
 
Acyl CoA carboxylase SREBP Xu et al 1999 
 
FATP PPAR Frohnert et al 1999 
 
LDLR SREBP Sato 2009 
 
SREBP PPAR Xu et al 1999 
 
Elongases SREBP Moon et al 2001 
 
HMG CoA synthase SREBP Worgall et al 1998 
 
Leptin SREBP Gurr et al 2002 
    
Steroidogenesis CYP17A1 PPAR, SREBP 
Froment et al 2006, 
Ozbay et al 2006 
 
CYP19 PPAR Froment et al 2006 
 
HSD3B1 PPAR Froment et al 2006 
    Others Plasminogen activator PPAR Froment et al 2006 
 
VEGF PPAR Yamakawa et al 2000 
 
MMP3 PPAR Froment et al 2006 
 
MMP9 PPAR Yee et al 1997 
 
 
by PPAR transcriptional activation (see Table 1.3). Consequently, restricting the 
ligands available to these nuclear receptors could potentially alter the expression of 
these genes.  33$5ȖLVNQRZQWR LQKLELW WKHH[SUHVVLRQRIDURPDWDVHE\GLVUXSWLQJ
WKHLQWHUDFWLRQRIWKHWUDQVFULSWLRQIDFWRU1)ț%ZLWKWKHDURPDWDVHSURPRWHU (Fan et 
al., 2005).  In one ovine in vitro VWXG\33$5ȖZDVUHSRUWHG WRVLJQLILFDQWO\ LQKLELW
granulosa cell proliferation and to stimulate follicular differentiation (Froment et al., 
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Figure 1.8 General overview of the transcriptional activation of PPAR. FA and their 
metabolites (e.g. eicosanoids) act as ligands for the PPARs. Once bound to a ligand, 
PPARs translocate to the nucleus where they form a heterodimer with RXR. This 
active complex binds to the DNA PPRE promoter region to activate gene 
transcription. MPL = membrane phospholipids; FA = fatty acids; ALOX = 
lipoxygenase; PTGS = prostaglandin synthase; RXR = retinoid X receptor; PPRE = 
peroxisome proliferator response element. 
 
 
2003). ,Q PLFH 33$5Ȗ DQG PPARĮ KDYH EHHQ IRXQG WR EH H[SUHVVHG LQ RYDULDQ
macrophages at levels dramatically higher than macrophages present in non-
reproductive tissues. Treatment with troglitazone D SRWHQW DFWLYDWRU RI 33$5Ȗ
reduces the activation of nitric oxide synthase-2 (NOS2) (an important 
proinflammatory enzyme that regulates ovulation) in macrophages present only in 
the preovulatory follicle, indicating that PPARs are hormonally regulated. In 
DGGLWLRQD WUDQVLHQWVXSSUHVVLRQRI33$5ȖH[SUHVVLRQRFFXUVwhich coincides with 
the structural reorganization of ovulation, requiring the production of inflammatory 
cytokines (Minge et al., 2006). 
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1.6.2 Sterol regulatory-element binding proteins (SREBP) 
 
SREBPs are a group of transcription factors which bind to the sterol regulatory 
element (SRE) DNA binding domain. Three isoforms have been identified; 
SREBP1a and 1c, which are encoded by the same gene but differ at the N-terminus, 
and SREBP2 (Sampath and Ntambi, 2004). SREBPs are endoplasmic reticulum 
membrane-bound transcription factors which, when activated, undergo proteolytic 
cleavage. This allows them to move into the nucleus where they bind to SREs, 
activating transcription of genes involved in cholesterol, triglyceride and fatty acid 
synthesis (Brown and Goldstein, 1997) (Table 1.3) (Figure 1.9). It has been shown 
that a diet supplemented with PUFAs showed decreased levels of SREBP within the 
nucleus of up to 85% and lower levels of SRE-regulated genes (Xu et al., 1999). This 
mechanism still remains unclear but PUFAs seems to regulate SREBP expression by 
interfering with the post-transcriptional regulation of the gene and by blocking 
proteolytic modifications of the membrane bound protein (Hannah et al., 2001; Xu et 
al., 2001). Experiments have also shown that SREBPs activate transcription of low 
density lipoprotein (LDL) receptor (LDLR), high density lipoprotein (HDL) 
scavenger receptor (SCARB1) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG 
CoA) synthase genes (Hua et al., 1993; Yokoyama et al., 1993; Lopez and McLean, 
1999), all of which are important in cholesterol metabolism and steroidogenesis in 
the ovary. Also, it seems that gonadotropic hormones enhance SREBP-dependent 
transcriptional activity of STAR, SCARB1, and LDLR promoters (Sekar and Veldhuis, 
2001; Shea-Eaton et al., 2001). 
 
1.6.3 Nuclear factor- NDSSD%1)ț% 
 
1)ț%LVPDGHIURPWZRVXEXQLWVSDQGSZKLFKELQGWRDQLQKLELWRU\VXEXQLW
(I-ț%WRIRUPDQLQDFWLYHKHWHURGLPHULQWKHF\WRSODVPRIFHOOV7KHGHJUHGDWLRQRI
I-ț%UHTXLUHVSKRVSKRU\ODWLRQDOORZLQJ1)ț%WRVHSDrate from I-ț%WUDQVORFDWHWR 
WKHQXFOHXVDQGUHJXODWHWKHH[SUHVVLRQRIDYDULHW\RIJHQHV)LJXUH1)ț%LVD 
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Figure 1.9 General overview of the transcriptional activation of SREBP and FA 
inhibition. SREBPs require activation by a cleavage step catalysed by SCAP. Once 
cleaved SREBP can translocate to the nucleus and bind to the DNA SRE promoter 
region to active gene transcription. FAs can inhibit the SCAP activation step. SREBP 
= sterol regulatory element binding protein; MPL = membrane phospholipids; FA = 
fatty acids; ER = endoplasmic reticulum; SRE = sterol regulatory element; SCAP = 
SREBP-cleavage activating protein. 
 
 
major component of the stress cascade and is important in the regulation of 
inflammatory cytokines/chemokines, cyclooxygenases, nitric oxide synthases, 
growth factors and adhesion molecules (McKay and Cidlowski, 1999, Wahle et al., 
 7DEOH 38)$V KDYH EHHQ VKRZQ WR UHJXODWH 1)ț% WUDQVORFDWLRQ ERWK
negatively and positively. Camandola et al (1996) have shown that AA (20:4,n-6) 
LQGXFHV1)ț%WUDQVORFDWLRQSRVVLEO\E\LQGLUHFWDFWLRQWKURXJK$$PHWDEROLWHVVXFK
as PGE2 which increases the availability of the p65 subunit. However, this effect was 
not observed with EPA (20:5n-3). Several groups have shown that EPA prevents 
1)ț% activation by decreasing phophorylation of I-ț% LQ FXOWXUHGFHOOV /R et al., 
1999; Zhao et al., 2004). This is supported by a study showing that transgenic mice 
that endogenously biosynthesise n-3 PUFA from n-6 PUFA are protected from colitis 
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through a deFUHDVH LQ 1)ț% DFWLYLW\ +XGHUW et al.,  1)ț% LV H[SUHVVHG E\
many cell types and is known to be endogenously expressed by granulosa cells (Fan 
et al., 2005) as well as the many immune cells that are present in the ovary 
(Brännström and Norman, 1993; %XNRYVN\  1)ț% SOD\V D NH\ UROH LQ
ovulation as it regulates the expression of many inflammatory genes required for this 
SURFHVV +RZHYHU WKH UROH RI 1)ț% LQ RYDULDQ IXQFWLRQ LV FRPSOLFDWHG E\
interactions with steroid hormones and their receptors. It has been established that 
WKHSURJHVWHURQHDQGRHVWURJHQUHFHSWRUFDQDOWHUWKHDFWLYLW\RI1)ț%ZKLFKFRXOG
provide an explanation for the inflammatory modulatory role of steroids. For 
example, the increase in immunoresponsiveness prior to ovulation is linked with the 
increase in oestradiol, while after ovulation this responsiveness decreases along with 
rising progesterone levels (van der Burg and van der Saag, 1996). It seems that not 
RQO\GRSURJHVWLQVVXSSUHVV1)ț%DFWLYLW\EXW1)ț%FDQUHSUHVVthe activity of the 
progesterone receptor, therefore a balance is required for regulating successful 
RYXODWLRQYDQGHU%HUJDQGYDQGHU6DDJ$VSUHYLRXVO\PHQWLRQHG33$5Ȗ
FDQLQKLELWDURPDWDVHV\QWKHVLVLQGLUHFWO\E\VXSSUHVVLRQRI1)ț%SRVVLEO\ through 
WKH SK\VLFDO LQWHUDFWLRQ RI 33$5Ȗ ZLWK WKH S VXEXQLW RI 1)ț% 7KLV VDPH
mechanism, it seems, has an important role in the inhibition of inflammatory 
F\WRNLQHV OHDGLQJ XS WR RYXODWLRQ 2QFH OHYHOV RI 33$5Ȗ EHJLQ WR GURS LQ WKH
periovulatory perioG 1)ț% H[SUHVVLRQ LQFUHDVHV DORQJ ZLWK WKH UHJXODWLRQ RI
inflammatory mediators required for successful ovulation (Fan et al., 2005). 
 
In the ovary PPARs, SREBPs DQG 1)ț% SOD\ important roles in the regulation of 
gene expression. Through various mechanisms and pathways these transcription 
factors are vital in all aspects of ovarian function, from the production of cytokines, 
and tissue remodelling factors to enzymes involved in steroidogenesis and eicosanoid 
production. The n-3:n-6 ratio content in cells strongly influences numerous cellular 
processes by affecting gene expression through many pathways. PUFA interaction 
can lead to a change in cellular function depending on the transcription factor, gene 
and the type of PUFA in question. Due to the important role PUFAs have in the 
DFWLYDWLRQ RU VXSSUHVVLRQ RI WKHVH JHQHV WKH\ KDYH EHHQ WHUPHG DV EHLQJ ³PDVWHU
VZLWFKHV´LQWKHUHJXODWLRQRIWKHVHIDFWRUV(Deckelbaum et al., 2006).   
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Figure 1.10 *HQHUDORYHUYLHZRIWKHWUDQVFULSWLRQDODFWLYDWLRQRI1)ț%DQG38)$
LQWHUDFWLRQ 7R DFWLYDWH 1)ț% ,ț% QHHGV WR EH SKRVSKRU\ODWHG 7KLV DOORZV WKH
DFWLYH1)ț%WRWUDQVORFDWHWRWKHQXFOHXVZKLFKWKHQDFWLYDWHVJHQHWUDQVFULSWLRQQ-6 
PUFA and metabolites can increase availability of p65 subunit whereas n-3 PUFA 
FDQ LQKLELW DFWLYDWLRQ E\ LQKLELWLQJ WKH SKRVSKRU\ODWLRQ RI ,ț%  SS   1)ț%
VXEXQLWV,ț% 1)ț%LQKLELWRU\VXEXQLW3 SKRVSKRU\ODWLRQ 
 
 
1.7 Development of working hypotheses 
 
There have been a number of studies which have investigated the effects of FA on 
reproductive parameters in ruminants. However, few have identified mechanistic 
explanations for any changes observed in these studies.  FAs are able to act directly 
on the follicle and those effects can be altered depending on the type of FAs 
available to the tissue. Few studies have looked at FA composition of ovarian cells 
and oocytes and to date results have been inconsistent. Omega-3 and -6 PUFAs are 
important biologically active FA involved in a range of reproductive processes. 
Altering the ratio of available PUFA can affect these processes and this thesis 
attempts to further investigate the mechanistic role of these FA in greater detail at 
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two different reproductive time points; steroidogenic cells of the pre-ovulatory 
ovarian follicle and the pre-implantation embryo. 
 
An in vivo experiment was designed which consisted of ewes fed one of two 
experimental diets; high n-3 or high n-6 PUFA. The experimental diets included 
bioactive fish oils as part of the n-3 PUFA source. Fish oils are rich in long chain 
PUFA such as EPA and DHA and were included to maximise any differential effects 
between dietary treatments and to assess the ability of the ovarian cell types to 
uptake these long chain pre-formed PUFA. Previous work in our laboratory 
highlighted an important observation from this study; ewes offered the n-3 enriched 
diet had increased levels of progesterone in the follicular fluid (Wonnacott et al., 
2010). This study failed to detect any alteration in steroid output in aspirated 
granulosa cells cultured with HDL from the sera of ewes fed n-3 or n-6 enriched 
diets. This study also sought to asses the mechanisms of FA uptake in the pre-
implantation embryo by culturing fractionated n-3 or n-6 HDL with IVM and IVF 
zygotes. Despite alterations in some transcripts between treatments there was no net 
uptake of FA. 
 
Very few studies have investigated the effect of PUFA on gene expression in the 
ovary.  Those that have, focussed on genes involved with eicosanoid production and 
steroid hormone synthesis. In order to identify other genes which may be 
differentially altered by n-3 vs n-6 PUFA, Chapter 2 focuses on an ovine gonad-
targeted cDNA macroarray. RNA from the granulosa cells of ewes fed either the n-3 
or n-6 experimental diet would be used in an attempt to identify changes in gene 
expression between the experimental diets. Chapter 3 sought to assess the effects of 
culturing primary granulosa and theca cells with LDL and HDL fractionated from the 
sera of ewes fed n-3 or n-6 enriched diets from chapter 2. LDL and HDL are the two 
most abundant lipoproteins in plasma and follicular fluid and were incorporated into 
culture media at physiological concentrations. The current thesis extended previous 
work by (i) including LDL as a potential source of PUFA delivery and also by 
investigating  effects in (ii) theca cells and (iii) a different sub-population of 
granulosa cells (mural as opposed to aspirated antral cells). These particular 
experiments were designed to test the hypothesis that PUFA, delivered by 
lipoproteins, are able to differentially alter steroid hormone synthesis in theca cells. 
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These experiments allowed a more detailed investigation into the uptake and 
metabolism of PUFA together with other FA and cholesterol, and the subsequent 
effects on gene expression, FA composition and steroid hormone production. 
Chapter 4 extended this investigation further by assessing the effects of culturing 
sheep zygotes in the presence of LDL and albumin fractionated from the sera of ewes 
fed n-3 or n-6 enriched diets from Chapter 2. This experiment tested the hypothesis 
that albumin is the main FA transporter delivering PUFA to developing pre-
implantation embryos. These experiments facilitated a detailed investigation into the 
consequences for the pre-elongation embryo in terms of developmental potential, FA 
uptake and the expression of genes involved in FA uptake and metabolism. 
 
In summary, this thesis aims to address the effect of dietary n-3 and n-6 PUFA on the 
ruminant ovary, particularly granulosa cells and theca cells, together with the pre-
implantation embryo. The main objective of this project is to build upon previous 
work in our laboratory and to further investigate the role of n-3 and n-6 PUFA on 
reproductive parameters in the ovine ovary. Studying how these PUFAs are taken up 
into these reproductive tissues, how they differentially alter gene expression and lipid 
metabolism, as well as activating down-stream signalling pathways, will allow us to 
explore and dissect the possible mechanisms of their action. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 35 
CHAPTER 2 
 
Validation of a cDNA macroarray for use in the detection of dietary PUFA 
induced alterations to gene expression. 
 
 
2.1 Introduction 
 
Omega-3 and -6 PUFAs are vital for a multitude of cellular mechanisms, all of which 
are involved in maintaining ovarian function. The PUFA regulation of gene 
expression has been widely reviewed (Jump et al., 1996; Wahle et al., 2003; 
Sampath and Ntambi, 2005; Schmitz and Ecker, 2008). PUFA-mediated gene 
expression can occur by two different mechanisms; firstly by the direct activation or 
inhibition of PUFA-VHQVLWLYHWUDQVFULSWLRQIDFWRUVHJ33$5V65(%3VDQG1)ț%
or by the indirect action of altering the availability of specific metabolites (e.g. 
eicosanoids) which in turn regulate the expression of genes by a series of complex 
signalling pathways. In terms of the ovary, these mechanisms could all potentially 
play a role in maintaining correct follicle development, oocyte maturation, 
steroidogenesis and embryo development The situation is complicated by the 
sometimes contrasting effects of n-3 vs n-6 PUFA and again by the levels of PUFA 
and ratio of n-3:n-6 which is available to the animal and tissues in vivo. 
 
The aim of this chapter was to investigate the effect of dietary n-3 vs n-6 PUFAs on 
gene expression in the ovine ovary, specifically granulosa cells. Firstly, an in vivo 
feeding study was conducted, with two dietary regimes created to offer an n-3 or n-6 
enriched diet to non-lactating ewes. Ovaries and cells were harvested for use in gene 
expression analysis. As PUFAs are involved in many cellular functions, the list of 
molecular targets which potentially could be investigated was extensive. 
Consequently, an ovine gonad-specific cDNA macro-array was used to utilise 
minimal sample quantities for maximal expression analysis. The array used for this 
study was received from Dr Olivier Sandra, INRA, Paris, France, and allowed a more 
focussed and targeted approach to the experiment than might be afforded by 
commercially available micro-arrays. The macroarray in question contained 88 target 
genes, 4 housekeeping or positive control genes and 2 vector-only or negative 
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controls. The target genes in the array covered a wide range of functions including 
steroidogenic enzymes, cytokines and inflammatory enzymes, tissue remodelling 
proteins, signalling molecules, DNA repair and growth factors. The majority of these 
genes are involved in follicle development, oocyte maturation and ovulation. For 
example; steroidogenic genes such as aromatase (CYP19A1), steroidogenic acute 
regulatory protein (STAR), 3-beta-hydroxysteroid dehydrogenase (HSD3B1), 
oestrogen receptors (ESR1 and  ESR2) and the progesterone receptor (PGR) are vital 
components of follicular function and altered expression in the genes can ultimately 
lead to reproductive dysfunction (Britt et al., 2001; Manna and Stocco, 2005; Szoke 
et al., 2009; Drummond and Fuller, 2010). Cytokines and inflammatory mediators 
(such as the interleukins (IL), interferons (IFN) and tumour necrosis factors (TNF)) 
are a vital part of reproductive function and have pivotal roles in ovulation and CL 
regression (Vinatier et al., 1995; Bukulmez and Arici, 2000). Tissue remodelling 
proteins such as the matrix metalloproteinases (MMP) and the tissue inhibitors of 
metalloproteinases (TIMP) carefully regulate the breakdown of the extracellular 
matrix in ovulatory follicles to ensure successful ovulation (Goldman and Shalev, 
2004). Signalling molecules such as the gap junction (GJ) proteins are vital for 
maintaining correct cross-talk between the cell types for successful follicle and 
oocyte development (Gershon et al., 2008).   
 
During the analysis of data from the in vivo feeding experiment described above, it 
became apparent that data generated from the array did not correlate with qRT-PCR 
data generated against specific genes also found on the array. Consequently an 
investigative experiment was designed to dissect out the nature of this inconsistency. 
This was achieved through the design of an in vitro study culturing ovine granulosa 
cells in conditions known to alter gene expression. This would allow for the 
production of large volumes of treated samples under defined culture conditions, 
which would allow a thorough investigation of all aspects of the methodology and 
allow us to ascertain where the problem lay. 
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2.2  Ovine in vivo study± Experiment 1 
 
2.2.1  Materials and methods 
 
2.2.1.1 Animals and experimental diets 
 
Thirty six mature Blackface ewes were randomly assigned to one of two dietary 
treatment groups, 18 animals per group. The diets contained oils rich in either n-3 or 
n-6 PUFA. Dietary formulations are presented in Table 2.1. Live weight was 
recorded every two weeks throughout the experimental period and on the day of 
slaughter. Ewes were introduced to diets over a period of 12 days with the amount of 
diet increasing every 2 days until all animals received 1 kg/day ( 2 x 500g per day). 
Hay was offered at 100g/day with the second daily feed to provide a source of 
roughage overnight. Ewes were offered 200g of one of the diets in the first week, 
increasing to 400g and 800g in the second week, and reaching the final amount of 
1kg in the third week. This amount of feed was maintained for a further 4 weeks. 
Blood samples were taken weekly throughout the study and on the day of slaughter. 
Weight and body condition score was measured fortnightly throughout the study. 
 
2.2.1.2 Oestrous synchronization 
 
Oestrous was synchronized with an intravaginal sponge impregnated with the 
synthetic progesterone analogue, Chronogest CR (30 mg fluorogestone acetate) 
(Intervet, Buckinghamshire, UK) inserted for 12 days with the sponges renewed on 
day 7. Ewes were given an intramuscular injection of the synthetic prostaglandin 
Estrumate®, 1ml per ewe at a concentration of 250µg/ml (Schering-Plough Animal 
Health Ltd, Middlesex, UK) at sponge insertion to induce luteolysis of any persistent 
corpora lutea. All ewes were treated with 8 equal doses of FSH (Ovagen, ICP Bio 
Ltd, Aukland, New Zealand), one every 12 hours, over 4 days starting on day 10 
after the initial sponge insertion, to stimulate superovulation. Animals were 
slaughtered by captive bolt and exsanguination on average 26 hours after removal of 
second sponge and 17 hours after the last FSH injection. 
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Table 2.1. Ingredients and chemical analysis of experimental n-3 and n-6 diets. 
  n-3 n-6 
Ingredient (g/kg) 
  Nutritionally improved straw 250 250 
Oat feed 190 190 
Barley 225 225 
Molassed Beet Pulp 100 100 
Hipro Soya 150 150 
Linseed Oil 10 - 
Sunflower Oil - 45 
Fish Oil 35 - 
Molasses 20 20 
0LQHUDOVDQG9LWDPLQV 20 20 
&KHPLFDODQDO\VLV 
  Dry matter, g/kg 889 896 
Crude protein, g/kg DM 134 129 
NDF, g/kg DM 371 383 
Acid hydrolysed, g/kg DM 64.1 57.3 
Starch, g/kg DM 172 161 
ME, MJ/kg DM 10.7 10.2 
NCGD %DM 65.2 62.7 
 
Minerals and vitamins: Calcium 170g/kg, Phosphorous 60g/kg, Sodium 70g/kg, Magnesium 
100g/kg, Cobalt 150mg/kg, Manganese 6g/kg, vitamin A 500,000 IU/kg, Vitamin D3 
100,000 IU/kg, Vitamin E 1,200 IU/Kg.  DM, dry matter; NDF, neutral detergent fibre; 
ME, metabolisable energy; NCGD, Neutral Cellulase Gammanase Digestibility. 
 
 
2.2.1.3 Tissue collection and storage 
 
Tissues were recovered on day 14 after the initial chronogest treatment before 
ovulation took place to ensure maximal tissue recovery. Each ovary was examined 
and information such as number and size of follicles recorded. Ovaries were 
collected and follicular fluid along with granulosa cells and oocytes were aspirated 
from medium to large follicles and separated in the lab. Oocytes were denuded of 
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cumulus cells, washed in PBS containing 0.1% PVA and then snap frozen in liquid 
nitrogen in a minimal volume (typically <2µl). Follicular fluid was snap frozen and 
stored at -80oC. Granulosa cells were washed 3 times in PBS/0.1% PVA. Red blood 
cells were removed via lysis and snap frozen in minimal volume. Some ovarian 
tissues containing follicles of various sizes were fixed in Bouins solution for 6 hours 
and transferred to 70% ethanol for storage at room temperature. A sample of liver 
was taken as control tissue which was snap frozen in liquid nitrogen and stored at -
80oC. Blood samples were collected into heparinised vacuum tubes. Blood was then 
centrifuged at 575g for 15 minutes and plasma stored at -20°C. For serum samples, 
blood was left to stand at room temperature in plain vacuum tubes for a minimum of 
3 hours. Samples were then centrifuged at 575g for 15 minutes. Serum was 
transferred into 30ml universals and stored at -20°C. 
 
2.2.1.4 RNA extraction  
 
From the initial 36 animals  granulosa cells from 15 were used in a parallel study to 
measure the fatty acid composition by gas chromatography (Wonnacott et al., 2010), 
leaving 21 samples for RNA extraction. RNA was extracted from harvested 
granulosa cells using the RNeasy Mini Kit (Qiagen Ltd., West Sussex, UK). In brief, 
samples were lysed in 350µl lysis buffer (RLT, supplied with kit) containing ȕ-
PHUFDSWRHWKDQROOȕ0(SHUPO5/7EXIIHU7KHO\VDWHZDVSDVVHGWKURXJKD
19 gauge needle several times then added directly into a QIAshredder spin column 
(Qiagen Ltd., West Sussex, UK) for compete disruption of material. The lysate was 
then passed through an RNeasy spin column, where total RNA binds to column. 
After several wash steps with RW1 and RPE wash buffers, RNA was eluted from the 
column in 30µl RNase-free water. Eluted samples were treated with RQ1 RNase-free 
DNase (Promega, Southampton, UK). The mix was incubated at 37°C for 30 
minutes, then 1µl of DNase stop solution was added to terminate the reaction. The 
mix was incubated at 65°C for 10 minutes to inactivate the enzyme. Samples were 
quantified by Nanodrop spectrophotometer (ND1000, Nanodrop, Wilmington, USA) 
and RNA was stored at -80°C. 
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Figure 2.1. An example of an Agilent bioanalyser electrophoresis trace showing 
RNA quality (RIN). 
 
 
2.2.1.5 RNA quality testing 
 
For the purpose of macroarray analysis, RNA was required to be of a certain quality 
and concentration. Those samples which were deemed to have a high enough 
concentration (>100ng/µl) were analysed for quality and degradation using the 
Agilent 2100 Bioanalyser system (Agilent Technologies UK Ltd, Cheshire, UK). The 
quality of RNA is determined through the RNA Integrity Number (RIN), which is a 
measure of any degradation products present in the electrophoresis trace of the 
sample (Figure 2.1). For macroarray analysis a RIN of around 7 and above is   
required (O Sandra, INRA, Paris, personal communication). Of the 21 samples 
available, only 13 were suitable for array analysis due to limited RNA concentration 
and quality (n-3, n=8; n-6, n=5).  
 
2.2.1.6 Sample preparation ± cDNA synthesis and amplification 
 
Extracted RNA was reverse transcribed into cDNA using the SMART PCR cDNA 
synthesis kit (Clontech Europe, Saint Germain-en-Laye, France) following 
manufacturers guidelines. 300ng total RNA in a maximum volume of 3µl was 
reverse transcribed to single stranded cDNA. RNA (made up to 3µl with deionised 
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PCR-JUDGH ZDWHU O ¶ 60$57 &'6 3ULPHU ,,$ 0 O 60$57 ,,$
oligonucleotide (12µM) were mixed and incubated at 70°C for 2 minutes. After 
denaturation, a reaction mix containing 2µl 5X first strand buffer, 1µl DTT (20mM), 
1µl dNTP mix (10mM each) and 1µl of superscript II reverse transcriptase (200U/µl) 
(Invitrogen Ltd., Paisley, UK), was added to the cDNA samples and incubated at 
42°C for 1 hour. 40µl Tris EDTA buffer was added to each of the samples and 
incubated at 72°C for 7 minutes to terminate the reaction. The RT reaction adds a 
VKRUWFKDLQRIGHR[\F\WLGLQHVWRWKH¶HQG of the DNA sequence allowing an oligo 
containing an extended deoxyguanine sequence to bind to that end extending the 
template to include a new primer sequence. Amplification of the cDNA was carried 
out using the Advantage 2 PCR kit (Clontech Europe, Saint Germain-en-Laye, 
France) following the manufacturers guidelines. 4µl of cDNA mix was used for the 
PCR amplification step. The PCR reaction mix contained 10µl 10X Advantage 2 
3&5EXIIHUO;G173P0HDFKO¶3&53ULPHU,,$0O;
Advantage 2 Polymerase mix. This mix was added to 4ul cDNA and made up to 
100µl with deionised PCR-grade water. The samples were then PCR amplified for 17 
cycles (see section 2.2.1.7 for optimization explanation) each consisting of 15 
seconds denaturation at 95°C, 30 seconds amplification at 65°C and 6 minutes 
elongation at 68°C. After PCR amplification was completed, 2µl of EDTA was 
added to terminate the reaction. The RT reaction CDS primer along with the SMART 
,,$ ROLJR FUHDWHV D SULPLQJ VLWH DW ERWK WKH ¶ DQG ¶ HQGV RI WKH PROHFXOH 7KLV
primer sequence is targeted during the PCR stage allowing end to end cDNA 
amplification. PCR products were purified using Qiaquick spin column (Qiagen Ltd., 
West Sussex, UK). The PCR product was mixed with 500µl PB buffer, added to the 
Qiaquick spin column and centrifuged. Column was washed with 750µl PE buffer 
and the DNA sample was eluted in 30µl EB buffer. 
 
2.2.1.7 Optimization of cDNA amplification 
 
The key optimization step for the amplification of cDNA for array work is to amplify 
the cDNA to a point where the PCR reaction is still in the log phase. If the sample is 
left to amplify to the plateau stage then the amounts of various cDNAs in the reaction 
could become disproportionate, thereby potentially nullifying any expression 
differences. During this study, Clontech withdrew the enzyme optimised for the 
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SMART PCR cDNA synthesis kit. Consequently, an alternative enzyme was sourced 
from Invitrogen which required further optimisation work to determine compatibility 
with the Clontech kit. Three cDNA synthesis reactions were set up; A) Invitrogen 
enzyme with Clontech kit buffer, B) Invitrogen enzyme with Invitrogen buffer, and 
C) Clontech Kit-supplied enzyme with kit buffer (a small amount of this remained 
from when the original enzyme was commercially available. A PCR reaction of 
100µl was set up for each reaction. Starting at 15 cycles, 15µl was removed every 3 
cycles until 30 cycles. Samples were run out on a gel, (Figure 2.2). The combination 
of reagents seen in figure 2.2 (run A) seems to have the best overall PCR efficiency, 
due to more observable PCR product. From the PCR products on the gel an optimal 
cycle number of 17 calculated. This was measured by taking the number of cycles 
taken to not quite reach the plateau stage and subtracting 1 away. Considering that 
the cycle number 18 shows a high amount of amplification, but not quite as high as 
21, it was decided to use 17 as the optimal cycle number. 
 
 
 
 
 
Figure 2.2 Agarose gel electrophoresis with optimization of PCR products. Samples 
from 15, 18, 21, 24 and 30 PCR cycles. A, B and C refer to different optimization 
conditions (refer to text). 
 
 
 
 
A B C 
15   18    21    24    27    30 15   18   21    24   27   30 15  18   21    24     27    30 
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2.2.1.8 Array manufacture 
 
Ovine cDNA arrays were received from INRA (kindly supplied by Dr Olivier 
Sandra, French National Institute for Agricultural Research, Jouy-en-Josas, Paris, 
France). 140 genes were selected from the literature for their involvement in gonad 
development and function and pregnancy in mammals. RNA from tissues of interest 
(ovary and uterus) was extracted and reverse transcribed. PCR amplification of each 
gene was carried out and a product of expected size was obtained for 83% of genes 
(116/140). Each of these products was sequenced and compared with existing 
sequence databases and 80% (94/116) of these were found to be homologous with 
sheep gene sequences. Each PCR product was inserted into a pCR®2.1-TOPO vector 
(Invitrogen Ltd., Paisley, UK) using TOPO cloning (Invitrogen Ltd., Paisley, UK) 
and after purification were deposited on nylon membranes in a 96-well format (94 
genes and 2 vector-only controls) by robot, with 4 spots for each gene at its location 
(Figure 2.3). 
 
2.2.1.9 Array labelling 
 
Membranes were firstly prehybridized in ExpressHyb hybridization buffer (Clontech 
Europe, Saint Germain-en-Laye, France) with added denatured single stranded 
salmon sperm DNA (Sigma-Aldrich Company Ltd, Dorset, UK) for blocking for 3 
hours at 68oC. A total of 500 ng of purified amplified double stranded cDNA for 
each sample was needed. cDNA was incubated with 2.42µl random primer 9 (New 
England Biolabs, Ipswich, UK) for 8 minutes at 100oC, cooled on ice and incubated 
at 50o& IRU  PLQXWHV ZLWK Į-33P dATP (GE Healthcare Life Sciences, 
Buckinghamshire, UK), 4µl Klenow enzyme (New England Biolabs, Ipswich, UK) 
and unlabelled dGTP, dCTP and dTTP (10µM each) (MP Biomedicals, Cambridge, 
UK). The reaction was stopped by placing on ice and adding 2µl 0.5M EDTA. At 
this stage 1µl of reaction mix is added to 2ml scintillant for counting later to 
determine percentage incorporation. Samples were purified using Nucleospin 
Extraction Kit (Machary Nagel, Düren, Germany) following manufacturers 
guidelines. One µl of eluted sample was placed in 2ml scintillation fluid for testing. 
From these values a percentage incorporation value was determined. This was 
needed to check for poor incorporated samples, which were then repeated. The total 
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reaction volume was added to the pre-hybridized membranes and incubated at 68oC 
for 18-20 hours. The membranes were washed twice for 30 minutes at 68oC in 1 x 
SSC, 0.5% SDS, then washed once for 30 minutes at 68oC in 0.1 x SSC, 0.5% SDS. 
After washing, membranes were kept damp by placing on 3mm chromatography 
paper, soaked in 0.1 x SSC, 0.5% SDS, wrapped in cling film. Membranes were 
exposed to a phosphor-imaging screen for 72 hours at room temperature and imaged 
using a Typhoon Trio+ scanner (GE Healthcare, Buckinghamshire, UK). 
 
2.2.1.10  Reprobing 
 
Due to pipetting errors and inaccuracies created by differences in sequence lengths 
(150-500bp) and therefore concentration differences, each gene spot on the array will 
contain variations in the total amount of cDNA spotted in each region. Due to these 
variations, the array must be reprobed with a vector-specific probe to quantify these 
differences. The data from the first experiment can then be normalized against the 
reprobed data to give a better representation of actual gene expression levels in each 
sample. The vector-specific oligo that was used to reprobe the array membranes is 
the T7 promoter sequence;  
 
¶7$$7$&*$&7&$&7$7$***¶ 
 
The membranes were thawed and stripped of any residual radioisotope left over from 
the initial hybridization, by washing three times with stripping buffer (0.1X SSC, 
0.2% SDS) for 1 hour each at 68°C. Membranes were then exposed in cassettes for 
24 hours to check for presence of remaining 33P. Membranes were prehybridized in 
ExpressHyb hybridization buffer (Clontech Europe, Saint Germain-en-Laye, France) 
with added denatured single stranded salmon sperm DNA (Sigma) for blocking for 3 
hours at 42°& 7KH SUREH ZDV ODEHOOHG XVLQJ Ȗ33P labelled dATP (Perkin Elmer, 
Massachusetts, USA) and a T4 polynucleotide kinase (New England Biolabs, 
Ipswich, UK) incubated at 37°C for 45 minutes. No other dNTPs are necessary as the 
reaction is an end-labelling reaction only. The reaction was stopped by placing on ice 
and purified using Mini Quick Spin Oligo Columns (Roche Diagnostics Ltd, West 
6XVVH[ 8. IROORZLQJ PDQXIDFWXUHU¶V JXLGHOLQHV WR UHPRYH DQ\ XQLQFRUSRUDWHG
label from the mix. The amount of incorporated label was determined by scintillation 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Ovine gonad targeted cDNA macroarray layout. Endogenous/positive control genes highlighted in yellow. Vector-only/negative 
controls highlighted in blue. Other key gene groups include; steroidogenesis (pink); inflammatory and immune regulators (green); TGF-beta 
family members (orange). For detailed gene information refer to Appendix 1. 
 
Vector DAZL HSD3B1 DMRT1 INHA TGFb2 TNF CSF-3 IL12B SOCS1 PTGDS TIMP2 
Vector MEL1A CYP19A1 WT1 INHBa TGFb3 BMPR1A IL1A IL13 SOCS2 PTGFR MMP3 
MSH4 ESR1 STAR SRY INHBb GDF9 BMPR1B IL1B IL16 SOCS3 OSBP2 VIM 
MSH5 ESR2 NR5A1 GATA4 INHBc AMH BMPR2 IL2 IL17 ALOX5AP GJA1 PAPPA 
SPO11 LHR FOXL2 TCF21 BMP4 IGF1 IGF2R IL7 Il18 ALOX12 GJC1 ACTB 
DDX4 PGR SOX2 CAV1 BMP7 IGF2 IGFBP1 IL8 IFNA PTGS1 GJB1 EEF1a1 
c-kit POU5F1 SOX9 PHB BMP15 PGF IGFBP2 IL10 IFNB HSL GJB2 GAPDH 
ZFX PTPRG SOX14 SDHA TGFb1 STC1 CISH IL12A IFNG PTGER3 TIMP1 HPRT1 
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counter. 2µl of sample was placed in 2 ml scintillant and ran in duplicate and the 
counts per minute from the two samples were averaged and adjusted for volume. A 
count of 2x107 was required for each membrane. The appropriate amount of labelled 
probe was denatured for 10 minutes at 100°C, cooled on ice and placed directly into 
the hybridization tubes. The membranes were incubated at 42°C for 24 hours in a 
rotating incubator. Membranes were washed twice with wash buffer (2XSSC, 0.1% 
SDS) at 42°C, rinsed with 2XSSC and exposed for 2 hours in an exposure cassette. 
Membranes were imaged using a Typhoon Trio+ Scanner (GE Healthcare, 
Buckinghamshire, UK).  
 
2.2.1.11 Array image analysis 
 
Phosphor-storage screens were scanned using a Typhoon Trio+ scanner and Typhoon 
Scanner Control V5.0 software. The images were analysed using Image Quant TL 
V2005 software with the Array Analysis option (all GE Healthcare, 
Buckinghamshire, UK) (Figure 2.4). The image analysis software bases the analysis 
on the total pixel intensity on a greyscale range over a given area. Each group of four 
spots representing a gene is assigned an area around it. The software measures the 
pixel intensity reading of the total area. Due to variations in background noise across 
the image, each spot area has a separate background value assigned to it, which is 
subtracted from the total area value. 
 
The value given for any one gene from the original experiment was normalised 
against the reprobed data for the same gene to account for spot-to-spot differences 
within the array. This normalised value was then normalised again to a positive 
control on the array to account for array-to-array differences. The positive control 
gene chosen for this purpose was -actin (ACTB). All housekeeping genes (ACTB, 
EEF1a1, HPRT and GAPDH) were highly correlated with each other (Figure 2.5) 
and none were affected by treatment.  
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Figure 2.4 Example of scanned array images; labelled sample hybridisation (A) and 
reprobed image (B). 
 
 
2.2.1.12 Quantitative real time-PCR 
 
Complementary DNA was quantitatively PCR amplified with gene specific primers 
and fluorescently-tagged hydrolysis probes using the Roche Lightcycler® 480 
amplification system. Probes used were either TaqMan (Eurofins MWG Operon, 
London, UK) or Universal Probe Library (UPL) (Roche Diagnostics Ltd., West 
Sussex, UK). Primer and probe sequences are shown in Table 2.2. UPL probes were 
used initially due to limitations in available reagents at that time. Primers were 
designed through either Primer Express (Applied Biosystems, Foster City, CA) or 
Roche Probe Finder software on the Roche Applied Science website. All Taqman 
SUREHV ZHUH ¶ ODEHOOHG ZLWK ¶-¶-carboxyfluorescin (FAM) (reporWHU DQG ¶
ODEHOOHG ZLWK ¶-¶-carboxy-111¶1¶-tetramthylrhodamine (TAMRA) (quencher). 
$OO 5RFKH SUREHV ZHUH ¶ ODEHOOHG ZLWK )$0 DQG ¶ ODEHOOHG ZLWK DQ XQUHSRUWHG
quencher dye. Sequence homology for each target gene was matched to the ovine 
(Ovis Aries) sequence, but when this sequence was not available, the bovine (Bos 
Taurus) sequence was used. If possible, primers were designed so that they span two 
exons to prevent amplification of any genomic DNA contamination in the sample. 
 
 
 
A) B) 
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Table 2.2 Alphabetical list of primer and probe sequences used for qRT-PCR 
analysis. F, forward primer, R, reverse primer. 
Name Sequence 5'-3' NCBI Accession Primer 
Efficiency 
ACTB 
  
 
F TGTGCGTGACATCAAGGAGAA AF129289 1.92 
R CGCAGTGGCCATCTCCTG Ovis aries  
Probe FAM-CTGCTACGTGGCCCTGGACTTCGA-TAMRA 
 
 
IL18  
  
 
F GAAGCTATTGAGCACAGGCATA NM_001009263.1 1.78 
R TTCCACAAAGCTGATGCAAT Ovis aries  
Probe Roche Universal probe library probe #46 (ATGGCTGC) 
 
 
33$5Ȗ 
  
 
F AGAGATCTCCAGCGACATCGA AY137204 1.94 
R TCAGCGGGAAGGACTTTATGTAC Ovis aries  
Probe FAM-CAGAGTCTGCTGACCTCCGGGCC-TAMRA 
 
 
PTGS2   
F GCACAAATCTGATGTTTGCAT U68486 1.92 
R AGCTGGTCCTCGTTCAATATCTG Ovis aries  
Probe FAM-TGCCCAGCACTTCACCCATCAATTTTT-TAMRA   
STAR    
F GCGACGTTTAAGCTGTGTGCT AF290202 1.87 
R TGCTGCCGCAGCCC Ovis aries  
Probe FAM-AGCTCCTATAGACACGTGCGCAGCATG-TAMRA   
Sequences for ACTB and PPARȖ were obtained from Wynn et al. (2006).  
 
Prior optimization was carried out for each primer and probe set to determine optimal 
primer and probe concentration. Optimised PCR products were run on a 1.5% 
agarose gel to confirm specificity and product size (Figure 2.6). A standard curve 
from combined ovine liver, theca and granulosa cell cDNA was used to ensure 
adequate expression levels, check assay linearity and determine primer efficiency 
values (Figure 2.7). A calibrator sample (sample from the midpoint of standard 
curve) and reagent blanks was run on each plate. The calibrator was used to adjust 
for any plate-to-plate variation in PCR efficiency. Relative expression of each gene 
was normalised against an endogenous control gene, beta actin (ACTB). The PCR 
reaction mix comprised the Roche Lightcycler 480 Probes Master mastermix (Roche 
Diagnostics Ltd., West Sussex, UK). A total reaction volume of 20µl was prepared 
using 10µl Probes Master 2X mix, 0.6µl (10µM) forward and reverse primers, 0.4µl 
(10µM) probe, 1.5µl cDNA and PCR H2O to make up the volume. All samples were 
run in duplicate. The 96 well PCR plate (LightCycler® 480 Multiwell Plate, Roche) 
was sealed using sealing foil (LightCycler® 480 sealing foil, Roche) and centrifuged 
for 2 minutes at 1500 x g in a swing bucket centrifuge. The plate was loaded into a 
Lightcycler® 480 and run using the parameters in Table 2.3. 
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Figure 2.5 Array data expressed relative to ACTB correlated against data relative to 
the other control genes; EEF1a1 (A), GAPDH (B) and HPRT (C). 
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Figure 2.6 Agarose gel electrophoresis to confirm primer specificity and PCR 
product size.  M = DNA marker, wells 1 and 8 PCR negatives, wells 2-7 single band 
of PCR product of PTGS2 at correct size (96bp). 
 
 
 
 
 
 
 
Figure 2.7 Snapshot of an example of a standard curve, in this case PTGS2 with a 
primer efficiency of 1.91 using Roche 480 Lightcycler® software. The flat lines 
extending beyond cycle 40 are negatives containing no signal. 
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Table 2.3. Programme and cycling parameters for qRT-PCR analysis using Roche 
Lightcycler® 480. 
Detection format   Block type   Reaction 
volume 
TaqMan probe 
 
96 
 
20µl 
Programme name   Cycles   Analysis mode 
Pre-incubation 
 
1 
 
None 
Amplification 
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Quantification 
Cooling 
 
1 
 
None 
Temperature 
targets 
        
Target (°C) Acquisition 
mode 
Hold 
(hh:mm:ss) 
Ramp 
rate 
(°C/sec) 
Acquisitions 
(per °C) 
Pre-incubation 
    
95 None 00:10:00 4.4 - 
Amplification 
    
95 None 00:00:10 4.4 - 
60 None 00:00:50 2.2 - 
72 Single 00:00:01 4.4 - 
Cooling 
    
40 None 00:00:10 1.5  - 
 
2.2.1.13 Statistical analysis 
 
Follicular fluid concentrations of steroids were analysed by ANOVA. Oestradiol and 
progesterone data were transformed (log10) prior to analysis to correct for differences 
in means and variance between treatments. Data are presented as geometric means 
with log10 means presented in italics. Standard errors of differences (S.E.D) in this 
case are presented on the log scale. Transcript expression (relative to that of ACTB) 
for each of the genes on the array was analysed by ANOVA using Genstat release 11 
(Genstat 2009). Subsequent qRTPCR analyses again were conducted by ANOVA. 
The term fitted to these models was Diet (n-3 vs. n-6). Data are presented as 
predicted means ± S.E.M. 
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2.2.2  Results 
 
2.2.2.1 Phenotypic and hormonal effects of dietary treatments in stimulated ovaries 
 
Follicle number and size were measured in all 36 experimental animals. There was 
no significant effect on follicle number or follicle size between the two experimental 
groups (Figure 2.8). Concentrations of progesterone detected in follicular fluid were 
greater (P<0.001) for ewes offered the n-3 PUFA diet than the n-6 PUFA diet (Table 
2.4). Oestradiol concentrations were not altered between treatment groups.  
 
2.2.2.2 Gene expression in granulosa cells by ovine cDNA array analysis 
 
Macroarray data was analysed to detect differences in gene expression in granulosa 
cells between the two dietary treatment groups. Two out of the 88 genes present on 
the array (SOCS3 and CISH) were discounted due to problems when the array was 
constructed (O Sandra, personal communication). Two genes were significantly 
altered in granulosa cells from n-3 vs n-6 PUFA fed ewes; IL18 (P=0.03) and STAR 
(P=0.05), (Figure 2.9 (A) and (B)). In both cases transcript expression was greater in 
n-3 group than n-6 fed ewes; with IL18 having a 3 fold increase and STAR a 2.5 fold 
increase in expression. 
n-3 n-6
0
10
20
30
40
50
60
70
Dietary treatment
N
um
be
r 
of
 
fo
lli
cl
es
n-3 n-6
0
1
2
3
4
5
Dietary treatment
Fo
llic
le
 
siz
e 
(m
m
)
A) B)
 
Figure 2.8. The effect of dietary treatment (n-3 vs n-6 PUFA) on follicle number (A) 
and mean follicle diameter (B) following oestrous synchronisation and ovarian 
stimulation with FSH. 
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Table 2.4 Concentrations of steroid hormones in follicular fluid of ewes offered diets 
enriched with n-3 or n-6 PUFA (Wonnacott et al., 2010). 
 
Experimental diet n-3 n-6 S.E.D. P 
Steroid hormone 
    
Oestradiol (E2) (ng/ml) 30.2 23.4 
  
(log10) (1.48) (1.37) (0.186) - 
Progesterone (P4) (ng/ml) 52.5 22.4 
  
(log10) (1.72) (1.35) (0.092) <0.001 
E2:P4 0.56 1.05 
  
(log10) (-0.25) (0.02) (0.156) - 
 
E2, P4 and E2:P4 expressed as geometric means, with means and S.E.D. on a log10 scale.  
 
 
2.2.2.3 Gene expression in granulosa cells by quantitative real time PCR 
 
Quantitative RTPCR analysis failed to detect any significant differences in the 
expression of IL18 and STAR between the two dietary groups (Figure 2.9 (C) and 
(D)). This illustrated that the expression pattern for these genes detected by the array 
and qRTPCR did not correlate. 
 
Due to their known relationship with PUFAs, two other gene candidates PPAR-Ȗ and 
PTGS2 were analysed by qRTPCR (Figure 2.10). Due to limitations in available 
gene sequences when the array was constructed, these genes were not included. 
Despite a trend of increased expression in both genes in the granulosa cells of n-6 
PUFA fed ewes, there was no significant effect of dietary treatment on transcript 
expression. 
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Figure 2.9 The effect of diet (n-3 vs. n-6 PUFA) on STAR and IL18 gene expression 
in ovine granulosa cells of ewes fed high n-3 or high n-6 diet. Gene expression was 
measured by cDNA macroarray (STAR: A, IL18: B) and qRTPCR analysis (STAR: C 
and IL18: D). Data expressed relative to ACTB + S.E.M. Note the lack of correlation 
between the 2 methods. 
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Figure 2.10 qRTPCR expression of PPAR-Ȗ (A) and PTGS2 (B) (relative to ACTB) 
in granulosa cells from ovaries of ewes offered either a high n-3 or n-6 PUFA diet.  
 
2.2.3 Discussion 
 
From the observed changes in progesterone output in follicular fluid of the 
experimental ewes it is clear that a mechanism controlling steroidogenic output has 
been altered by dietary treatments. Unfortunately the current methodology has been 
unable to highlight any potential candidates for further study. This line of study will 
be readdressed in Chapter 3.  
 
It was clear from these observations that the suitability of this particular cDNA 
macroarray for use in this study was in question. The differences observed between 
the array and qRTPCR data highlights a problem somewhere in the methodology. 
The second part of this chapter highlights these potential issues and thoroughly tests 
the array methodologies.  
 
2.3  In vitro validation ± Experiment 2 
 
2.3.1 Introduction 
 
Due to the inconsistencies between the array and qRTPCR data, and since the 
qRTPCR methodology is well established, it was likely that the problem lay with the 
array methodology. Consequently, further investigations focussed on the array 
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methodology including sample preparation. Possible reasons for a lack of correlation 
were hypothesised: (i) the amplification method of sample preparation may not be 
suitable. Many array techniques utilise a PCR-amplification method to increase the 
amount of cDNA for hybridizing. There are arguments as to whether this technique 
gives a true representation of the relative levels of transcripts in the original sample, 
and some commentators have proposed that, due to the differences between 
transcripts (such as length, tertiary structure, GC content etc), this PCR step could 
potentially amplify transcripts disproportionately (Baugh et al., 2001; Degrelle et al., 
2008). (ii) The array is not sensitive enough to detect gene expression differences. 
Most commercial array technologies use a twofold difference in expression as the 
threshold for gene expression scoring (Clarke et al., 2001; Jenson et al., 2003). Since 
the array used for this study is not a commercially available platform, the question 
regarding the sensitivity of fold difference detection level needed to be addressed.  
 
2.3.2 Materials and Methods 
 
2.3.2.1 Experimental design 
 
A cell culture experiment was designed to create a substantial amount of material in 
order to fully test the array methodologies. Granulosa cells obtained from abattoir 
derived ovaries were cultured in vitro for 144 hours in the presence of either 0, 10 or 
20% FCS. Media were harvested at 48, 96 and 144 h, and cells at 144 h for cell 
counts and RNA extraction. The experiment was conducted in a 24-well plate on 
three separate occasions. Serum in culture is known to affect granulosa cell 
differentiation and steroid hormone output (Luck 1990), thus we predicted that genes 
involved in these mechanisms would be differentially altered between treatments. 
This produced enough experimental material to not only thoroughly test the array but 
also the PCR amplification steps used prior to array hybridization. The focus areas 
for testing were as follows; 
 
1. Testing the ability of the PCR amplification method to amplify all transcripts 
in a linear manner. Due to the large volume of cDNA required for 
hybridization to arrays, PCR amplification is required when sample volumes 
are low. This could potentially amplify cDNA disproportionately. Amplified 
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samples were tested against non-amplified samples by qRTPCR (Figure 
2.11). Any indication of disproportional amplification would explain the lack 
of correlation between the array and qRTPCR methods. 
2. Testing the ability of the array to detect differences in gene expression in 
cultured cells without prior pre-amplification by PCR. The culture 
experiment assured enough sample without the need for PCR amplification. 
We were able to hybridise experimental cDNA direct to the array. The 
resulting data was then compared with qRTPCR analysis of the same samples 
(Figure 2.11). 
 
Figure 2.11 outlines the 2 in vitro approaches described above and how this 
compares to the original array method using in vivo generated samples. Of the 88 
genes present on the array a small selection were used for analysis in this study. 
Transcripts for qRTPCR analysis included the steroidogenic genes, CYP19A1, 
HSD3B1, and STAR. Others include, insulin growth factors 1 (IGF1) and 2 (IGF2) 
and tissue inhibitor of metalloproteinases (TIMP1). IGF1 and 2 have been reported to 
be involved in ovarian steroidogenesis by stimulating progesterone synthesis as well 
as enhancing the proliferation of granulosa cells in vitro (Sekar et al., 2000; 
Demeestere et al., 2004). Additional to its role in tissue remodelling at ovulation 
TIMP1 expression has been reported to be stimulated by progesterone production in 
granulosa (Boujrad et al., 1995) and theca cells (Shores and Hunter, 2000). 
 
2.3.2.2 Granulosa cell culture 
 
Ovine ovaries were obtained from an abattoir and washed briefly with 70% industrial 
methylated spirits (IMS) before washing in warm PBS (37oC). Granulosa cells were 
harvested by aspiration with a syringe. Follicular contents were placed into a sterile 
petri dish and oocytes were removed. The remaining follicular fluid and cells were 
spun down and follicular fluid discarded. The cell pellet was resuspended briefly in 
water to lyse any blood cells present, then 10X PBS immediately added to regain 
isotonicity. Cells were then washed in PBS/PVA (0.1%) to help reduce the viscosity 
of the sample. Cells were resuspended in medium and a viable cell count was carried 
out by trypan-blue exclusion. From the cell counts, a cell suspension was created to 
provide a seeding density of 3.5x105 cells per well in 500µl of a 24 well 
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Figure 2.11 Flow diagram representing experimental procedure for the original in 
vivo sheep study (Box A) and subsequent investigative in vitro experiments (Box B).  
Equivalent numbers in red indicate where data comparisons were made. 
 
 
culture plate. Cell culture medium consisted of; 90% v/v TCM199 (Sigma) and 10% 
v/v double distilled water. Medium was supplemented with 1mg/ml fatty acid free 
(FAF) BSA, 100ng/ml L-glutamine, 10ng/ml insulin, 0.5µg/ml transferrin, 0.5ng/ml 
sodium selenite, 50IU/ml penicillin, 50µg/ml streptomycin, 1ng/ml FSH and 
100ng/ml testosterone. Media was supplemented with 0, 10 or 20% FCS. Cells were 
incubated at 38.8qC in a humidified atmosphere of 5% CO2 for 144 h. Eighty percent 
of media was collected at 48 h and replaced with fresh media, all spent media was 
stored at -20°C, further media was collected at 96 and 144 h. Cells were harvested 
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with trypsin EDTA and cell counts performed at 144 h. All cells were snap-frozen in 
liquid nitrogen prior to storage at -80°C. A total of 3 experimental replicates were 
run with 2 wells per treatment per experiment. 
 
2.3.2.3 Progesterone ELISA 
 
Progesterone concentrations in spent media samples were determined by enzyme 
linked immunosorbent assay (ELISA). Progesterone ELISA kit was purchased from 
Ridgeway Science (Ridgeway Research Ltd, Gloucesershire). Media samples were 
diluted in PBS in the range of 1:5 to 1:100 (determined by time point and serum 
concentration of sample). Samples were run in duplicate along with standards (0, 0.5, 
1, 2, 5, 10, and 20ng/µl) and QCs (2 and 4 ng/µl), both supplied with the kit.  All 
ELISA plates, samples and reagents were brought to room temperature. Protective 
foil and buffer were removed from the plate. 10µl of either standard, QC or sample 
were added to the wells and 200µl progesterone-enzyme label was added to each 
well.  The plate was then mixed gently on a plate vortex for 10 minutes and left at 
room temperature for 2 hours and 15 minutes. All wells were washed three times in 
wash buffer (200µl per well for 2 minutes) and the plates tapped dry on tissue paper 
after each wash. 200µl alkaline phosphatase substrate was added to each well 
(substrate was dissolved in 25ml substrate buffer 30 minutes before use and kept in 
the dark until needed). The plate was mixed gently on a plate vortex for 30 seconds 
and incubated at room temperature for 30 minutes. The plate was read using Thermo 
Labsystems Multiscan Ascent plate reader and Ascent Software Version 2.6 
(Thermo-Fisher, Loughborough, UK) at an optical density of 570nm. Concentrations 
of samples were calculated from the standard curve with a minimum detection limit 
of 1ng/ml. Intra and inter-assay CV were 8.2% and 5.4% respectively. 
 
2.3.2.4 Oestradiol radioimmunoassay 
 
Spent media was diluted in assay buffer (0.05M PBS, 0.1% gelatine, 0.1% sodium 
azide). All samples (total counts, standards, non specific binding, total binding) were 
set up in triplicate. Standard concentrations were 1.95, 3.9, 7.8, 15.6, 31.3, 62.5, 125 
and 250pg/100µl. Quality control concentrations were 5, 25 and 50 pg/100µl and run 
at the front and back of the assay and also at every 100 tubes. Oestradiol was 
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iodinated using chloramine T, which is an oxidising agent capable of converting 
iodide to a more reactive form. The reaction is terminated by adding sodium 
metabisulphate. The following was added in sequence: 10µl E2 TME buffer, 30µl 
0.5M PO4 buffer (pH 7.5), 10µl I125 (1mCi), 10µl chloramine T (10µg) in 0.05M PO4 
buffer (pH 7.5). After addition of chloramine T, solution was left for 2 minutes to 
react. 10µl sodium metabisulphate (10µg) in 0.05M PO4 buffer (pH 7.5) and 200µl 
0.05M PO4 buffer (pH 7.5) were then added. The reaction was transferred to a 10cm 
Sephadex G 25 column equilibrated in 0.05M PO4 buffer (pH 7.5). The reaction was 
then rinsed with 200µl 0.05M PO4 buffer (pH 7.5) and applied to the column. 
Column was eluted with 0.05M PO4 buffer (pH 7.5) and 1ml fractions were collected 
into numbered LP3 tubes containing 200µl of 0.5M PO4 buffer (pH 7.5). The 
radioactivity of each fraction was counted and the fractions that showed the highest 
peak were collected and stored at 4ºC. Rabbit anti-oestradiol serum was used as 
primary antibody at 1:40,000 dilution from stock and was added to total binding, 
standards, QCs and sample tubes. Iodinated oestradiol label with a count of 10,000-
12,000 was added to each tube after the addition of primary antibody, mixed on a 
vortex mixer and incubated at room temperature for 4 hours. Bound and unbound 
hormone were separated by the addition of a second antibody, donkey anti-rabbit 
serum at 1:80 dilution combined with normal rabbit serum at 1:400 dilution. This 
was added to the tubes and incubated overnight at 4ºC. After incubation, 250µl of 
1% Tween 20 in assay buffer was added to same tubes as second antibody (i.e. all 
but total counts) as a detergent to reduce non-specific bonding and tubes were 
centrifuged at 3000rpm at 4ºC for 30 minutes. The supernatant was removed. The 
radioactivity of the remaining pellet was counted in an automatic gamma counter. 
The unlabelled antigen in the sample was quantified using the standard curve. The 
minimum detection limit was 4.4pg/100µl. Intra and inter-assay CV were 5.6% and 
6.9% respectively. 
 
2.3.2.5 RNA extractions and cDNA synthesis 
 
RNA was extracted as described in section 2.2.1.4 using RNeasy mini kit (Qiagen, 
West Sussex, UK). The RNA to cDNA reverse transcription reaction was carried out 
XVLQJ 6XSHUVFULSW ,, ,QYLWURJHQ /WG 3DLVOH\ 8. IROORZLQJ PDQXIDFWXUHUV
instructions. For each cDNA reaction 5µl of RNA (concentration > 300ng/µl) was 
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added to 1µl Oligo(dT)12-18 primers (500µg/ml), 1µl dNTP mix (10mM each) and 
nuclease free water made up to a final volume of 12µl. Samples were heated to 65°C 
for 5 minutes and quick chilled on ice. Following centrifugation, 4µl 5X first strand 
buffer and 2µl 0.1M DTT was added to each sample. The contents were mixed and 
KHDWHG WR & IRU  PLQXWHV 2QH O 6XSHUVFULSW ,, UHYHUVH WUDQVFULSWDVH ZDV
added to each sample which were then incubated for a further 50 minutes at 42°C. 
The reaction was inactivated by heating to 70°C and stored at -20°C. 
 
2.3.2.6 Array labelling and reprobing 
 
Sample labelling and array hybridisation was carried out as detailed in section 
2.2.1.9. To ensure adequate coverage of all transcripts 5µg of unamplified cDNA 
was used per membrane. Array reprobing and image analysis was carried out as 
detailed in sections 2.2.1.10 and 2.2.1.11. A total of 3 samples per treatment group 
were used (0, 10 and 20% serum), equalling 12 membranes in total. 
 
2.3.2.7 Quantitative real-time PCR 
 
Quantitative RTPCR was carried out as described in section 2.2.1.12. Details of 
primers and probes can be found in Tables 2.2 and 2.5. Cycling parameters can be 
found in Table 2.3. Transcripts were analysed relative to ACTB. 
 
2.3.2.8 Statistical analysis 
 
Progesterone and oestradiol concentrations in spent media from 24-well plates were 
analysed by repeated measures ANOVA using Genstat release 11 (Genstat 2009). To 
recap, there were three plates and three treatments (0, 10 and 20% serum) within 
plate. Media was pooled from a pair of wells within treatment at three time points 
(48, 96 or 144 h) within plate. This, therefore, led to there being 4 replicates within 
plate. Cell counts and transcript expression (relative to that of ACTB) in cells 
harvested at 144 h for each of the genes on the array was analysed by ANOVA. 
Analysis was based on cells pooled from the same pairs of wells within treatment 
(giving 4 replicates within plate).  Data are presented as means ± S.E.M. 
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Table 2.5 Alphabetical list of primer and probe sequences used for qRTPCR 
analysis. F, forward primer, R, reverse primer. 
 
Name Sequence 5'-3' NCBI 
Accession 
Primer 
Efficiency 
CYP19A 
  
 
F TGGGTTGCCATTGCCTTC AJ012152 1.99 
R GGACAGTAAGGAGCTGGAGTGAG Ovis aries  
Probe FAM-CCGTTGGAAAAGACAAGTCACCAGCAA-TAMRA 
 
 
HSD3B1 
  
 
F CCAGGCTAGTGTGCCAGTCTTT NM_001135932 1.97 
R CTCCCTGTAGGCGTTGGGCC Ovis aries  
Probe FAM-TCCACACCAGCACCATAGAGGTGGCT-TAMRA   
IGF1    
F TCCGTGCCCAGCGC M31736 1.99 
R TGCTTGTGTTCTTCAAATGTACTTCC Ovis aries  
Probe FAM-CACCGACATGCCCAAGGCTCAGA-TAMRA   
IGF2    
F CCGCGGCTTCTACTTCAGC X53554 1.99 
R ACTCTTCCACGATGCCAC Ovis aries  
Probe FAM-CCAGCCGCATAAACCGACGCA-TAMRA   
TIMP1    
F CACCCACAGACGGCCTTCT S67450 1.99 
R TGCGGTCCCCACGAAC Ovis aries  
Probe FAM-AACTCCGAAGTCGTCATCAGGGCCA-TAMRA   
 
 
2.3.3  Results  
 
2.3.3.1 Phenotypic effects of serum on cell proliferation, oestradiol and progesterone 
levels in cultured granulosa cells 
 
To determine if the period of cell culture and serum treatment induced luteinisation 
and associated changes in steroid hormone secretion, steroid hormone levels were 
measured at 48, 96 and 144 hours (Figure 2.12). Progesterone concentrations 
generally increased (P<0.001) whilst oestradiol concentrations decreased (P<0.001) 
with time during culture. Cells treated with 20% serum produced lower levels of 
progesterone (P<0.001) and oestradiol (P=0.01) over all time points. Cells were 
counted at 144 hours and revealed that cell proliferation increased (P<0.001) with 
serum concentration. Furthermore, when steroid levels were adjusted for cell 
number, the pattern of hormone production was maintained (Figure 2.13).  
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2.3.3.2 Testing the PCR amplification step 
 
Quantitative RT-PCR analysis was carried out on cDNA from granulosa cells and on 
cDNA which was previously PCR amplified by the method detailed in section 
2.2.1.6. This was carried out to determine if the transcript abundance profiles 
remained the same after PCR amplification. Correlations between data sets show a 
close relationship between both methods (Figure 2.14) with HSD3B1, TIMP1, IGF1 
and STAR expression being highly correlated (R2 > 0.75, P<0.01). 
 
2.3.3.3 Testing the ability of the array to detect differences in transcript levels 
 
Firstly an experiment was set up in which doubling concentrations of cDNA were 
labelled and hybridised to the array to check for linearity. Samples containing 500, 
1000 or 2000ng cDNA from one sample were analysed as in section 2.2.1.11 (Figure 
2.15. Data was not expressed relative to ACTB as absolute levels only were required. 
The array failed to detect doubling concentrations of cDNA and no linearity was 
observed. 
 
A second experiment used cDNA from granulosa cells cultured with either 0, 10 or 
20% FCS for 144 hours. Since differences in hormone synthesis and cell 
proliferation had been demonstrated (Fig 2.13), it was anticipated that would be 
reflected by differences in gene expression. The cDNA was hybridised directly to the 
array membrane after radioisotope labelling without any previous amplification step. 
The array failed to detect any significant differences in gene expression in any gene 
between treatment groups (Figure 2.16). Subsequent qRT-PCR analysis was carried 
out on the same cDNA samples and all transcripts showed a significant reduction 
(P<0.001) in expression between 0% and 10% and between 0% and 20% treatment 
groups (Figure 2.17). CYP19A was not detected with treatment of 10 and 20 % FCS, 
while HSD3B1 shows approximately a 30 fold reduction in expression with treatment 
of 10 and 20 % FCS. All other transcripts (IGF1, IGF2, TIMP1 and STAR) showed a 
reduction with inclusion of 10 and 20% FCS compared to untreated cells, albeit a 
much smaller decrease; STAR (1.5 fold), TIMP1 (2.1 fold), IGF1 (2.7 fold) and IGF2 
(4 fold).  
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Figure 2.12 Effect of 0, 10 or 20% serum on progesterone (A) and oestradiol (B) 
production after 48, 96 and 144 hours of culture. Data are the average of 6 replicates 
+S.E.M. Different superscripts indicate P<0.05. 
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Figure 2.13 Cell count data at 144 hours after treatment with 3 serum concentrations 
(A). Progesterone (B) and Oestradiol (C) levels in culture media at 144 hours, 
adjusted for cell number. Data average of 6 replicates + S.E.M. Different superscripts 
indicate P<0.01. 
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Figure 2.14 Correlations of qRTPCR data for pre-amplified vs non-amplified cDNA 
for HSD3B1 (A), TIMP1 (B), IGF1 (C) and STAR (D) expression relative to ACTB. 
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Figure 2.15 Array data showing absolute levels of detectable transcript after 
hybridisation with 500, 1000 or 2000 ng of labelled cDNA from a single cDNA 
sample. Data average of all genes + S.E.M. 
 
 
2.4  Discussion 
 
2.4.1 cDNA macroarray vs. qRT-PCR for detection of gene expression differences 
in ovine granulosa cells 
 
From the samples analysed in the original in vivo sheep study, none of the genes 
selected for qRT-PCR analysis showed a correlation with data from the cDNA 
macroarray. Given the subtle changes in gene expression that may result from the 
dietary study described, cell culture experiments were set up to ensure a series of 
samples containing measurable changes in gene expression. Quantitative RT-PCR 
analysis showed that this was the case, with all chosen genes showing a reproducible 
expression profile across treatment groups. These expression differences were not 
detected by the array. 
 
There are a number of possible reasons as to why the array and qRT-PCR results did 
not correlate. The first potential reason for the observed discrepancies was the 
method of cDNA amplification and whether it was disproportionately amplifying 
transcripts. It has been reported that cDNAs with differing lengths and compositions 
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Figure 2.16 cDNA macroarray analysis of the effect of treatment on the expression 
of CYP19A, HSD3B1, STAR, TIMP1, IGF1 and IGF2 in granulosa cells cultured 
with either 0, 10 or 20% FCS supplement at 144 h. cDNA was not amplified prior to 
hybridisation. Data are the mean of 3 replicates + S.E.M. 
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Figure 2.17 qRT-PCR analysis of the effect of treatment on the expression of 
CYP19A, HSD3B1, STAR, TIMP1, IGF1 and IGF2 in granulosa cells cultured with 
either 0, 10 or 20% FCS supplement at 144 h. Data are the mean of 3 replicates + 
S.E.M. Different superscripts indicate P<0.001. 
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could be amplified with differing efficiencies therefore skewing expression data 
(Lockhart et al., 1996; Baugh et al., 2001). Microarray expression profiling 
experiments usually require RNA in larger quantities than are available from small 
biological samples (Jenson et al., 2003). There are two main methods for increasing 
nucleic acid concentration, the first being a linear amplification method utilising in 
vitro transcription (IVT) which involves cDNA being synthesized from RNA to 
provide a template for amplification by T7 RNA polymerase. An IVT reaction is 
then performed during which complementary RNA (cRNA) transcript is generated. 
However, since the second strand is synthesised using random priming, IVT products 
are not always full length copies DQG ¶ HQG VHTXHQFHV DUH RIWHQ XQGHUUHSUHsented 
(Wilhelm et al., 2006). The PCR-based non-linear amplification method used for this 
study overcomes these issues and a limited number of studies indicate that the 
method preserves abundance relationships (Iscove et al., 2002; Ji et al., 2004; 
Wilhelm et al., 2006). The method also works with markedly less RNA reducing the 
amount of starting material by up to a million-fold (Iscove et al., 2002). 
 
The second potential reason is that the array may not be sensitive enough to detect 
subtle dietary-induced expression changes. From the series of culture experiments it 
was clear from the qRT-PCR data that the expression profiles of those genes chosen 
were clearly altered between groups. These changes were not subtle (e.g. a 30 fold 
difference was detected in HSD3B1 through qRT-PCR), yet were still not detectable 
by the array despite most array technologies using a twofold difference in expression 
as the threshold for gene expression scoring (Jenson et al., 2003; Clarke et al., 2001). 
These conclusions were backed up by the results of the experiment set up to detect 
doubling dilutions of cDNA, in which no linearity following the increasing levels of 
cDNA was detected by the array. 
 
Given the lack of correlation between the array and qRT-PCR data, this study has 
dissected each of the possible steps including the amplification method. The qRT-
PCR data presented in this chapter conclusively shows that the amplification step 
maintains gene expression profiles and therefore supports previous published studies. 
From the comparison of qRT-PCR analysis using amplified vs. non-amplified cDNA 
we have shown that this particular method of sample preparation maintains the 
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original expression profile of transcripts (R2 YDOXHV DOO !  S YDOXHV DOO 
indicating that the pre amplification method by PCR used in this study did not 
disproportionately alter transcript levels and can be used reliably to increase low 
sample levels for array hybridisation. This is consistent with a study which concludes 
that a non linear amplification method (specifically the Clontech SMART system as 
used in this project) was more comparable with unamplified samples than IVT 
(Wilhelm et al., 2006).  
 
Despite the evidence pointing towards a robust sample preparation but a potentially 
poor array platform we must also consider the problems arising from low sample 
numbers. Only 13 (8 x n-3, 5 x n-6) out of a possible 21 samples were analysed by 
array in this study due to insufficient RNA yields and quality. Furthermore, in the 
validation experiments only 9 samples (3 per treatment group) were analysed. This 
number of replicates may be enough to detect expression differences by qRT-PCR 
but this type of array may need substantially more. Due to noise and variability, array 
technologies highlight a certain percentage of false positives and negatives which 
could mask true results (Hatfield et al., 2003). This false discovery rate can change 
depending on experimental variability and the type of statistical analysis used (Zhou 
et al., 2007), and potentially can fail to detect up to 70% of genes showing a 2 fold 
change in expression (Cole et al., 2003). However, the array may have been 
unsuccessful for several other reasons; degraded cDNA on the array causing poor 
hybridisation; lack of sequence specificity (bovine vs ovine); or underlying analysis 
software issues (poor sensitivity). Unfortunately these issues were out of the confines 
of this thesis to investigate. 
 
2.4.2  Effect of serum on granulosa cells in culture 
 
An added benefit to the optimisation studies described is that data was generated on 
the actual effect of serum in granulosa culture on the expression of steroidogenic 
related genes. The study demonstrated that progesterone levels generally increased 
over time whilst oestradiol levels fell, which is consistent with published data 
(Henderson and Moon, 1979; Henderson et al., 1987; Luck et al., 1990). Patterns of 
hormone production observed in this study are consistent with the luteinisation of 
granulosa cells in vitro over time as serum in culture is known to augment the 
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luteinisation of granulosa cells (Luck, 1989; Luck, 1990), which is reflected in the 
reduced levels of oestradiol. However, progesterone levels are lower than expected 
with 20% serum. Conversely, it has been noted that high levels of serum in granulosa 
culture could reduce hormone production (Luck 1989), although the mechanism 
remains unclear. This is consistent with the reduced level of progesterone that was 
detected at 144 hours with 20% FCS. Levels of oestradiol also drop to the lowest 
concentrations detected at 144 hours with 20% FCS. This at first seemed consistent 
with the luteinisation of the cells but could in fact be at such low levels due to this 
inhibitory mechanism brought on by high serum levels in the culture media. 
Unfortunately, due to cell number restraints we were unable to set up a time course 
study for a more in depth look at gene expression leading up to this point.  
 
All transcripts show higher expression in cultures absent of serum. The reduction in 
these steroidogenic-related genes with inclusion of serum in culture media is 
consistent with the observed reduction of oestradiol levels. However, despite the 
reduction in STAR and HSD3B1 transcripts, progesterone levels were greater with 
10% serum at 144 hours. This could indicate that either the level of transcript has not 
yet affected the translated protein levels and/or downstream pathways or that other 
factors which have not been measured are compensating in some way to maintain 
hormone levels. 
 
2.5 Conclusions 
 
After a thorough investigation of the macroarray associated methodologies, several 
issues regarding its sensitivity have been highlighted. The amplification system used 
for sample preparation has been shown to maintain true abundance relationships 
within samples, allowing us to disregard this as the cause for the discrepancies seen.  
The main cause for concern is that the array itself fails to detect differences in 
expression up to 30 fold (HSD3B1), even despite low replicate numbers, a sizable 
difference such as this should be picked up when most array platforms set a 
biologically significant fold difference of 2 as a baseline. Additional to this, with the 
lack of correlation between the macroarray data and qRT-PCR, one can conclude that 
this particular cDNA macroarray is unsuitable for quantitative gene expression 
analysis.  
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CHAPTER 3 
 
The effect of LDL and HDL obtained from serum of ewes fed n-3 or n-6 PUFA 
enriched diets on granulosa and theca cells cultured in vitro 
 
3.1 Introduction 
 
We have previously reported a significant increase in progesterone levels in the 
follicular fluid of ewes fed a high n-3 compared to a high n-6 PUFA diet, section 
2.2.1.1 (Wonnacott et al., 2010). Ovine granulosa cells aspirated from abattoir 
derived ovaries were cultured in the presence of HDL derived from n-3 or n-6 PUFA 
fed ewes in that study, but steroid production was unaltered by PUFA source. 
Lipoproteins are the main transporter of FA in ruminants, with HDL being the most 
abundant comprising over 80% of the total, and LDL accounting for less than 10% 
(Palmquist 1976; Bauchart 1993). Both HDL and LDL have been shown to be 
involved in ovarian steroid hormone production in humans and non-primate animals 
(Carr et al., 1982; Veldhuis et al., 1984; 2¶6KDXJKQHVV\ et al., 1990; Bao et al., 
1995; Ragoobir et al., 2002). HDL is present in ruminant follicular fluid at high 
OHYHOV SULRU WR RYXODWLRQ 2¶6KDXJKQHVV\ et al., 1990), with the concentration of 
HDL being up to 20-fold greater than LDL (Wonnacott et al., 2010). However, 
despite low levels, one of the major functions of LDL is cholesterol tissue 
distribution and delivery; it is therefore important for steroidogenic tissues and has 
been implicated as such in ruminants (Bauchart, 1993).   
 
The in vivo ovine study described in Chapter 2 was extended to consider the effect of 
n-3 and n-6 PUFA enriched LDL and HDL fractions on cultured granulosa and theca 
cells in the current chapter. As HDL did not seem to affect steroidogenesis in 
aspirated granulosa cells (Wonnacott et al., 2010), a different sub-population was 
used; mural granulosa cells, collected via scraping the follicle wall. Theca cells are a 
highly vascularised sub-layer of the ovarian follicle and are key regulators of ovarian 
steroidogenesis. Therefore it was important to culture these cells with the same 
lipoprotein and PUFA treatments as granulosa cells, as the in vivo effects reported by 
Wonnacott et al. (2010) may have been due to this population of cells rather than 
granulosa. Experiments in this chapter were designed to assess the effects of 
 74 
culturing ovine mural granulosa and theca cells in the presence of physiological 
levels of LDL and HDL derived from sera of ewes offered enriched n-3 and n-6 
PUFA diets described in Chapter 2.   
 
The expression of genes involved in steroidogenesis and lipid metabolism was 
analysed by quantitative real-time PCR. Transcripts included; cholesterol side chain 
cleavage (CYP11A1), 17-alpha-hydroxylase (CYP17A), steroidogenic acute 
regulatory protein (STAR), 3 beta-hydroxysteroid dehydrogenase (HSD3B1), 
scavenger receptor class B member 1 (SCARB1), low density lipoprotein receptor 
(LDLR), stearoyl-CoA desaturase (delta-9-desaturase) (SCD), elongase 2 (ELOVL2), 
elongase 5 (ELOVL5), delta-5-desaturase (FADS1) and delta-6-desaturase (FADS2). 
The molecular analysis was carried out to determine (i) the mechanism by which 
PUFA alter steroid output in the follicle and (ii) how theca and granulosa cells differ 
in the uptake and metabolism of FA by expression of key metabolic genes. It was 
important to look at expression levels for the steroidogenic enzymes CYP11A1, 
CYP17A and HSD3B1 and also STAR (regulator of cholesterol transfer into 
mitochondria) to determine the mechanism by which progesterone is increased in 
ovarian steroidogenic cells. SCARB1 (the HDL scavenger receptor) sequesters 
cholesterol by selectively removing cholesterol esters from the HDL molecule. LDLR 
mediates cholesterol uptake via internalisation of the entire LDL particle and its 
receptor. The desaturase (SCD, FADS1 and FADS2) and elongase (ELOVL2 and 
ELOVL5) enzymes are important in the synthesis of long chain fatty acids and it was 
important to identify the expression of these transcripts in granulosa and theca cells.  
FA analysis was carried out (i) to determine if both cell types are able to sequester 
and utilise FA from the culture media and (ii) to ascertain which lipoprotein (i.e. 
LDL or HDL) is the most efficient at delivering FA to follicular cells.  
 
3.2 Materials and methods 
 
All reagents were obtained from Sigma-Aldrich unless otherwise stated. Granulosa- 
and theca-cell cultures were carried out using four treatments. Standard culture 
media (TCM199 for granulosa cells and DMEM/F12 Hams for theca cells) were 
supplemented with either LDL or HDL fractions obtained from serum of ewes fed n-
3 or n-6 PUFA enriched diets (sections 2.2.1.1 and 2.2.1.3). The culture experiments, 
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therefore, were a 2x2 factorial arrangement (LDL vs HDL and n-3 vs n-6 PUFA) and 
were conducted in 24-well plates (Nunc, Thermo fisher Scientific, Loughborough, 
UK). Cells within plate and within treatment combination were harvested at 48, 96 
and 144 h, giving 2 replicates per treatment combination and per time point per plate. 
Two plates were cultured on any one occasion and there were 3 occasions, given a 
total of 6 plates per cell type (experiment).  
 
3.2.1 Fatty acid analysis 
 
3.2.1.1 Fractionation of lipoproteins from serum 
 
Serum from ewes offered n-3 and n-6 PUFA diets (study detailed in sections 2.2.1.1 
and 2.2.1.3) were pooled according to dietary group. Lipoproteins were fractionated 
according to density by sequential ultracentrifugation. Serum was inverted to 
maximise homogenicity. Potassium bromide (KBr) was added to achieve the 
required density according to the Radding-Steinberg Formula: 
 
X = [(V(df - di)] / [1- (0.312 x df)] 
 
Where X= grams of KBr; V=volume of serum (ml); di=initial density; df=final 
density; 0.312 = partial specific volume of KBr. 
 
Serum samples were added to Beckman quick seal ultracentrifuge tubes (Beckman 
Coulter (UK) Ltd., Buckinghamshire, UK) using a 10ml syringe and needle. To obtain 
the VLDL fraction, samples were topped up with 1.006g/ml KBr solution (Max 12ml 
per tube in total). Tubes were sealed with Beckman Tube sealer and samples spun at 
39,000 RPM for 16 hours under vacuum at 12°C using a 70.1Ti rotor in a Beckman 
XL-70 Preparative ultracentrifuge with no brake on deceleration. After 
centrifugation, the top fraction (VLDL) was removed by cutting the top of the tube in 
a Kontron bench top tube slicer. The top fraction was removed and stored at -20°C. 
The remaining sample was resuspended from the pellet at bottom of tube and density 
adjusted to 1.063g/ml by adding solid KBr using above equation. Samples were 
added to ultracentrifuge tubes and topped up with 1.060g/ml KBr solution and 
sealed. Tubes were spun under the same conditions as before but for 20 hours. The 
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top fraction (LDL) was removed as before and stored at -20°C. The density of the 
remaining sample was adjusted to 1.21g/ml by adding solid KBr, added to new 
centrifuge tubes and topped up with 1.24g/ml KBr. The tubes were centrifuged under 
the same conditions as before but for 40 hours. The top fraction was removed (HDL) 
and stored at -20°C. The remaining sample was a lipoprotein deficient fraction 
containing mainly albumin and this was also stored at -20°C.   
 
3.2.1.2 Purification of lipoprotein fractions via dialysis 
 
In order to remove excess KBr from fractionated lipoproteins, samples required 
dialysis. Dialysis tubing was placed in boiling water for 10 minutes to soften. 
Approximately 10 inches of 25mm tubing was used for 15 mls of sample. One end of 
tube was clipped and the tube was rinsed out with 0.15M Sodium chloride (NaCl). 
Sample was then added to the empty tube, bubbles were removed and the tube closed 
with a second clip. All dialysis tubes and samples were added to 5 litres 0.15M NaCl, 
1mM EDTA, pH 7.4 and placed at 4°C with stirring. After 1 hour, the NaCl solution 
was replaced, and this was repeated an hour later followed by an overnight 
incubation. After this dialysis period, samples were removed from the solution and 
transferred into labelled 15ml falcon tubes for storage at -20°C. 
 
3.2.1.3 Analysis of serum and serum fractions by gas chromatography 
 
One ml serum or serum fraction was pipetted directly into a labelled tube together 
with 3.75mls of cold, freshly made chloroform:methanol (1:2 v/v) and 200µl 
200µg/ml pentadecanoic acid (C15:0; internal standard). Samples were then vortexed 
for 1 minute. A further 1.25mls chloroform and 1.25 mls HPLC grade water was then 
added and following a second vortex tubes were centrifuged at 3400 x g at 15°C for 
15 minutes. The top water layer was then removed and discarded and the lower 
organic chloroform phase was carefully collected into a clean labelled tube, taking 
care not to disturb the mid protein layer. The chloroform was then evaporated to 
dryness under a steady stream of nitrogen at 40°C. Dried samples were then 
methylated by initially adding 3ml of methanolic HCL. Samples were then purged 
with N2 gas to remove oxygen after which the tubes were sealed tightly and heated at 
70°C for 2 hrs in a heated block. Tubes were then removed and left to equilibrate to 
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room temperature.  To stop the methylation reaction 2ml HPLC water was added and 
vortexed to mix. 500µl HPLC hexane was added, vortexed and centrifuged 3400 x g 
at 15°C for 15 minutes. Using a glass Pasteur pipette the upper hexane layer was 
removed and transferred to a GC vial for immediate analysis or storage at -20°C.  
 
3.2.1.4  Gas chromatograph instrumentation and run parameters 
 
The instrument used was an Agilent 6890 series GC system with a 7683 series 
injector (Agilent Technologies, Cheadle, UK). The column used was a Varian CP-Sil 
88 fused silica capillary column (100m x 0.25mm ID, 0.2µm film) (Varian Scientific, 
Oxford, UK). Fatty acid methyl esters (FAME) suspended in hexane were injected at 
a volume of 2µl. Two hexane blanks were injected between each sample to prevent 
carry-over contamination. Identification of individual FAME peaks was based on 
retention time with reference to a known standard (37 component mix, Supelco, 
Poole, UK) using Agilent HPCORE Chemstation software (version 1.1). Twenty-six 
FA from C16:0 upwards were identified.  Calibration was achieved by comparison of 
peak areas for individual FA with peak area for a known concentration of internal 
standard (C15:0). Run parameters for gas chromatograph are detailed in Table 3.1. 
 
3.2.2 Cell culture 
 
3.2.2.1 Lipoprotein treatments in culture media 
 
LDL and HDL lipoprotein fractions (A.2.3 and A.2.4) were added to culture based 
on their TFA content. The levels added were formulated to deliver physiological 
amounts of FA to the theca and granulosa cells. Fatty acid levels equivalent to 5% 
serum were added to culture media. Inclusion rates of up to 10% serum in culture 
media are standard in our laboratory and elsewhere (May and Schomberg, 1984; 
Spicer et al., 1993; Roberts and Echternkamp, 1994; Kayani et al., 2009). Serum 
TFA concentration (1442µg/ml) was determined before fractionation (A.2.1). 
Consequently 5% equivalent was calculated to deliver 72.1µg/ml of TFA. Therefore, 
on average, 57µl of either LDL fraction or 22µl of either HDL fraction was added to 
each ml of culture media. 
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Table 3.1 Gas chromatograph column, injection and oven parameters for FA 
analysis. 
Inlet Mode:Splitless Gas: H2     
     
Heater temperature 255°C 
   
Pressure 27.8 psi 
   
Total flow 67.7 ml/min 
   
Purge flow to split vent 60ml/min for 0.75 min 
   
Gas saver 20ml/min for 5 min 
   
     Column         
     
Mode Constant flow 
   
Pressure 28.7 psi 
   
Flow 2.0 ml/min 
   
Average velocity 36 cm/sec 
   
     Oven         
     Oven ramp °C/min Next °C Hold min Run time 
Initial 
 
59 0.75 0.75 
Ramp 1 8 110 0 7.1 
Ramp 2 6 170 10 27.1 
Ramp 3 3 240 6 56.5 
     Detector         
     
Detector temperature 300°C 
   
H2 flow 30 ml/min 
   
Air flow 400 ml/min 
   
N2 makeup flow 30 
   
Lit offset 2 
   
 
3.2.2.2 Granulosa and theca cell culture 
 
Sheep ovaries were collected from an abattoir and transported in a flask containing 
warm PBS to the laboratory within 2 hours.  Ovaries were rinsed with 70% ethanol 
and then with fresh, sterile warm PBS and kept at 37°C in a heated box until needed.  
Large (>5mm) amber-coloured clear follicles were dissected from the ovaries and 
kept in warm PBS until the number required (i.e. 30-40) was collected. Follicles 
were placed in a petri dish containing warm PBS/0.1% PVA. Follicles were cut open 
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and granulosa cells scraped from inner follicle wall using a sterile inoculation loop. 
Both mural and antral granulosa cells were collected and searches were performed to 
remove oocytes.  Cells were then spun at 800 x g for 5 minutes. Theca cells were 
removed by pinching the inner wall with curved forceps and peeling away from the 
outer shell. Theca sheets were kept in warm media containing 50 IU/ml penicillin 
and 50µg/ml streptomycin. Once all theca cells had been collected, they were spun at 
800 x g for 5 minutes. Theca sheets were then added to a dissociation solution 
containing 18.5ml DMEM/Hams F12 media with 50IU/ml penicillin, 50µg/ml 
streptomycin, 5 mg/ml collagenase I, 1mg/ml hyaluronidase and 25µg/ml 
(188Units/ml) DNase1. Cells were incubated at 37°C for 30 min in shaking water 
bath.  5% FCS was added to terminate the reaction, and the cell suspension was 
passed through a 70µm filter to remove remaining clumps.  Cells were spun again at 
800 x g for 5 minutes and washed twice in warm PBS/0.1% PVA. The supernatant 
for both cell types were discarded and 9 mls of double-distilled water was added to 
WKHFHOOVDQGPL[HG LQRUGHU WR O\VH UHGEORRGFHOOVPO['XOEHFFR¶V3%6ZDV
added to the tube and mixed again to restore isotonicity. Cells were centrifuged at 
800 x g for 3 minutes and washed twice with warm PBS/0.1% PVA, then 
resuspended in 1ml warm basal culture media. 10µl suspension was removed for cell 
counts (see section 3.2.2.3) and cells plated down in a 24 well plate at an initial 
seeding density of 3.5x105 (granulosa) and 2x105 (theca) live cells per well in 500µl 
culture media in 24-well plates. Plates used for theca cultures were pre-coated with 
fibronectin (500µl of 6µg/ml fibronectin per well at 39°C for 4 h, removed then air 
dried for 2 h).  Basal media for granulosa cultures consisted of 90% v/v TCM199 and 
10% v/v double distilled water supplemented with 1mg/ml BSA, 100ng/ml L-
glutamine, 10ng/ml insulin, 0.5µg/ml transferrin, 0.5ng/ml sodium selenite, 50IU/ml 
penicillin, 50µg/ml streptomycin, 1ng/ml FSH and 100ng/ml testosterone. Theca 
culture media consisted of DMEM/Hams F12 supplemented with 1mg/ml BSA, 
100ng/ml L-glutamine, 10ng/ml insulin, 0.5µg/ml transferrin, 0.5ng/ml sodium 
selenite, 50IU/ml penicillin, 50µg/ml streptomycin, 1ng/ml LH.  Both media were 
kept at pH 7.4 and 270-280 mOsm. Basal media was supplemented with either n-3 
LDL, n-6 LDL, n-3 HDL or n-6 HDL. Lipoproteins were added at 5% serum fatty 
acid equivalent (LDL 57µl, HDL 22µl per 1ml media) (section 3.2.2.1). Cells were 
incubated at 38.8qC in a humidified atmosphere of 5% CO2 for 144 h. Eighty percent 
of media was collected at 48-h intervals, and replaced with fresh media. Two wells 
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per treatment were harvested with trypsin EDTA and cell counts performed (section 
3.2.2.3). Further cells and media were collected at 96 hours and 144 hours. All cells 
were snap-frozen in liquid nitrogen prior to storage at -80°C. 
 
3.2.2.3 Cell counts via trypan blue exclusion and trypsin EDTA removal of cultured 
cells 
 
Cells were resuspended in a known volume of culture media containing FAF-BSA 
(1%), 50IU/ml penicillin and 50µg/ml streptomycin. A 10µl aliquot was taken and 
added to 40µl of PBS and 50µl trypan blue solution and mixed thoroughly. The 
mixture was pipetted into each chamber of a haemocytometer and the number of 
viable (white) and non-viable (stained blue) cells were counted under x10 
magnification of a microscope. Live cells per ml of suspension were then estimated.   
Prior to addition of trypsin EDTA, all spent media was removed from 24-well plate 
wells. 200µl trypsin EDTA was added to each well and incubated at 38°C for 3 
minutes. The well bottom was rinsed with a pipette using trypsin EDTA already 
present, until all cells had detached from the well, and then transferred to a labelled 
eppendorf. 100µl media containing 5% FCS was added to each well and used to rinse 
the bottom to ensure maximal cell recovery. This was then added to the rest of the 
cells in labelled tubes. Cells were washed and resuspended in warm PBS/0.1% PVA 
and a 10µl aliquot was taken and added to 15µl of PBS and 25µl trypan blue solution 
and used to perform cell counts as above. All cells were snap frozen in liquid 
nitrogen and stored at -80°C for later analysis. 
 
3.2.3 Steroid hormone analysis 
 
3.2.3.1 Oestradiol ELISA 
 
Oestradiol concentrations in spent media were measured by ELISA. Media samples 
were diluted up to 1:10 in PBS. All samples were run in duplicate along with 
standards (3.9, 7.8, 15.6, 31.25, 62.5, 125, 250, 500 and 1000pg/100µl) and QCs (7.8 
and 31.25 pg/100µl). 96-well plates (Immuno-Maxisorp, Nuncbrand Fisher 
Scientific) were coated with 17-beta Estradiol 3 antibody (Abcam) at a dilution of 
1:64000 in coating buffer (50mM Sodium bicarbonate, 50mM Sodium carbonate, pH 
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9.6). Plates were sealed and incubated overnight at 4qC. Plates were washed 4 times 
in wash buffer (PBS, 0.05% Tween20, pH7.4). Plates were then tapped dry and 
100µl blocking solution (PBS, 3%BSA) added to each well and incubated at room 
temperature for 2 h.  Plates were then washed again 4 times and tapped dry.  100µl of 
either sample, standard or QC was added to each well together with 100µl HRP 
conjugate  and incubated for 2 h at room temperature. Plates were washed 4 times 
and tapped dry. 50µl Tetramethylbenzidine (TMB) was added to each well and 
incubated for 12 min at room temperature. 50µl stop solution (1N H2SO4) was added 
to each well and plates read at 450nm. Intra and inter-assay CV were 9.8% and 4.2% 
respectively. 
 
3.2.3.2 Progesterone ELISA 
 
Progesterone ELISA was carried out on spent media as previously described in 
section 2.3.2.3. Samples were diluted up to 1:400 for theca cell media and up to 
1:100 for granulosa cell media in PBS.  Intra and inter-assay CV were 7.9% and 
8.4% respectively. 
 
3.2.4 Fatty acid analysis of granulosa and theca cells via gas chromatography 
 
Frozen cells were thawed over ice and transferred to a labelled tube together with 
3.75ml of cold, freshly made chloroform:methanol (2:1 v/v) and 100µl 200µg/ml 
pentadecanoic acid, and vortexed to mix. Samples were wrapped in foil and placed in 
a fridge overnight. 1.25ml of 0.88% KCl solution was added to each sample to aid 
quantitative transfer of residual material. Tubes were centrifuged at 800 x g at 8°C 
for 15 min. The top water layer was removed and discarded. The lower organic 
chloroform phase was collected into a clean labelled tube, careful not to disturb the 
mid protein layer. 1.25 ml cold chloroform was added to each tube containing protein 
and cell debris and mixed and centrifuged again to maximise extraction. The 
remaining chloroform was collected and added to the previously collected sample. 
Chloroform was evaporated to dryness at 40°C, under a steady stream of nitrogen 
gas. For methylation, 3ml of methanolic HCL (5% v/v) was added to the dried 
sample. Samples were purged with N2 gas to remove oxygen and tubes sealed tightly 
then heated at 70°C for 2 h in a heated block. Tubes were removed and left to 
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equilibrate to room temperature. To stop the methylation reaction 2ml HPLC water 
was added and vortexed to mix. 200µl HPLC hexane was added, vortexed and 
centrifuged at 3400 x g at 15°C for 15 min. The upper hexane layer was removed 
using a glass pasteur pipette and transferred to a clean GC vial for immediate 
analysis or storage at -20°C.  GC oven parameters are detailed in section 3.2.1.4 and 
Table 3.1. 
 
3.2.5 RNA extraction and RT reaction 
 
RNA was extracted from cells and reverse transcribed into cDNA as previously 
described in sections 2.2.1.4 and 2.3.2.5.   
 
3.2.6 Quantitative RT-PCR 
 
Transcripts were analysed by qRT-PCR as previously described in section 2.2.1.12.  
SCARB1, ELOVL2 and FADS1 used forward and reverse primer concentrations of 
1.2µl (10pmol/µl); all other primers used 0.6µl (10pmol/µl) of each primer. Cycling 
parameters and primer and probe sequences can be found in Tables 2.3 and 3.2 
(HSD3B1 details can be found in table 2.5). Transcripts were analysed relative to ȕ-
actin (ACTB) (Table 2.2). 
 
3.2.7  Statistical analysis 
 
To recap, granulosa and theca cell experiments were conducted separately, each as a 
2 x 2 x 3 factorial (i.e. LDL vs HDL; n-3 vs n-6 PUFA; and three sample times (48, 
96 and 144 h)) arrangement in 6 x 24-well plates. Cells within plate and within 
treatment combination were harvested from separate wells at 48, 96 and 144 h for FA 
and transcript analyses, and spent culture media analysed for steroid hormones.  
 
All statistical analyses were conducted using Genstat release 11.1 (Genstat, 2009). 
FA and steroid concentrations in media and cells were analysed by ANOVA as a 
three-way factorial randomised block design. Progesterone data were transformed 
(log10) prior to analysis to correct for differences in means and variance across the  
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Table 3.2 Alphabetical list of primers and probes used for qRT-PCR. (F = forward 
primer, R = reverse primer). 
 
Name Sequence 5'-3' NCBI Accession Primer 
Efficiency 
ACTB 
  
 
F TGTGCGTGACATCAAGGAGAA AF129289 1.92 
R CGCAGTGGCCATCTCCTG Ovis aries  
Probe FAM-CTGCTACGTGGCCCTGGACTTCGA-TAMRA 
 
 
CYP11A1 
  
 
F TCGGCAATTTGGAGTCAGTTT D50057 1.96 
R GGTAGGATCCCTCGAACTTAAAGAG Ovis aries  
Probe FAM-ATCATTCACCCTGAAGGCGTGGCC-TAMRA 
 
 
CYP17A 
  
 
FP TCATCTCGCCATCGTTAAGCT AF251388 1.96 
RP CGGGCTAGCATCTCACCTACA Ovis aries  
Probe FAM-TTGCCCTTTGGAGCCGGACCC-TAMRA 
 
 
ELOVL2 
  
 
F TTCCTTGTGGGCAAAGTTTCTT BC114786 1.99 
R GCCCGTAGTAGGAGTACATGAGGAT Bos Taurus  
Probe FAM-ACGTCTACCACCACGCCTCCATGTTT-TAMRA 
 
 
ELOVL5 
  
 
F TCACGGTCCTGCATGTGTATC BC105391 1.83 
R GACCCAGTTCATCACGAACCA Bos Taurus  
Probe FAM-CCACGCCAGCATGCTCAACATCTG-TAMRA 
 
 
FADS1 
  
 
F AGCTGCCCCTGAGGATATTTC EU272818 1.91 
R CGACCACTCGAAGATGTCGTT Ovis aries  
Probe FAM-CTGCTGCCAACTCCATGGCTTTCC-TAMRA 
 
 
FADS2 
  
 
F TGGCCTGCATGCTCATCA BC133520 1.98 
R TGGAAGATGTTGACGTGGAGAT Bos Taurus  
Probe FAM-AGGTCCCTGCTGGCCCACCC-TAMRA 
 
 
LDLR 
  
 
F GAGCGTGGGTGCCCTATACA K01830 1.87 
R TTCCGAAGGCCAGGAGG Bos Taurus  
Probe FAM-CGTCCTCCCCATCGCACTGCTC-TAMRA 
 
 
SCARB1 
  
 
F TCCAAGGCCAGAAGCCAC AF019384 1.77 
R GCTCTTGTGCCTGAACTCCC Bos Taurus  
Probe FAM-TGCAGGAGCACGGGCCTTATGTGTA-TAMRA 
 
 
SCD 
  
 
F CGAACCTACAAAGCTCGGCT NM_001009254 1.97 
R TGGAACGCCATGGTGTTG Ovis aries  
Probe FAM-CCCCTACGGGTCTTCCTGATCATCG-TAMRA 
 
 
STAR 
  
 
F GCGACGTTTAAGCTGTGTGCT AF290202 1.87 
R TGCTGCCGCAGCCC Ovis aries  
Probe FAM-AGCTCCTATAGACACGTGCGCAGCATG-TAMRA 
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three time points. Data are presented as geometric means with log10 means and SED 
presented in italics. Where a FA was not detectable in a single treatment (i.e. a FA 
percentage < 0.03g/100g TFA), then the FA percentage in the other treatment was 
analysed by using a two-tailed t-test to determine if it was significantly greater than 
the detection limit. Data are presented as predicted means ± SEM.  
 
3.3 Results 
 
3.3.1 Treatment effects on cell proliferation and steroid hormone synthesis 
 
3.3.1.1 Granulosa cells 
 
There was no effect of treatment on granulosa cell proliferation (Table 3.3a). Cell 
number peaked (P<0.001) at 96 h and decreased between 96 and 144 h.  Cell 
number-adjusted oestradiol concentrations decreased (P<0.001) over time and were 
lowest at 144 h. In contrast, cell number-adjusted progesterone concentrations 
increased (P<0.001) over time and were maximal at 144 h. There was no effect of 
treatment on steroid hormone production in these cells.  
 
3.3.1.2 Theca cells 
 
Theca cell number increased (P<0.001) with time during culture (Table 3.3b), and 
interacted (P=0.012) with lipoprotein fraction to determine the rate of increase, 
which was greater for LDL than HDL supplemented cells (LDL supplemented cells 
witnessed a two fold increase between 48 and 144 h, whereas HDL supplemented 
cells witness a 1.6 fold increase over the same time period). Cell number adjusted 
progesterone concentrations increased (P<0.001) over time, and were influenced by 
dietary source (P<0.001), with n-3 PUFA producing greater levels of progesterone 
than n-6. When all time points considered there was no effect of lipoprotein on 
progesterone output, however at 144 hours there was a lipoprotein x dietary source 
interaction with an increase (P=0.037) in progesterone production with n-3 HDL 
compared to all other treatments (Figure 3.1). In contrast, cell number-adjusted 
oestradiol concentrations remained at a constant low level across all treatments and 
timepoints.
  
Tables 3.3 Effect on (a) granulosa and (b) theca cell proliferation, oestradiol (E2) and progesterone (P4) production during 144 h culture.  Media 
supplemented with LDL or HDL from serum of ewes offered diets enriched with either n-3 or n-6 PUFA. 
 
(a) Granulosa 
Lipoprotein (L) LDL HDL 
 
     Time of culture (hours) (T)   Significance 
Dietary Source (D) n-3   n-6  n-3 n-6 SED 48 96 144 SED L D T LxD LxT 
n 36 36 36 36 
 
48 48 48             
Cell number (x105) 2.93 3.00 3.18 3.02 0.152 2.81x 3.41y 2.86x 0.132 - - <0.001 - - 
E2 (pg/105 cells) 1289 1276 1259 1186 77.1 2337x 847y 566z 66.8 - - <0.001 - - 
P4 (pg/105 cells) 345a 281ab 256b 232b 
 
49x 442y 959z 
      
(log10) (2.538) (2.450) (2.408) (2.366) (0.0577) (1.694) (2.645) (2.982) (0.0499) 0.012 - <0.001 - - 
 
(b) Theca 
Lipoprotein (L) LDL HDL 
 
Time of culture (hours) (T) 
 
Significance 
Dietary Source (D) n-3 n-6 n-3 n-6 SED 48 96 144 SED L D T LxD LxT 
n 36 36 36 36 
 
48 48 48 
      
Cell number (x105) 2.47a 2.39a 2.29a 2.31a 0.10 1.70x 2.36y 3.03z 0.091 - - <0.001 - 0.012 
E2 (pg/105 cells) 69 70 69 66 7.5 74 62 69 6.5 - - - - - 
P4 (pg/105 cells) 149a 100a 218b 105a 
 
14x 231y 783z 
      
(log10) (2.172) (2.000) (2.339) (2.020) (0.0842) (1.139) (2.364) (2.894) (0.0729) - <0.001 <0.001 - - 
 
Means within a row with different superscripts (i.e. a, b or c; x, y or z) are significantly different (P<0.05). SED, Standard error of d
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Figure 3.1 Progesterone production at (A) 48 hours, (B) 96 hours and (C) 144 hours 
by theca cells cultured in vitro supplemented with LDL or HDL from sera of ewes 
offered diets enriched with either n-3 or n-6 PUFA (n=12). 
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3.3.2 Fatty acid composition of in vitro cultured cells 
 
3.3.2.1 Granulosa cells 
 
Total FA content per 100,000 granulosa cells at 144 h of culture did not differ 
between treatment groups (Table 3.4).  Proportions of saturated and total unsaturated 
FA also did not differ between culture groups.  The proportional increase (P=0.04) in 
MUFA for LDL relative to HDL, was largely attributable to the n-6 LDL culture 
group. The proportion of PUFA was higher (P=0.004) in cells cultured with HDL 
irrespective of PUFA source. The proportion of n-6 PUFA increased (P=0.014) in 
cells cultured with n-6 LDL or HDL and the proportion n-3 PUFA increased 
(P=0.04) in the presence of either n-3 LDL or HDL. The ratio of n-6 to n-3 FA was 
higher (P=0.02) for cells cultured in the presence of n-6 compared to n-3 LDL or 
HDL. 
 
In the present study, the most abundant FA in granulosa cells was oleic acid (C18:1n-
9c), comprising on average 30.9 ± 0.35 g/100g of TFA (Table 3.5). Its content was 
greater (P<0.05) in LDL than HDL, and n-6 than n-3 cultured cells. In fact, its 
content was greatest for n-6 LDL supplemented group. The second most abundant 
FA was palmitic acid (C16:0) comprising 23.18 ± 0.18 g/100g TFA, and stearic acid 
(C18:0) was the third (11.5 ± 0.66 g/110g TFA). Of the seven n-6 PUFA identified, 
three were increased in cells cultured with n-6, regardless of lipoprotein delivery, 
Linoleic (C18:2n-6) 3 Ȗ-linolenic (C18:3n-6) (P=0.02), and eicosadienoic 
(C20:2n-6) (P=0.02). The remaining four n-6 FA were numerically greater but not 
statistically significant. Similarly, of the five n-3 PUFA identified, four were 
increased in cells cultured with n- Į-linolenic acid (C18:3n-3) (P=0.002), 
eicosapentanoic acid (C20:5n-3) (P<0.001), docosapentaenoic acid (C22:5n-3) 
(P=0.003) and docosahexaenoic acid (C22:6n-3) (P=0.02). 
 
3.3.2.2 Theca cells 
 
Total FA content per 100,000 granulosa cells at 144 h of culture did not differ 
between treatment groups (Table 3.4). Proportions of saturated, unsaturated FA and 
PUFA did not differ between culture groups. The proportional increase (P<0.001) in 
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MUFA for n-6 relative to n-3 was largely due to the n-6 LDL culture group. This 
increase led to a significant (P=0.004) interaction of lipoprotein vs dietary source (n-
3 or n-6). The proportion of n-6 PUFA increased (P<0.001) in cells cultured with n-6 
and n-3 increased (P<0.001) in n-3 treated cells irrespective of lipoprotein delivery.  
The ratio of n-6 to n-3 FA was higher (P<0.001) for cells cultured in the presence of 
n-6 compared to n-3. 
 
As for granulosa cells, the most abundant FA was oleic acid (C18:1n-9c), comprising 
on average 31 ± 0.35 g/100g of TFA (Table 3.6).  Its content was greatest (P<0.001) 
in cells cultured with n-6 PUFA. The second most abundant FA was palmitic acid 
(C16:0) comprising 21.2 ± 0.52 g/100g TFA, and stearic acid (C18:0) was the third 
(12.35 ± 0.26 g/110g TFA).  Of the seven n-6 FA identified, four were increased in 
cells cultured with n-6; Linoleic (C18:2n-6) (P<0.001), eicosadienoic (C20:2n-6) 
(P=0.002), dihomo-Ȗ-linolenic acid (C20:3n-6) (P=0.009) and arachidonic acid 
(P<0.001). Similarly, all five identified n-3 FA were increased in cells cultured with 
n-3 (all P<0.001). Lipoprotein did not have an effect on FA uptake in these cells. 
 
3.3.3 Transcript expression of in vitro cultured cells 
 
3.3.3.1 Granulosa cells 
 
Transcript expression for SCARB1 and LDLR was unaffected by time or treatment 
(Table 3.7).  Expression of SCD increased (P<0.001) by 7.5 fold between 48 and 144 
h of culture, whereas FADS1 increased (P<0.001) at 144 h. Transcript expression for 
FADS2 increased (P<0.001) by 96 h and declined by 144 h.  Levels of SCD, FADS1 
and FADS2 expression were not altered by treatment and ELOVL5 expression was 
not affected by time or inclusion of culture treatment. By 96 h of culture, transcript 
levels of HSD3B1 had decreased (P<0.001) and increased again by 144 h, but was 
not affected by culture treatment.  Inclusion of LDL during culture led to an increase 
(P=0.018) in transcript expression of STAR compared to HDL, dietary source (n-3 vs 
n-6) had no effect on transcript expression. STAR transcript levels also increased 
(P<0.001) over time.  CYP11A1 expression was not affected by time or inclusion of 
culture treatment. Transcripts for ELOVL2 and CYP17A were not detected in these 
cells. 
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Table 3.4 Fatty acid composition (g/100g) of granulosa and theca cells cultured for 
144 hours in media supplemented with LDL or HDL from serum of ewes offered 
diets enriched with either n-3 or n-6 PUFA (n=4). 
 
 
Lipoprotein (L) LDL HDL   SED Significance 
Dietary source (D) n-3 n-6 n-3 n-6     L D LxD 
Granulosa cells 
         
          TFA (µg/105 cells) 5.55 6.5 6.11 6.04 
 
0.7 - - - 
Saturated 40.2 38.0 39.1 38.8 
 
0.71 - - - 
Unsaturated 54 56.2 55.2 55.6 
 
0.76 - - - 
MUFA 36.1a 38.0b 35.6a 35.9a 
 
0.55 0.04 - - 
PUFA 17.9a 18.2a 19.6b 19.6b 
 
0.41 0.004 - - 
n-6 series 10.4a 12.3b 10.8a 13.4b 
 
0.73 - 0.014 - 
n-3 series 7.51a 5.95b 8.82a 6.22b 
 
0.86 - 0.04 - 
Ratio n-6:n-3 1.44a 2.24b 1.25a 2.23b 
 
0.3 - 0.02 - 
 
                  
Theca cells 
         
          TFA (µg/105 cells) 3.62a 4.76b 4.33ab 4.14ab 
 
0.42 - - 0.04 
Saturated 38.6 35.3 35.9 36.9 
 
1.12 - - - 
Unsaturated 55.6 58.8 58.3 57.3 
 
1.06 - - - 
MUFA 32.6a 37.2b 34.7c 35.5c 
 
0.77 - <0.001 0.004 
PUFA 22.9 21.7 23.6 21.8 
 
0.89 - - - 
n-6 series 11.7a 15.8b 12.2a 16.1b 
 
0.44 - <0.001 - 
n-3 series 11.3a 5.8b 11.4a 5.7b 
 
0.5 - <0.001 - 
Ratio n-6:n-3 1.03a 2.74b 1.07a 2.84b 
 
0.08 - <0.001 - 
                    
 
Means within a row with different superscripts are significantly different (P<0.05).  SED, standard 
error of the difference; TFA, total fatty acids. 
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Table 3.5 Fatty acid composition of ovine granulosa cells cultured for 144 hours in 
vitro in media supplemented with low or high density lipoprotein (LDL, HDL) from 
serum harvested from ewes offered diets enriched in n-3 or n-6 PUFA (n=4). 
 
Lipoprotein (L) LDL  HDL    SED Significance 
Dietary source (D) n-3 n-6 n-3 n-6   
 
L D LxD 
Fatty acids g/100g TFA           
C16:0 23.4 22.4 23.5 23.4 
 
0.31 - - - 
C17:0 0.54 0.49 0.56 0.52 
 
0.03 - - - 
C18:0 11.4 11.8 11.4 11.4 
 
0.17 - - - 
C20:0 0.27 0.25 0.26 0.24 
 
0.01 - - - 
C21:0 0.42a 0.41a 0.28b 0.33ab 
 
0.05 0.05 - - 
C22:0 0.12 0.12 0.13 0.1 
 
0.01 - - - 
C23:0 3.94 2.57 2.91 2.55 
 
0.98 - - - 
C24:0 0.1 0.06 0.12 0.26 
 
0.07 - - - 
          C16:1 2.49 2.11 2.4 2.31 
 
0.11 - - - 
C17:1 0.47 0.62 0.55 0.77 
 
0.15 - - - 
C18:1n-9t 0.6 0.51 0.61 0.56 
 
0.36 - - - 
C18:1n-9c 30.5a 32.8b 30.1a 30.4a 
 
0.55 0.03 0.04 - 
C20:1 1.27a 1.35b 1.18c 1.20ac 
 
0.03 0.005 - - 
C22:1n-9 0.73a 0.63b 0.76a 0.63b 
 
0.04 - 0.02 - 
          C18:2n-6t 0.51 0.21 0.22 0.28 
 
0.08 - - - 
C18:2n-6c 4.95a 5.72b 5.26a 5.70b 
 
0.1 - <0.001 - 
C18:3n-6 0.37a 0.45b 0.33a 0.41ab 
 
0.03 - 0.02 - 
C20:2n-6 0.40a 0.46b 0.42a 0.47b 
 
0.02 - 0.02 - 
C20:3n-6 0.51 0.87 0.62 0.69 
 
0.2 - - - 
C20:4n-6 3.52 4.38 3.75 5.67 
 
0.63 - - - 
C22:2n-6 0.19 0.19 0.21 0.2 
 
0.02 - - - 
C18:3n-3 0.52a 0.37b 0.54a 0.38b 
 
0.04 - 0.002 - 
C20:3n-3 0.13 1.05 0.12 0.07 
 
0.49 - - - 
C20:5n-3 1.63a 0.58b 2.11a 1.02b 
 
0.21 - <0.001 - 
C22:5n-3 3.31a 2.35b 3.77a 2.81b 
 
0.24 - 0.003 - 
C22:6n-3 1.91a 1.60b 2.27c 1.95ab 
 
0.11 0.01 0.02 - 
          Unidentified 5.82 5.77 5.62 5.62 
 
0.22 - - - 
                    
 
Means within a row with different superscripts are significantly different (P<0.05). SED, standard 
error of the difference; TFA, total fatty acids. 
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Table 3.6 Fatty acid composition of ovine theca cells cultured for 144 hours in media 
supplemented with low or high density lipoprotein (LDL, HDL) from serum 
harvested from ewes offered diets enriched in n-3 or n-6 PUFA (n=4). 
 
Lipoprotein (L) LDL HDL   SED Significance 
Dietary source (D) n-3 n-6 n-3 n-6   
 
L D LxD 
Fatty acids g/100g TFA           
C16:0 23.3a 21.1b 19.6b 20.8b 
 
0.89 - 0.037 - 
C17:0 0.66 0.68 0.74 0.66 
 
0.05 - - - 
C18:0 12.3 12.5 11.7 12.9 
 
0.39 - - - 
C20:0 0.23 0.24 0.22 0.25 
 
0.01 - - - 
C21:0 0.18 0.16 0.12 0.2 
 
0.03 - - - 
C22:0 0.23 0.23 0.22 0.24 
 
0.01 - - - 
C23:0 1.41 1.44 1.54 1.31 
 
0.14 - - - 
C24:0 0.22a 0.47b 0.26a 0.51b 
 
0.06 - <0.001 - 
          C16:1 0.89 0.74 1.11 0.88 
 
0.09 - - - 
C17:1 0.42 0.57 0.36 0.42 
 
0.08 - - - 
C18:1n-9t 0.21a 0.37b 0.25a 0.31b 
 
0.04 - 0.01 - 
C18:1n-9c 29.2a 32.7b 30.8b 31.3b 
 
0.51 - <0.001 0.012 
C20:1 1.10a 1.54b 1.07a 1.34b 
 
0.08 - <0.001 - 
C22:1n-9 0.83 1.3 1.13 1.19 
 
0.13 - - - 
          C18:2n-6t 0.19 0.19 0.17 0.2 
 
0.02 - - - 
C18:2n-6c 6.92a 8.58b 7.23a 8.22b 
 
0.25 - <0.001 - 
C18:3n-6 0.25a 0.15b 0.27a 0.11b 
 
0.03 - <0.001 - 
C20:2n-6 0.62a 0.80b 0.52a 0.84b 
 
0.07 - 0.002 - 
C20:3n-6 0.90a 1.04b 1.00b 1.10b 
 
0.04 - 0.009 - 
C20:4n-6 2.55a 4.79b 2.78a 5.35b 
 
0.28 - <0.001 - 
C22:2n-6 0.22 0.31 0.23 0.29 
 
0.04 - - - 
C18:3n-3 0.76a 0.50b 0.75a 0.62b 
 
0.04 - <0.001 - 
C20:3n-3 0.24a 0.08b 0.22a 0.07b 
 
0.01 - <0.001 - 
C20:5n-3 2.67a 0.65b 2.62a 0.40b 
 
0.12 - <0.001 - 
C22:5n-3 5.18a 2.92b 5.26a 2.91b 
 
0.26 - <0.001 - 
C22:6n-3 2.47a 1.66b 2.59a 1.72b 
 
0.15 - <0.001 - 
          Unidentified 5.78 5.86 5.74 5.85 
 
0.19 - - - 
                    
 
Means within a row with different superscripts are significantly different (P<0.05). SED, standard 
error of the difference; TFA, total fatty acids. 
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3.3.3.2 Theca cells 
 
Transcript expression for SCARB1 increased (P<0.001) over time (Table 3.8). There 
was a lipoprotein x diet interaction (P=0.008) with highest transcript levels observed 
with inclusion of n-3 LDL. LDLR was unaffected by culture treatment or time. 
Transcript levels increase for SCD (P>0.001), FADS1 (P<0.001) and ELOVL5 
(P<0.001) over time, but none are affected by culture treatment. Expression of 
FADS2 was not affected by treatment or time. Transcripts expression for CYP11A1 
increased (P<0.001) over time, whereas expression for CYP17A decreased (P<0.001) 
with time during culture so that, by 144 h, levels were around 8% of those at 48 h. 
HSD3B1 transcripts levels increased (P<0.001) by 8-fold between 48 and 144 h. 
Transcripts for CYP11A1, CYP17A and HSD3B1 were not affected by culture 
treatment. Transcripts levels for STAR increased (P<0.001) over time and inclusion 
of n-3 PUFA led to an increase (P=0.006) of expression compared to n-6 PUFA, 
lipoprotein source did not have an effect. Transcript for ELOVL2 was not detected in 
these cells. 
 
3.4 Discussion 
 
Experiments in this chapter demonstrated that both granulosa and theca cells cultured 
in the presence of LDL and HDL were able to successfully proliferate and undergo 
steroidogenesis. This study is the first to demonstrate the effects of LDL and HDL 
from either an n-3 or n-6 dietary source on fatty acid composition of theca cells 
cultured in vitro. It is also the first to demonstrate the effects of these culture 
conditions on transcripts expression of ELOVL5, FADS1 and FADS2 in both 
granulosa and theca cells and SCD in theca cells in vitro.  The major finding of this 
study is that HDL from an n-3 PUFA background, but not an n-6 PUFA background, 
increases progesterone production at 144 hours in cultured theca, but not granulosa 
cells. This observation supports the increase in progesterone in follicular fluid 
observed in ewes offered an n-3 PUFA enriched diet, and our previous failure to 
detect differences in progesterone in cultured granulosa cells (Wonnacott et al., 
2010). Data presented in this chapter indicates that this increase is mediated by an 
HDL-specific signalling mechanism and this is associated with an increase in STAR 
expression in response to n-3 PUFA. 
  
Table 3.7 Granulosa cell transcript abundance (relative to ACTB) after culture in media supplemented with either HDL or LDL 
fractionated from sera of ewes offered n-3 or n-6 PUFA enriched diets (n=3).   
 
Lipoprotein (L) LDL HDL 
 
Time of culture (hours) (T) 
 
Significance 
Dietary Source (D) n-3 n-6 n-3 n-6 SED 48 96 144 SED L D T LxD 
n 9 9 9 9 
 
12 12 12 
   
  
              
SCARB1 0.545 0.537 0.516 0.604 0.1230 0.508 0.518 0.627 0.1066 - - - - 
LDLR 0.0175 0.0177 0.0179 0.0218 0.2792 0.0158 0.0217 0.0187 0.0024 - - - - 
SCD 0.0753 0.0704 0.0734 0.0925 0.0087 0.0197x 0.0666y 0.1475z 0.0076 - - <0.001 - 
FADS1 0.0036 0.003 0.0034 0.0038 0.0008 0.0024x 0.0024x 0.0056y 0.0007 - - <0.001 - 
FADS2 0.0007 0.0008 0.0008 0.0007 0.0001 0.0005x 0.0010y 0.0007z 0.0001 - - <0.001 - 
ELOVL5 0.166 0.14 0.149 0.166 0.0283 0.153 0.148 0.165 0.0245 - - - - 
CYP11A1 0.1127 0.1065 0.0997 0.1001 0.0222 0.108 0.1003 0.1059 0.0193 - - - - 
HSD3B1 0.0731 0.0677 0.0667 0.0782 0.0090 0.0796x 0.0405y 0.0941x 0.0080 - - <0.001 - 
STAR 0.0049a 0.0044a 0.0033b 0.0033b 0.0007 0.0015x 0.0033y 0.0069z 0.0006 0.018 - <0.001 - 
              
 
Means within a row with different superscripts are significantly different (P<0.05), SED, standard error of differences. 
 
 
  
Table 3.8 Theca cell transcript abundance (relative to ACTB) after culture in media supplemented with either HDL or LDL fractionated 
from sera of ewes offered n-3 or n-6 PUFA enriched diets (n=3).   
 
Lipoprotein (L) LDL HDL 
 
Time of culture (hours) (T) 
 
Significance 
Dietary Source (D) n-3 n-6 n-3 n-6 SED 48 96 144 SED L D T LxD 
n 9 9 9 9 
 
12 12 12 
   
  
              
SCARB1 0.2334a 0.2017b 0.1917b 0.2208a 0.0149 0.1226x 0.2347y 0.2785z 0.0129 - - <0.001 0.008 
LDLR 0.0059 0.0062 0.0063 0.0070 0.0011 0.0063 0.0056 0.0073 0.0008 - - - - 
SCD 0.0142 0.0177 0.0115 0.0132 0.0017 0.0085x 0.0102x 0.0191y 0.0014 - - <0.001 - 
FADS1 0.0029 0.0028 0.0029 0.0033 0.0003 0.0017x 0.0031y 0.0041z 0.0003 - - <0.001 - 
FADS2 0.0012 0.0013 0.0013 0.0013 0.0001 0.0013 0.0013 0.0013 0.0001 - - - - 
ELOVL5 0.1069a 0.0776b 0.0836b 0.0898b 0.0098 0.0741x 0.0790x 0.1153y 0.0085 - - <0.001 0.018 
CYP11A1 0.0633 0.0671 0.0642 0.0694 0.0062 0.0423x 0.0612y 0.0945z 0.0053 - - <0.001 - 
CYP17A 0.0052 0.0049 0.0039 0.0045 0.0012 0.0118x 0.0012y 0.0009y 0.0010 - - <0.001 - 
HSD3B1 0.0539 0.0612 0.0562 0.0655 0.0129 0.0127x 0.0599y 0.105z 0.0112 - - <0.001 - 
STAR 0.018a 0.010b 0.018a 0.012b 0.0031 0.004x 0.012y 0.027z 0.0027 - 0.006 <0.001 - 
              
 
Means within a row with different superscripts are significantly different (P<0.05), SED, standard error of differences. 
. 
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3.4.1 Cell proliferation and steroidogenesis 
 
Several studies have reported that both LDL and HDL can provide cholesterol for 
steroid hormone synthesis and aid proliferation of theca and granulosa cells in 
FXOWXUH2¶6KDXJKQHVV\et al., 1989; Bao et al., 1995; Bao et al., 1997; Ragoobir et 
al., 2002; Cherian-Shaw et al., 2009). However, studies so far have reported effects 
in granulosa and granulosa-lutein cells, and thus far effects in theca cells have been 
reported only by Bao et al. (1995). In agreement with Bao et al. (1995), who have 
shown HDL promoting progesterone production in granulosa cells having undergone 
partial luteinisation, the current study found progesterone levels increase and 
oestradiol decease over time in granulosa cells, which is indicative of luteinisation. 
However no difference between LDL and HDL were noted. Theca cells in this study 
produced oestradiol at very low levels throughout and progesterone levels increased 
over time. This is also in agreement with Bao et al. (1995), who also noted that HDL, 
but not LDL increased progesterone production in theca cells.  In the current study 
HDL also increased progesterone production between 96 and 144 h compared to 
LDL, but only HDL from the n-3 source, and not the n-6, led to this increase. This 
indicates that HDL stimulates progesterone production by a mechanism not solely 
reliant on cholesterol delivery. To illustrate this, Chandras et al. (2004) found that 
lipid-free apolipoprotien-A1 (the major protein component of HDL) increased 
progesterone production in human granulosa-lutein cells following 3 days of culture. 
 
3.4.2 Transcript expression 
 
Transcript levels for HSD3B1 and STAR increased in granulosa cells over time, this 
is consistent with the increase in progesterone production over the same time frame. 
This finding is consistent with a study by Zheng et al. (2009) who noted a similar 
pattern in bovine granulosa cells over the same time scale. SCD transcript levels also 
increased over time, but were not altered by treatment. A study by Marra and de 
Alaniz (1989) reported a significant increase in SCD expression in the liver of rats 
given an injection of testosterone. Testosterone is included as standard in granulosa 
culture as a precursor for oestradiol synthesis, and is replenished every 48 hours with 
media changes. Insulin is also included in our cultures as standard and has been 
reported to increase SCD expression in adipose tissue of sheep (Daniel et al., 2004). 
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Transcript levels of FADS1 increased at 144 h, whereas FADS2 increased at 96 and 
dropped again by 144 h. These enzymes also have been shown to be upregulated by 
insulin (Brenner, 2003) and testosterone in rat sertoli cells (Hutado de Catalfo and de 
Gomez Dumm, 2005). 
 
In theca cells, transcript levels for CYP11A, HSD3B1 and STAR increased over time. 
This again is consistent with the increase in progesterone production over time. LH 
and insulin have been reported to increase STAR expression in cultured porcine theca 
cells (Zhang et al., 2000). CYP11A1 and HSD3B1 have also been shown to be 
increased with addition of LH in culture (Keeney and Mason 1992; Clemens et al., 
1994). Again, insulin and LH are standard additives for theca culture in our 
laboratory. Levels of CYP17A decreased over time to lowest levels at 144 h, 
suggesting that by this stage of culture theca cells have begun to luteinise (Demeter-
Arlotto et al., 1993). Transcript levels for ELOVL5, SCD and FADS1 increased with 
time during culture. As mentioned previously, desaturases have been shown to be 
mediated by insulin (Brenner, 2003), but it seems that very few studies have 
investigated the regulation of elongase expression.  It seems that the PUFA-sensitive 
transcription factors SREBP and PPAR play a role in the regulation of these genes 
(Jakobsson et al., 2006) but the time dependant increase seen in the current study is 
not yet fully understood. 
 
An interesting effect on STAR transcript is that n-3 PUFA-enriched lipoproteins 
increased expression compared to n-6 PUFA-enriched lipoproteins. This would 
explain the increased progesterone production seen with inclusion of n-3 HDL, but 
would suggest that further mechanisms are involved which are active with delivery 
by HDL but not LDL. Published data have reported that arachidonic acid (AA, 
C20:4n-6) is essential for STAR expression (Wang et al., 2000), via a variety of 
complex mechanisms, none of which have been fully elucidated. All treatments in 
this study contained AA, and subsequent FA analysis revealed that theca cells 
contained approximately 2.6g/100g TFA in n-3 PUFA treatments and 5g/100g in n-6 
PUFA treatments. The increase in STAR expression seen in both n-3 cultures relative 
to n-6 treatment could be explained, at least in part, by a reduction in levels of n-6 
PUFA metabolites that are known to inhibit STAR expression (Wang et al., 2005; 
Wang et al., 2006). Other mechanisms could include the inhibition of transcription 
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factors by PUFA. The STAR gene is known to contain promoter regions for many 
transcription factors, including PPAR-Ȗ(Kowalewski et al., 2009) and SREBP (Shea-
Eaton et al., 2001), both of which can be positively and negatively regulated by 
PUFA (Jump et al., 1996; Duplus et al., 2000; Grimaldi, 2001; Sampath and Ntambi, 
2004; Schmitz and Ecker, 2008). This PUFA-regulation of gene expression could 
also explain the differences observed in SCARB1 and ELOVL5 transcripts between 
treatments; both transcripts were expressed at their highest levels in the presence of 
n-3 PUFA from an LDL source (Table 3.8) and are known to be regulated by the 
SREBP family transcription factors (Lopez and McLean 1999; Moon et al., 2001).   
 
3.4.3 Fatty acid composition 
 
The proportions of n-3 and n-6 PUFA detected in granulosa and theca cells reflect 
the composition of the treatments added to culture media (A.2.3 and A.2.4). This 
demonstrates that both cell types are capable of taking up FA via LDL and HDL 
from the culture media. However, uptake of FA from lipoproteins by these cell types 
in vivo is not fully understood. It seems that the basement membrane could 
potentially restrict access by granulosa cells to the full complement of lipoproteins 
found in peripheral circulation, whereas thecal and luteal cells are exposed to all 
lipoprotein classes (Grummer and Carroll 1988). Only a few studies (Reis et al., 
2002; Adamiak et al., 2006; Zachut et al., 2010; Wonnacott et al., 2010) have 
determined the FA composition profile of granulosa cells and none have reported this 
information for theca cells. Levels of MUFA and PUFA in granulosa cells are similar 
to that observed by Adamiak et al. (2006) and levels of saturates and unsaturates are 
similar to that reported by Wonnacott et al. (2010) and Reis et al. (2002). Proportions 
of PUFA, on average, are higher in theca cells than granulosa (Table 3.4) with 10 out 
of the 12 identified PUFA being significantly altered by dietary source (i.e. n-3 vs n-
6), as opposed to 7 out of 12 in granulosa. This suggests a more efficient uptake 
mechanism is in place in theca compared to granulosa cells. SCD transcript levels 
increased by 7-fold from 48 to 144 h, which may indicate why oleic acid (C18:1n-9) 
constitutes such a large proportion of TFA (30.9 ± 0.35 g/100g) in granulosa cells at 
144 h of culture. This observation is consistent with levels of oleic acid observed in a 
previous study in our laboratory (Wonnacott et al., 2010). Both theca and granulosa 
cells contain approximately 35g/100g MUFA, whereas the serum fractions added to 
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culture media contain approximately 20g/100g MUFA (A.2.1), suggesting a selective 
uptake or de novo synthesis of MUFA in these cells, which also may contribute 
towards the observed high levels of oleic acid in both cell types. A study by Mu et al. 
(2001) demonstrated that human granulosa cells cultured with palmitic (C16:0) and 
stearic (C18:0) acid underwent apoptosis in a dose-dependent manner, whereas other 
FA such as oleic (C18:1n-9), arachidonic (C20:4n-6) and linoleic acid (C18:2n-6) 
did not have the same effect. This may provide another reason for the high levels of 
SCD transcript and oleic acid observed in the current study, as SCD utilises stearic 
acid as preferred substrate for production of oleic acid, minimizing levels of 
potentially harmful FA.   
 
3.5 Conclusions 
 
In this study, HDL and LDL were added to culture at physiological levels, according 
to TFA concentration. LDL contains approximately four-fold higher levels of 
cholesterol than HDL. Therefore, the fact that HDL, on average, evoked a greater 
steroid response than LDL suggests that the efficiency of cholesterol delivery 
between these two particles differs, or that HDL-specific intra-cellular signalling is 
key for steroidogenesis. However, due to the greatest steroid response being 
observed with n-3 HDL, maximal steroid output seems to rely on other mechanisms 
which are stimulated by n-3 PUFA. Such mechanisms include; gene regulation 
through PUFA-sensitive transcription factors and/or alteration of PUFA-mediated 
signalling pathways. To the best of our knowledge this is the first time that n-3 
PUFA-enriched HDL in combination with HDL-specific signalling has been 
demonstrated to increase progesterone production via mediation of STAR regulation. 
Also, transcript expression for ELOVL5, FADS1 and FADS2 has been reported, to 
the best of our knowledge, for the first time in mammalian granulosa and theca cells 
indicating that these cell types are actively metabolising FA. 
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CHAPTER 4 
 
The effect of serum and serum derived LDL and albumin from ewes fed n-3 or 
n-6 PUFA enriched diets on the development, fatty acid composition and  
gene expression of ovine blastocysts 
 
4.1 Introduction 
 
The growth and maturation of the follicular-enclosed oocyte relies on a complex 
exchange of metabolites and molecules between the germ cell and surrounding 
somatic cells of the ovary (Cecconi et al., 2004). Adamiak et al. (2006) observed that 
oocytes assimilate and metabolise FA from the follicular environment which may 
affect the quality of the oocyte. The intrinsic quality of the oocyte is the key factor 
determining the proportion of zygotes developing to the blastocyst stage (Lonergan 
et al., 2003). A previous study in our laboratory cultured in vitro derived ovine 
embryos with HDL from an either n-3 or n-6 PUFA source (Wonnacott et al., 2010). 
There was no net uptake of FA by embryos in that study although PUFA 
supplementation altered the expression of several transcripts indicating that embryos 
were responsive to the culture conditions. 
 
The current chapter considered the effects of physiological levels of n-3 and n-6 
PUFA enriched serum, LDL and albumin fractions on in vitro cultured embryos. 
LDL is the second most abundant lipoprotein in the follicular fluid of ruminants 
(Argov et al., 2004; Wonnacott et al., 2010). Albumin is known to be a fatty acid 
transporter and is the predominant protein found in follicular fluid in humans and 
cattle where the concentration increases with increasing follicular size (Mortarino et 
al., 1999; Wen et al., 2009). Albumin has also been identified as one of the major 
lipid carriers in oviductal fluid and accounts for up to 80% of all oviductal proteins 
(Menezo and Guerin, 1997). Previous work has indicated that embryos cultured with 
individual FAs complexed with BSA have been able to assimilate FA (Reis et al., 
2003). The current study tested the hypothesis that serum-derived lipids are delivered 
to developing embryos only by the albumin fraction. Therefore, albumin delivered n-
3 and n-6 PUFA were expected to exert a greater differential effect on pre-
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implantation embryo development than either LDL or HDL (the latter fraction was 
tested by Wonnacott et al., 2010). 
 
FA analysis by gas chromatography was used to asses the composition of the 
embryos and therefore the ability of LDL and albumin fractionated from the sera of 
n-3 and n-6 PUFA fed ewes to successfully deliver FA to the embryo. Transcripts for 
the following genes involved in lipid uptake and metabolism were selected for 
analysis in blastocysts by qRT-PCR; SCARB1, LDLR, SCD, ELOVL2, ELOVL5, 
FADS1, FADS2 as previously described in section 3.1 and superoxide dismutase 
(SOD1). The desaturase enzymes (SCD, FADS1 and FADS2) and elongase (ELOVL2 
and ELOVL5) enzymes are important in the synthesis of long chain fatty acids and 
the expression of these transcripts (except SCD) have never previously been reported 
in the pre-implantation embryo. SOD1 expression is a marker for cellular stress from 
reactive oxygen species which have the ability to induce damaging lipid 
peroxidation. The molecular analysis was carried out to determine (i) how LDL and 
albumin might differ in initiating intracellular signalling thus affecting the expression 
of the chosen transcripts and (ii) how n-3 and n-6 PUFA differ in their ability to 
regulate the expression of these genes.  
 
4.2 Materials and methods 
 
All reagents were obtained from Sigma-Aldrich unless otherwise stated. Embryo 
cultures were divided into two experiments; 1) FAF-BSA vs n-3 or n-6 serum, and 2) 
FAF-BSA vs n-3 or n-6 LDL or albumin. The second experiment was sub divided 
into 2 parts; samples to be used for FA analysis and those for qRT-PCR experiments.  
Samples to be used for FA compositional analysis were cultured with all 5 treatments 
running in parallel (i.e. FAF-BSA, n-3 LDL, n-6 LDL, n-3 albumin, n-6 albumin). 
Samples destined for qRT-PCR were run separately (i.e. (a) FAF-BSA with n-3 or n-
6 LDL and (b) FAF-BSA with n-3 or n-6 albumin). Experiments were carried out 
using standard culture media (SOF, A.3.7) with supplements (i.e. serum, LDL or 
albumin). Omega-3 and -6 sera were obtained from ewes fed diets enriched with n-3 
or n-6 PUFA (sections 2.2.1.1 and 2.2.1.3). LDL and albumin fractions were 
obtained from sera of n-3 or n-6 fed ewes via ultracentrifugation (sections 3.2.1.1 
and 3.2.1.2).  
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4.2.1 Media supplements 
 
For the first experiment, serum from n-3 or n-6 FA fed ewes (A.2.2) was added to 
SOF media at 5% v/v. LDL and albumin fractions were separated from serum from 
ewes fed either a high n-3 or high n-6 diet (A.2.3 and A.2.5). The LDL and albumin 
fraction treatments were added to culture based on their TFA content. The levels 
added were formulated to deliver physiological amounts of FA to the blastocysts. 
Fatty acid levels equivalent to 1% v/v serum were added to culture media. This was 
in keeping with previous work in our laboratory (Wonnacott et al., 2010). Levels of 
up to 10% serum in culture media are standard in our laboratory and elsewhere 
(Rizos et al., 2003; Carolan et al., 1995; Lonergan et al., 2004). TFA content of 
whole serum was calculated before fractionation (1442µg/ml) (Table A.2.1), 
consequently 1% equivalent was calculated to deliver 14.4µg/ml of TFA. Therefore, 
on average, 11.4µl of either LDL fraction or 160µl of either Albumin fraction was 
added to each ml of culture media. 
 
4.2.2 Embryo culture 
 
Ovine ovaries were collected from a local abattoir and transported in warm (37°C) 
sterile PBS to the laboratory. On arrival ovaries were rinsed with 70% ethanol and 
warm sterile PBS. Ovaries were kept at 37°C in PBS in a hot box during aspiration. 
Follicles were aspirated and cumulus-oocyte complexes (COCs) of grades 1 and 2 
(IETS, 1998) were washed 3 times in pre-warmed search media (A.3.1) and washed 
once in pre-warmed and gas-equilibrated maturation media (A.3.2). Up to 70 COC 
were then transferred to a single well of a 4-well culture plate containing maturation 
medium and placed in a humidified incubator at 38.8°C and 5% CO2 for 24 h. 
Matured oocytes were gently pipetted in the wells to remove expanded cumulus 
cells. Oocytes were washed twice in warmed PBS/0.1%PVA and once in fertilisation 
medium (A.3.5) before being placed in groups of up to 70 in wells containing 460µl 
equilibrated fertilization medium. A frozen semen pellet from a single ram was 
thawed by immersing a glass tube in water at 35°C for 30-60 seconds. 125µl of 
thawed semen was layered under 3ml of sperm wash media in conical tubes for 
swim-up procedure (A.3.4). Tubes were placed in a humidified atmosphere at 39°C 
and 5% CO2 for 1 h. The top layer of the solution containing  motile spermatozoa 
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was transferred to a second tube and centrifuged at 300xg for 10 min. Supernatants 
were removed leaving approximately 200µl, and pellets were resuspended. 10µl of 
this solution was added to 90µl water and sperm concentration was established using 
a haemocytometer. Spermatozoa were added to fertilization media to establish a final 
concentration of 1x106 motile spermatozoa/ml (A.3.5). The oocytes and spermatozoa 
were incubated in a humidified atmosphere at 38.8°C and 5% CO2 for 24 h. 
Presumptive zygotes were transferred to a 35mm petri dish containing HEPES SOF 
medium (A.3.6) and denuded of any remaining cumulus cells and attached sperm by 
gentle pipetting. Denuded zygotes were washed once in HEPES SOF and then 
transferred to fresh media and incubated at 38.8°C and 5% CO2 for 24 hours. 
Cleaved embryos were then transferred to treatment media (either SOFaaBSA, 
SOFaaSerum n-3, SOFaaSerum n-6 SOFaaLDL n-3, SOFaaLDL n-6, 
SOFaaAlbumin n-3 or SOFaaAlbumin n-6) for 72 hours. Morphological assessments 
of embryo development and quality were carried out on days 5, 6 and 7 after IVF 
according to the International Embryo Transfer Society (IETS) classification system 
(IETS, 1998). On day 7 blastocysts were washed 6 times in PBS/0.1%PVA, quality 
was recorded and these embryos were then frozen in either liquid nitrogen or on dry 
ice for GC analysis or transcript analysis, respectively.  
 
4.2.3 RNA extraction 
 
RNA was extracted from ovine blastocysts using Dynabeads® mRNA DIRECT kit 
(Invitrogen, Paisley, UK). This method uses oligo (dT) primers, covalently bound to 
the surface of magnetic beads to hybridise the poly-A tail of mRNA for specific 
isolation. Blastocysts were lysed in 150µl of kit-supplied lysis buffer for 15 min at 
room temperature. Dynabeads were washed and suspended in lysis buffer and 40µl 
of bead solution added to each sample and incubated for 10 minutes at room 
temperature with rotation. The supernatant was removed by placing the tubes on a 
magnet (Dynal-MPC-S), after several seconds the beads form a pellet on the side of 
the tube allowing removal of supernatant by pipetting. The beads were washed 3 
times (100µl each) with buffer A and 2 times with buffer B. The beads were then 
resuspended in 10µl of RNase-free water and incubated for 2 min at 65°C.  Samples 
were transferred to ice immediately to prevent RNA re-annealing to beads. All 
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supernatants (10µl of RNase-free water containing mRNA) were removed and 
transferred to clean tube.  RNA was stored at -80°C.   
 
4.2.4 Reverse transcription 
 
Reverse transcription of RNA to cDNA was carried out using the QuantiTect® RT kit 
(Qiagen Ltd., West Sussex, UK). This kit provides high yields of cDNA from low 
levels of RNA with removal of genomic DNA. RNA was thawed on ice and 10µl 
RNA (eluted from Dynabeads) was added to the following; 2µl gDNA Wipeout 
Buffer (x7) and 2µl RNase-free water. The mix was incubated for 2 min at 42°C and 
placed on ice immediately. For the ±RT reaction, 1µl of the mix was removed and 
kept on ice. To the remaining 13µl the following was added; 1µl Quantiscript reverse 
transcriptase, 4µl Quantiscript RT buffer (x5), 1µl RT primer mix (contains both 
oligo(dT) and random primers), 1µl diluted gDNA wipeout buffer (2µl gDNA 
wipeout buffer and 12µl RNase free water), totalling 20µl reaction volume. Samples 
were incubated at 42°C for 30 min and then at 95°C for 3 min to inactivate the 
enzyme. Samples were stored at -20°C. For the ±RT reaction, 7.4µl of RNase-free 
water was added to the 1µl saved from earlier and incubated at 95° for 3 min. The 
cDNA was diluted with water to 0.131 blastocysts per µl and stored at -20°C. 
 
4.2.5 Quantitative RT-PCR 
 
Transcripts were analysed by qRT-PCR as previously described (section 2.2.1.12). 
Cycling parameters and primer and probe sequences can be found in Tables 2.3, 3.2 
and 4.1. SCARB1, ELOVL2 and FADS1 used forward and reverse primer 
concentrations of 1.2µl (10pmol/µl); all other primers used 0.6µl (10pmol/µl) of each 
primer. A total of 2µl cDNA was used per PCR reaction (0.26 blastocysts/reaction) 
and all samples were run in duplicate. All transcripts were measured relative to the 
reference gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
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Table 4.1 Primer and probe sequences for GAPDH and SOD1. 
 
Name Sequence 5'-3' NCBI 
Accession 
Primer 
Efficiency 
   
 
GAPDH 
  
 
F TCCGTTGTGGATCTGACCTG AF030943 1.82 
R TGCTTCACCACCTTCTTGATCTC Ovis aries  
Probe FAM-CGCCTGGAGAAACCTGCCAAGTATGA-TAMRA 
 
 
   
 
SOD1 
  
 
F GCCGTCTGCGTGCTGAA XM 584414 1.99 
R ACTGTATTTCCCTTTGCCTCGA Bos Taurus  
Probe FAM-CCCGGTGCAAGGCACCATCC-TAMRA 
 
 
 
 
 
 
 
 
4.2.6 Analysis of embryos by gas chromatography 
 
Procedures for the preparation of embryos for analysis by gas chromatography were 
described previously for theca and granulosa cells (Section 3.2.4), except that 50µl 
200µg/ml pentadecanoic acid was added to each sample as an internal standard. 
Refer to section 3.2.1.4 and Table 3.1 for run and GC oven parameters. 
 
4.2.7 Statistical analysis 
 
All statistical analysis was conducted by Genstat release 11 (Genstat, 2009). The 
proportion of zygotes that developed to blastocysts was analysed by analysis of 
deviance using Generalized Linear Models (GLM) assuming binomial errors with 
logit link functions. The effects of culture treatment and morphological assessments 
of embryo stage and grade were assessed by ordinal regression analysis assuming 
multinomial errors with logit link functions. Transcript and FA data for Day 7 
blastocysts were analysed by ANOVA.  
 
To recap, two experiments were conducted to determine the FA composition of 
blastocysts (a serum experiment and an experiment which added LDL and albumin). 
The serum experiment consisted of three treatments FAF-BSA vs n-3 PUFA serum 
vs n-6 PUFA serum, which was replicated 4 times. The LDL and albumin 
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experiment consisted five treatment groups (FAF-BSA vs n-3 LDL vs n-6 LDL vs n-
3 albumin vs n-6 albumin), which was replicated three times. 
4.3 Results 
 
4.3.1 In vitro embryo development 
 
4.3.1.1 Experiment 1 (FAF-BSA vs n-3 or n-6 serum) 
 
The proportion of cleaved zygotes that developed to the blastocyst stage by Day 6 of 
culture was greater (P<0.001) for the two serum treatments than for FAF-BSA 
(Figure 4.1 A). By day 7 the proportion of blastocysts in the FAF-BSA treatment 
group had increased but was still lower than in both serum groups (P=0.048). There 
was no effect of serum or PUFA source on the proportion of blastocysts classified 
(IETS, 1998) by stage of development (Figure 4.2A). The inclusion of PUFA 
enriched serum increased (P<0.001) the proportion of lower grade (IETS, 1998) Day 
7 blastocysts (Figure 4.3 A), PUFA source had no effect on morphological grade. 
 
4.3.1.2 Experiment 2a (FAF-BSA vs n-3 or n-6 LDL) 
 
The proportion of cleaved zygotes that developed to the blastocyst stage by day 6 
and 7 of culture in both LDL treatment groups was equal to those observed in the 
FAF-BSA control group (Fig 4.1B). There was no effect of LDL or of PUFA source 
on the proportion of blastocysts classified by stage of development (Figure 4.2B). 
The inclusion of PUFA enriched LDL also did not affect the proportion of Day 7 
blastocysts classified by grade (Figure 4.3 C). 
 
4.3.1.3 Experiment 2b (FAF-BSA vs n-3 or n-6 albumin) 
 
The proportion of cleaved zygotes that developed to the blastocyst stage by Day 6 of 
culture was greater (P<0.001) for both albumin treatments compared to FAF-BSA 
control (Fig 4.1 C).  By Day 7 the proportion of blastocysts in FAF-BSA group had 
increased but numbers were still greater for both albumin groups (P<0.001). PUFA 
source (i.e. n-3 vs n-6) did not affect development. There was no effect of albumin or 
PUFA source on the proportion of blastocysts classified by stage of development 
  
106 
(Figure 4.2C). The inclusion of PUFA enriched albumin increased (P<0.001) the 
proportion of lower grade Day 7 blastocysts (Figure 4.3 C). PUFA source once again 
had no effect. 
 
4.3.2 Fatty acid composition of in vitro produced blastocysts 
 
4.3.2.1 Experiment 1 (FAF-BSA vs n-3 or n-6 serum) 
 
TFA content (ng/blastocyst) did not differ between treatments (Table 4.2). No 
significant difference was found between treatments for saturated, unsaturated 
MUFA and PUFA. There was a reduction (P=0.004) in n-6 PUFA with inclusion of 
serum compared to FAF-BSA.  Compared to FAF-BSA control, inclusion of serum 
increased (P<0.001) n-3 PUFA and was greatest (P=0.004) with inclusion of sera 
from the n-3 PUFA source. The most abundant FA in these blastocysts was stearic 
acid (C18:0) comprising, on average, 30.5 ± 1.26 g/100 g TFA (Table 4.3). Oleic 
acid (C18:1,n-9) was the second most abundant FA at 29.1 ± 1.53 g / 100 g TFA and 
palmitic acid (C16:0) the third at 22.8 ± 0.76 g/100g TFA. Oleic acid was lowest 
(P=0.04) with inclusion of n-6 serum compared to FAF-BSA and n-3 serum 
treatments. Four out of the five identified n-3 PUFA were increased with inclusion of 
serum compared to FAF-BSA; eicosatrienoic acid (C20:3,n-3) (P=0.03), 
eicosapentanoic acid (C20:5,n-3) (P=0.004), docosapentaenoic acid (C22:5,n-3) 
(P=0.004) and docosahexaenoic acid (C22:6,n-3) (P<0.001). Of these four, three had 
significantly increased levels following inclusion of n-3 serum compared to n-6 
serum; i.e. eicosapentanoic acid (C20:5,n-3) (P=0.004), docosapentaenoic acid 
(C22:5,n-3) (P=0.04) and docosahexaenoic acid (C22:6,n-3) (P<0.001). 
 
 4.3.2.2 Experiment 2 (FAF-BSA vs n-3 or n-6 LDL or albumin) 
 
TFA (ng/blastocyst) was greater (P=0.024) with the inclusion of albumin compared 
to FAF-BSA and LDL treatments (Table 4.3). No significant difference was found 
between treatments for saturated, unsaturated, MUFA and PUFA. There was a 
reduction (P=0.014) in n-6 PUFA and an increase (P=0.001) in n-3 PUFA with 
inclusion of albumin, regardless of PUFA dietary source. The most abundant fatty     
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Figure 4.1 Mean (±SEM) blastocysts of cleaved following 6 or 7 days of culture in 
SOF media supplemented with A) FAF-BSA, n-3 or n-6 PUFA enriched serum, B) 
FAF-BSA, n-3 or n-6 PUFA enriched LDL and C) FAF-BSA, n-3 or n-6 PUFA 
enriched Albumin, all fractionated from sera of ewes offered n-3 or n-6 PUFA 
enriched diets.  
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Figure 4.2. Effect of culture treatment on stage of development of Day 7 sheep 
blastocysts. (A) FAF-BSA, n-3 or n-6 PUFA enriched serum, (B) FAF-BSA, n-3 or 
n-6 PUFA enriched LDL and (C) FAF-BSA, n-3 or n-6 PUFA enriched albumin 
fractionated from sera of ewes offered n-3 or n-6 PUFA enriched diets. EB = early 
blastocyst; B = blastocyst; Ex = expanding blastocyst; Ht = hatching blastocyst; Htd 
= Hatched blastocyst. 
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Figure 4.3. Effect of culture treatment on morphological grade of Day 7 sheep 
blastocysts.  (A) FAF-BSA, n-3 or n-6 PUFA enriched serum, (B) FAF-BSA, n-3 or 
n-6 PUFA enriched LDL and (C) FAF-BSA, n-3 or n-6 PUFA enriched albumin 
fractionated from sera of ewes offered n-3 or n-6 PUFA enriched diets. Grade 1 = 
Excellent, grade 4 = Degenerating (IETS 1998).  
  
110 
acid in these blastocysts was oleic acid (C18:1n-9), comprising on average, 45.9 ± 
0.51 g/100g TFA (Table 4.4). Stearic acid (C18:0) was the second most abundant FA 
at 14.9 ± 0.27 g/100g TFA and palmitic acid (C16:0) the third at 13.6 ± 0.23 g/100g 
TFA. None of these three FA differed between treatments. Two out of the twenty-six 
FA reported were not detected in these blastocysts from any treatment group. Four 
out of the five identified n-3 PUFA were significantly increased with inclusion of 
albumin compared with FAF-BSA and LDL; i.e. eicosatrienoic acid (C20:3,n-3) 
(P=0.02), eicosapentanoic acid (C20:5,n-3) (P=0.003), docosapentaenoic acid 
(C22:5,n-3) (P=0.003) and docosahexaenoic acid (C22:6,n-3) (P<0.001). 
 
4.3.3 Transcript expression of in vitro produced blastocysts 
 
4.3.3.1  FAF-BSA vs n-3 or n-6 serum 
 
The addition of serum in culture reduced (P<0.001) LDLR transcript levels by 7-fold, 
dietary source (i.e. n-3 vs n-6) had no effect (Figure 4.4). SCARB1 expression was 
also not affected by treatment. Levels of SOD1 were increased (P=0.004) with the 
addition of serum in culture. Transcript expression for SCD decreased (P<0.001) 
with inclusion of serum, but again dietary source had no effect (Figure 4.5). 
Expression of FADS2 increased (P=0.012) with inclusion of n-6 PUFA serum 
compared to n-3PUFA serum and FAF-BSA control. Serum had no effect on 
expression of ELOVL5. Transcripts for FADS1 and ELOVL2 were not detected. 
 
4.3.3.2 FAF-BSA vs n-3 or n-6 LDL 
 
Inclusion of n-3 LDL in embryo culture media reduced LDLR (P=0.003) and 
SCARB1 (P=0.029) expression compared with FAF-BSA control (Fig 4.4). Dietary 
source of LDL also affected SCARB1 with addition of n-3 PUFA causing a reduction 
(P=0.008) in expression. SOD expression was not affected by treatment. SCD 
expression was reduced (P=0.014) with inclusion of n-3 compared with n-6 PUFA  
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Table 4.2 Fatty acid composition (g/100g TFA) of ovine blastocysts cultured in vitro 
in the presence of media supplemented with FAF-BSA or serum of ewes fed a high 
n-3 or n-6 diet (n=4). 
 
Treatment (T) BSA Serum SED Significance 
Dietary Source (D)   n-3 n-6 
 
T TxD 
TFA (ng/blastocyst)  150.6 157.8 166.6 5.17 - - 
Saturated 55.5 56.2 58.0 0.88 - - 
Unsaturated 40.7 40.2 38.3 0.82 - - 
MUFA 32.6 31.8 30.8 0.52 - - 
PUFA 8.10 8.32 7.49 0.35 - - 
n-6 series 7.17a 6.11b 6.10b 0.25 0.004 - 
n-3 series 0.93a 2.21b 1.48c 0.16 <0.001 0.004 
Ratio n-6:n-3 7.67a 2.71b 4.19c 0.53 <0.001 0.05 
 
Means within a row with different superscripts are significantly different (P<0.05): SED, standard 
error of difference; TFA, total fatty acids. 
 
 
 
 
LDL and FAF-BSA control (Figure 4.5). FADS2 expression was not affected by 
treatment. Transcript expression for ELOVL5 was reduced (P=0.003) with inclusion 
of LDL from both dietary sources compared with FAF-BSA control. Transcripts for 
FADS1 and ELOVL2 were not detected. 
 
4.3.3.3 FAF-BSA vs n-3 or n-6 albumin 
 
Inclusion of n-3 PUFA enriched albumin from an n-3 source reduced transcript 
expression for LDLR (P=0.025) and SCARB1 (P=0.032) compared with n-6 PUFA 
albumin and FAF-BSA control (Fig 4.4). SOD1 expression was increased (P=0.05) 
with inclusion of albumin in culture compared to FAF-BSA; PUFA source had no 
effect. All other transcripts were not significantly altered. FADS1 and ELOVL2 
transcripts were not detectable. 
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Table 4.3 Fatty acid composition (g/100g TFA) of ovine blastocysts cultured in vitro 
in the presence of media supplemented with FAF-BSA, LDL or albumin enriched 
with n-3 or n-6 PUFA (n=3).  
 
Treatment (T) BSA Lipoprotein Fraction         
Fraction (F) 
 
LDL Albumin SED Significance 
Dietary Source (D) 
  n-3 n-6 n-3 n-6 
 
T TxF TxD 
          TFA (ng/blastocyst) 119.2a 115.3a 121.1a 126.6b 131.1b 5.43 - 0.024 - 
Saturated 33.0 34.2 33.2 31.0 33.3 1.35 - - - 
Unsaturated 63.2 61.9 63.1 65.4 62.7 1.06 - - - 
MUFA 48.9 47.5 47.9 50.2 48.9 1.32 - - - 
PUFA 14.2 14.4 15.2 15.2 13.9 0.83 - - - 
n-6 series 12.9ab 13.3a 14.4a 11.6b 11.6b 1.03 - 0.014 - 
n-3 series 1.36a 1.10a 0.74a 3.54b 2.29b 0.57 - 0.001 - 
Ratio n-6:n-3 9.75a 12.2b 19.7c 3.31d 6.75d 2.32 - <0.001 0.01 
          
 
Means within a row with different superscripts are significantly different (P<0.05): SED, standard 
error of difference; TFA, total fatty acids. 
 
 
 
4.4 Discussion 
 
The current study has demonstrated that pre-implantation embryos can assimilate FA 
from the surrounding environment via albumin binding and uptake. This is the first 
study to demonstrate the effects of LDL and albumin fractionated from the sera of 
experimental animals on fatty acid composition and transcript expression in 
blastocysts. The important finding from this study is that whilst sheep embryos can 
respond to LDL and HDL (HDL investigated previously in our laboratory, 
Wonnacott et al., 2010) in terms of altered transcript expression, only serum and 
albumin alters their FA composition. Also, this is the first study to report the 
presence of ELOVL5 and FADS2 transcripts in mammalian embryos. 
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Table 4.4. Fatty acid composition (g/100g TFA) of ovine blastocysts cultured in 
vitro in the presence of media supplemented with FAF-BSA or serum of ewes fed a 
high n-3 or n-6 PUFA diet (n=4). 
 
Treatment (T) BSA Serum SED Significance 
Dietary Source (D)   n-3 n-6 
 
T TxD 
C16:0 22.4 22.7 23.3 0.29 - - 
C17:0 ND ND ND - - - 
C18:0 30.0 30.4 31.1 0.29 - - 
C20:0 1.14 1.16 1.16 0.02 - - 
C21:0 0.13 0.22 0.18 0.06 - - 
C22:0 ND ND ND - - - 
C23:0 1.40 1.05 1.8 0.45 - - 
C24:0 0.39 0.59 0.57 0.12 - - 
       C16:1 0.78 0.79 0.76 0.03 - - 
C17:1 ND ND ND - - - 
C18:1n-9t 1.59 1.55 1.46 0.12 - - 
C18:1n-9c 29.8a 29.1a 28.3b 0.47 0.048 - 
C20:1n-9 0.36 0.41 0.37 0.03 - - 
C22:1n-9 ND ND ND - - - 
       C18:2n-6t ND ND ND - - - 
C18:2n-6c 3.79a 4.18b 4.13b 0.09 0.01 - 
C18:3n-6 ND ND ND - - - 
C20:2n-6 0.03a 0.04a 0.18b 0.05 - 0.046 
C20:3n-6 0.35 ND ND - - - 
C20:4n-6 2.95a 1.89b 1.67c 0.19 <0.001 - 
C22:2n-6 0.05 ND 0.03 - - - 
       C18:3n-3 0.33 0.41 0.36 0.02 - - 
C20:3n-3 0.24a 0.34b 0.32b 0.03 0.034 - 
C20:5n-3 0.11a 0.35b 0.18c 0.04 0.004 0.004 
C22:5n-3 0.05a 0.57b 0.30c 0.10 0.004 0.04 
C22:6n-3 0.21a 0.55b 0.32c 0.03 <0.001 <0.001 
       Unidentified 3.83 3.67 3.63 0.23 - - 
       
 
Means within a row with different superscripts are significantly different (P<0.05): NS, not 
significant: SED, standard error of difference; ND, below detectable limit (<0.03): 
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Table 4.5 Fatty acid composition (g/100g TFA) of ovine blastocysts cultured in vitro 
in the presence of media supplemented with FAF-BSA, LDL or albumin enriched 
with n-3 or n-6 PUFA (n=3). 
 
Treatment (T) BSA Serum Fraction         
Fraction (F) 
 
LDL Albumin SED Significance 
Dietary Source  
(D) n-3 n-6 n-3 n-6 
 
T TxF TxD 
C16:0 13.5 14.3 13.2 12.8 13.9 0.54 - - - 
C17:0 0.09 0.09 ND 0.14 ND - - - - 
C18:0 15.0 15.2 15.0 13.9 15.3 0.77 - - - 
C20:0 0.34 0.37 0.36 0.22 0.37 0.07 - - - 
C21:0 0.07 ND ND ND ND - - - - 
C22:0 ND ND ND ND ND - - - - 
C23:0 3.61a 4.13b 4.58b 3.84a 3.81a 0.21 0.02 0.008 - 
C24:0 0.33 0.07 ND 0.06 ND 0.06 <0.001 - - 
          C16:1 1.4 1.25 0.75 1.19 1.09 0.29 - - - 
C17:1 ND 0.2 ND 0.15 ND - - - - 
C18:1n-9t 1.47 0.31 0.72 0.5 1.35 0.56 - - - 
C18:1n-9c 45.2 45.1 45.7 47.9 45.9 1.44 - - - 
C20:1n-9 0.59 0.58 0.59 0.51 0.53 0.04 - - - 
C22:1n-9 0.16 ND 0.15 ND ND - - - - 
          C18:2n-6t 0.22 0.12 ND 0.08 ND - - - - 
C18:2n-6c 6.69 6.79 7.35 7.09 7.03 0.39 - - - 
C18:3n-6 ND ND ND ND ND - - - - 
C20:2n-6 ND ND 0.11 ND ND - - - - 
C20:3n-6 ND 0.82 1.02 0.06 0.44 - - - - 
C20:4n-6 5.53a 5.46a 5.68a 4.22b 3.92b 0.74 - 0.02 - 
C22:2n-6 0.45 0.14 0.27 0.16 0.17 0.17 - - - 
          C18:3n-3 0.38 0.35 0.38 0.36 0.34 0.04 - - - 
C20:3n-3 0.26a 0.34a 0.2a 0.57b 0.51b 0.14 - 0.02 - 
C20:5n-3 ND ND ND 0.73 0.23 - - 0.003 - 
C22:5n-3 0.43a 0.11b 0.17b 0.89c 0.53a 0.19 - 0.003 - 
C22:6n-3 0.29 0.3 ND 0.99 0.69 - - <0.001 0.05 
          Unidentified 3.85 3.88 3.72 3.66 3.94 0.37 - - - 
 
Means within a row with different superscripts are significantly different (P<0.05): NS, not 
significant: SED, standard error of difference; ND, below detectable limit (<0.03). 
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 Figure 4.4 Transcript expression (relative to GAPDH) in Day 7 blastocysts  cultured 
in synthetic oviductal fluid media supplemented with either fatty acid-free BSA 
(BSA, white) or one of three supplements  (serum, left column; LDL, middle 
column; albumin, right column) from an n-3 (grey) or n-6 (black) PUFA source. 
Different superscripts indicate significance of P<0.05. NS = not significant (n=4). 
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 Figure 4.5 Transcript expression (relative to GAPDH) in Day 7 blastocysts  cultured 
in synthetic oviductal fluid media supplemented with either fatty acid-free BSA 
(BSA, white) or one of three supplements  (serum, left column; LDL, middle 
column; albumin, right column) from an n-3 (grey) or n-6 (black) PUFA source. 
Different superscripts indicate significance of P<0.05. NS = not significant (n=4). 
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Figure 4.6 Relationship between oleic (A) and linoleic (B) acid and SCD transcript 
expression in Day 7 sheep blastocysts. Data points are means for embryos cultured in 
FAF-BSA for each of the three culture experiments (i.e. serum, LDL and albumin). 
 
 
4.4.1 In vitro embryo development 
 
A greater proportion of embryos cultured in the presence of either serum or albumin 
developed to the blastocyst stage by day 6 compared with LDL treated embryos.  
This suggests that the albumin portion of serum is the driving force behind this 
accelerated development. However, serum is an undefined supplement and contains 
many other components including growth factors, hormones and a range of proteins, 
vitamins and inorganic minerals (Freshney, 2005). The albumin fraction also is not 
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defined and may contain other serum components bound to albumin or unbound that 
perhaps could aide blastocyst development. The accelerated development brought 
about by the addition of serum to embryo culture media is in keeping with the 
observations of others (Thompson et al., 1995; Van Langendonckt et al., 1997; 
Lonergan et al., 1999). This accelerated development, however, was associated with 
poorer morphological grades. This is also in keeping with the observations of others 
who noted reduced embryo quality with inclusion of serum in culture (Thompson et 
al., 1995; Reis et al., 2005).  
 
4.4.2 Fatty acid composition  
 
TFA content (ng/blastocyst) was greatest in embryos cultured with the serum 
(158ng) (A.2.2) and the albumin (128ng) (A.2.5) fractions compared to LDL fraction 
(118ng) (A.2.3) or FAF-BSA control (119ng). The FA profile of embryos cultured 
with either serum or albumin was altered by culture treatment, showing differences 
in the n-3 and n-6 PUFA content. This was not observed in LDL-cultured embryos. 
Taken together, this indicates that there was no significant net uptake of FA by 
inclusion of LDL and that serum and albumin in culture facilitate the uptake of FA 
from the culture environment. A number of studies have reported lipid accumulation 
during in vitro embryo production supplemented with serum in ruminants 
(Thompson et al., 1995; Ferguson and Leese, 1999; Rizos et al., 2002; Reis et al., 
2003). The increase in TFA content in the current study was associated with a visible 
increase in lipid droplet accumulation within the embryo (data not presented), again 
this is consistent with others (Thompson et al., 1995; Reis et al., 2005). The TFA 
content measured in these experiments is greater than that reported by Wonnacott et 
al. (2010) (60 to 80 ng/blastocyst) and Reis et al. (2002) (69 to 124 ng/blastocyst). 
Differences in FA composition in the FAF-BSA treated embryos over the various 
experiments (119 to 150ng/blastocyst) and the differences in total amounts of 
saturates and unsaturates detected in the same samples have highlighted fundamental 
differences in the composition of the oocytes from which these embryos were 
derived. The difference in FA composition in the control group is unlikely to come 
from the culture media as it contained only trace amounts of FA (Table A.2.6).  
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The FA composition of embryos is different to that observed in granulosa and theca 
cells (Chapter 3, Tables 3.4, 3.5 and 3.6). Levels of PUFA in blastocysts (average 
11g/100g TFA) are approximately half that observed in somatic cells of the ovarian 
follicle (average 20g/100g TFA), however levels of n-6 PUFA are comparable (10 vs 
12 g/100g TFA, respectively). Haggarty and colleagues (2006) observed that in 
discarded human pre-implantation embryos, those that developed beyond the 4-cell 
stage have a higher relative percentage of PUFA, specifically linoleic acid (C18:2,n-
6). Levels of linoleic acid measured in blastocysts in this study were approximately 
6g/100g TFA. This is comparable to that detected in sheep oocytes (6.9g/100g TFA) 
(McEvoy et al., 2000), and bovine cumulus oocyte complexes (5.7g/100g TFA) 
(Zachut et al., 2010). These data suggests an important role for n-6 PUFA, especially 
linoleic acid in oocyte maturation and embryo development; however recent data 
indicates that FA uptake by the maturing oocyte is limiting and additional dietary n-3 
and n-6 PUFA have only a modest effect on embryo development (Fouladi-Nashta et 
al., 2009). In contrast, recent work has reported that inclusion of linoleic acid (n-6) 
and linolenic acid (n-3) in media for IVM and IVF of oocytes have adverse and 
beneficial effects on maturation and early embryo development respectively (Marei 
et al., 2009; Marei et al., 2010).  
 
An interesting observation with the current study is the amount of n-3 PUFA 
detected in embryos cultured with albumin. The amount of individual n-6 PUFAs 
were not differentially altered with inclusion of n-6 albumin compared to n-3 
albumin. However, four out of the five n-3 PUFAs were significantly altered. These 
data indicate that albumin may preferentially bind and transport n-3 PUFA. The 
affinity for albumin to bind FA increases as chain length increases (Spector, 1975), 
but to date no information is available regarding albumin binding affinities for n-3 vs 
n-6 PUFAs. However, along with chain length, the number and position of double 
bonds in the carbon chain may affect the binding efficiencies of FA to albumin 
(Petitpas et al., 2001) which could begin to explain the differences observed in the 
present study. 
 
Lipid accumulation in oocytes and embryonic cells is an integral part of energy 
storage. These inclusions are metabolically active and the lipid is in a constant state 
of hydrolysis and resynthesis (Reis et al., 2005). It is probable that a selective uptake 
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mechanism has developed to ensure that minimal levels of potentially detrimental 
PUFA are maintained within the oocyte and developing embryo in vivo. However, it 
seems that this selective mechanism can be bypassed in vitro as demonstrated by the 
current study and others (Thompson et al., 1995, Kim et al., 2001; Reis et al., 2005). 
Excessive lipid accumulation in embryos cultured in vitro has been associated with 
reduced cryotolerance and elevated levels of stress responsive genes (Abe et al., 
2002; Rizos et al., 2003).  
 
Additional PUFA supplementation during oocyte maturation in vitro can improve 
early embryo development (Marei et al., 2010). However, this is not as clear-cut as it 
seems. Bovine oocyte exposure to D-linolenic acid can improve embryo development 
in vitro (Marei et al., 2010) whereas addition of linoleic or palmitic acid to mouse 
embryos inhibits development (Nonogaki et al., 1994). The FA composition of 
follicular fluid is a complex mixture of saturates, MUFA and PUFA of varying chain 
lengths and series (n-3, n-6, n-9 etc.), free or bound to transport molecules (Renaville 
et al., 2010; Sinclair et al., 2008; Jones and King 2009; Wonnacott et al., 2010; 
Zachut et al. 2010). In vivo exposure of oocytes to lipid never occurs in isolation of a 
single type of FA and optimal embryo development is likely to be associated with 
ratios between certain FAs and not the presence or absence of any single FA 
(Waterman and Wall, 1988).  
 
4.4.3 Transcript expression 
 
Wonnacott et al., (2010) demonstrated that despite no net uptake of FA from HDL, 
transcripts for LDLR and SCD were reduced, presumably acting via SCARB1, with 
little effect observed between n-3 vs n-6 PUFA. The same observations were seen in 
the present study with inclusion of LDL in the culture media, where LDLR and 
SCARB1 transcripts were reduced with inclusion of LDL compared with FAF-BSA 
control. The HDL signalling cascade is not yet fully elucidated (Fidge et al., 1999) 
and it could be that LDL signalling is more complicated than first thought. The 
LDLR is regulated by the SREBP family of transcription factors and requires several 
post translational modifications before it becomes active (Kong et al., 2006) and 
despite the detection of LDLR transcript, actual levels of the active protein may not 
correlate. 
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Expression levels for SOD1 were increased with inclusion of both serum and 
albumin, but not LDL, in culture media. Elevated levels of SOD1 are indicative of 
increased superoxide toxicity in embryos (Lequarre et al., 2001), and in the present 
study, heightened levels are associated with increased lipid accumulation and poorer 
morphological grades in embryos. PUFA source did not affect SOD1 transcript 
levels. FADS2 was not altered by treatment, however a substantial increase in 
expression was observed with addition of n-6 PUFA serum. This increase is 
inscrutable and would require further investigation to elucidate the mechanism 
involved. 
 
SCD transcript has been shown to be regulated by PUFA (Landschulz et al., 1994; 
Keating et al., 2006), with different FA affecting this regulation with varying degrees 
of potency. A study by Landschulz et al. (1994) demonstrated that culturing 
hepatocytes with a range of individual FA at the same concentration varied the rate 
of suppression of SCD, with arachidonic (C20:4,n-6) and eicosapentanoic acid 
(C20:5,n-3) having the greatest effect. In fact, the potency of inhibition increased 
with the number of double bonds. In the current study, comparisons of SCD 
transcripts levels between experiments highlighted differences in expression. These 
differences had a negative correlation with levels of oleic and linoleic acid (i.e. high 
SCD, low FA) (Figure 4.6). Oleic acid was the most abundant FA within the embryo 
in all experiments with a range of 30-45g/100g TFA and concentrations were 
between 9 to 14 fold higher than arachidonic acid and 90 to 150 fold higher than 
eicosapentanoic acid. Keating et al. (2006) suggest that oleic acid, as the main 
product of SCD activity, could self regulate via a negative feedback mechanism, 
thereby maintaining the stearic acid to oleic acid ratio (also known as the desaturase 
index), which is a measurement of membrane fluidity, a key factor in maintaining 
normal cell function (Ntambi, 1995). This negative regulation of SCD by FA is most 
likely due to inhibition of SREBP transcription factors (Zulkifli et al., 2010) which 
are well known to be regulated post-transcriptionally by FA, by reducing the amount 
of active SREBP available for nuclear translocation (Jump and Clarke, 1999; Xu et 
al., 1999; Sampath and Ntambi, 2005). 
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Large differences in transcript expression between studies in the FAF-BSA control 
have highlighted fundamental differences in oocytes obtained from abattoir derived 
ovaries. Levels of ELOVL5 and SCD transcripts are much lower in the LDL and 
albumin experiments compared to the serum experiment. These experiments were 
conducted at different times of the year (serum experiment conducted between 
November and December 2009; LDL and albumin conducted in parallel between 
January and March 2010). This taken together with the FA composition of FAF-BSA 
control embryos of the same experiments suggests not only a seasonal effect but the 
composition of abattoir derived oocytes for IVF can vary greatly depending on diet, 
age and genotype of the animal. Experimental animals with controlled diets would 
reduce this effect, however in order to collect enough oocytes for IVF would make 
that option too expensive and beyond the confines of the current study. 
 
4.5 Conclusions 
 
The current study has provided evidence that albumin is the main FA transport 
mechanism for uptake into developing pre-implantation embryos. However FA 
uptake was associated with an observed increase in poor morphology and stress 
response. Nonogaki et al. (1994) suggested that lipid radicals can be generated easily 
in early stage embryos with blastomeres being the most sensitive to damage by lipid 
peroxidation. The current study was designed so that FAs were delivered to embryos 
at physiological concentrations, in fact less than that typically found in serum. 
However the amount of FA available to cells solely by albumin in vivo is 
substantially less. Therefore the detrimental effects observed may be due simply to 
over abundance of available FA. Transcript expression for ELOVL5 and FADS2 has, 
to the best of our knowledge, been described in mammalian embryos for the first 
time, indicating that FA metabolism is active in early blastocysts. 
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CHAPTER 5 
 
General discussion and conclusions 
 
5.1 General discussion 
 
Declining fertility in cattle, especially dairy cows, has become an international 
problem due to the genetic selection for high milk yield. Studies have shown that 
supplementing ruminant diets with FA can have a range of beneficial effects on 
reproductive function. For example, positive effects have been observed with 
follicular development (Lammoglia et al., 1997) improved corpus luteum function 
(Petit et al., 2002), improved fertilization (Cerri et al., 2009) and enhancement of 
embryo quality and maintenance of pregnancy (Santos et al., 2008). PUFA are able 
to influence reproductive processes by a variety of mechanisms. They are precursors 
for inflammatory eicosanoids and can modulate the expression of a wide range of 
genes including those involved in steroid hormone synthesis. Alterations in the levels 
of dietary n-3 and n-6 PUFA could greatly affect these processes at the level of the 
ovary. FA compositional profiles have previously been investigated in granulosa 
cells, oocytes and embryos (Reis et al., 2002; Adamiak et al., 2006) and some studies 
have demonstrated that alterations in dietary FA can change the composition of these 
reproductive tissues (Wonnacott et al., 2010; Zachut et al., 2010). Studies indicate 
that the beneficial effects brought on by supplemental dietary FA  may occur at the 
level of the ovary but there is a lack of information regarding the mechanisms by 
which dietary FA affect these tissues. There is also a paucity of information 
regarding the mechanisms by which n-3 and n-6 PUFAs are transported to and taken 
up by the ruminant ovary, and how the ovarian cells and developing pre-implantation 
embryo utilise these lipids. 
 
Previous work in our laboratory have shown that follicular fluid progesterone is 
increased in n-3 compared to n-6 PUFA fed ewes (Wonnacott et al., 2010). This 
study showed that diets supplemented with contrasting sources of PUFA could alter 
the FA composition of plasma, follicular fluid, granulosa cells and oocytes of these 
animals. Surprisingly, when the serum from ewes fed on either the n-3 or n-6 
enriched diet was HDL fractionated and used for the in vitro culture of granulosa 
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cells, no differences on progesterone secretion was observed. These data suggested 
that either granulosa cells were not responding to the dietary differences or that HDL 
was not the lipoprotein that delivered FA to these cells.  
 
The experiments in this thesis used a combination of in vivo and in vitro studies to 
investigate the effects of dietary n-3 and n-6 PUFA on various ovine reproductive 
parameters. Granulosa cells and serum were collected from ewes fed n-3 and n-6 rich 
diets. Gene expression was investigated by array and qRTPCR in granulosa cells and 
serum was fractionated and analysed for FA composition by GC. PUFA enriched 
fractions were used to supplement granulosa, thecal and embryo cultures and 
molecular techniques used to elucidate the effects. The FA compositional profiles of 
granulosa cells, theca cells and pre-implantation embryos were also investigated. 
Specifically, the effects of n-3 and n-6 PUFA enriched HDL and LDL on granulosa 
and theca cell gene expression and steroidogenesis were explored. Sheep zygotes 
were cultured with LDL and albumin enriched with n-3 or n-6 PUFA to examine the 
mechanism of FA uptake by the pre-implantation embryo and subsequent 
development and gene expression.  
 
This thesis sought to identify the mechanisms by which dietary n-3 and n-6 PUFA 
bind to HDL or LDL and alter steroid hormone synthesis in ovarian steroidogenic 
cells. Data presented in this thesis indicate that both HDL and LDL are able to 
deliver FA to both granulosa and theca cells in vitro. However, the FA composition 
of theca cells more closely resembled that of the culture treatments indicating a more 
effective uptake mechanism is in place in these cells. This may be explained by the 
fact that, in vivo, theca cells are exposed to the full range of lipoprotein classes found 
in the circulation as opposed to granulosa cells which have limited access due to the 
basement membrane (Grummer and Carroll, 1988). Also, this study is the first to 
report the FA compositional profile of theca cells. 
 
A major finding from the in vitro studies is that n-3 PUFA increase STAR expression 
compared with n-6 PUFA in theca cells. This, together with an HDL-specific 
mechanism, may account for the increased progesterone production by n-3 HDL 
treated cells. These data suggest that a similar mechanism may account for the 
increased follicular fluid progesterone levels in ewes fed the n-3 PUFA enriched diet 
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(Chapter 2). Both the n-3 and n-6 PUFA culture media contained the full range of FA 
(including all n-3 and n-6 PUFA) and it seems that it is the n-6:n-3 ratio that drives 
the alteration seen in STAR H[SUHVVLRQ :LWKRXW WKH LQFOXVLRQ RI D µFRQWURO¶ JURXS
(i.e. no FA), however, the question remains as to whether n-3 PUFA increases or n-6 
PUFA reduces STAR expression and subsequently progesterone production. In order 
to elucidate the mechanisms behind these alterations further analyses would be 
needed. Several directions would be beneficial; i) measuring arachidonic acid (AA) 
metabolites (e.g. prostaglandins) in in vitro media, and to extend this further by 
investigating concentrations in the follicular fluid from the in vivo study. Several 
studies have reported that AA metabolites have a critical role in steroid biosynthesis, 
acting both positively and negatively (Fiedler et al., 1999; Wang and Stocco, 1999; 
Zosmer et al., 2002; Wang et al., 2006), thus it would be interesting to observe how 
the n-6:n-3 PUFA ratio altered these metabolites. ii) Measuring protein levels of 
PUFA-sensitive transcription factors in in vitro cultured theca cells. The PPARs and 
SREBPs are the most likely candidates for investigation, as they are both regulated 
post-transcriptionally by PUFA with n-3 and n-6 PUFA having differential effects 
(Jump et al., 1996; Duplus et al., 2000; Grimaldi, 2001; Sampath and Ntambi, 2004; 
Schmitz and Ecker, 2008).  
 
Data presented in this thesis (Chapter 4) indicate that embryos acquire FA from the 
surrounding environment via albumin. Wonnacott et al., (2010) found that pre-
implantation sheep embryos responded to HDL enriched with n-3 or n-6 PUFA in 
terms of alterations in the expression of transcripts for LDLR and SCD but that the 
FA composition was not altered. This is in keeping with the current study where it 
was observed that embryos cultured with LDL enriched with n-3 or n-6 PUFA 
altered the expression of LDLR and SCD transcripts but FA profiles were not 
changed. When cultured with serum or albumin, fractionated from serum, both from 
ewes fed n-3 or n-6 PUFA, the FA composition of embryos was significantly altered 
together with an increase in TFA. The uptake of FA by serum and albumin also 
coincided with accelerated development, poorer quality embryos and an increase in 
oxidative stress (i.e. increase in SOD1 transcript expression). An interesting and 
unique observation from this study was that albumin tended to preferentially bind 
and transport n-3 PUFA to the pre-implantation embryo regardless of the dietary 
background source of the albumin. This may be due to varying binding efficiencies 
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of different FA (Spector, 1975; Petitpas et al., 2001), but to date no information is 
available regarding the binding of albumin to n-3 vs. n-6 PUFA. It is noteworthy that 
the albumin fraction in this study contained the lowest n-6:n-3 ratio out of all 
fractions measured (Table A.2.1). This may suggest that there is an evolutionary 
explanation as to why developing embryos utilise albumin to transport FA and not 
LDL or HDL, perhaps to limit the exposure to potentially harmful n-6 PUFA such as 
LA (Marei et al., 2010). 
 
In order to further investigate the mechanisms behind gene expression alterations 
brought on by the binding of lipoproteins to their receptors, a detailed investigation 
into these complex signalling pathways would be beneficial. It is clear that HDL 
stimulates progesterone production, not necessarily by cholesterol delivery alone. 
One study suggests that apolipoprotien-A1, the major protein component of the HDL 
molecule is the inducer of steroidogenesis, without the need for parallel cholesterol 
uptake (Chandras et al., 2004) and that embryos respond to HDL (Wonnacott et al., 
2010) and LDL in terms of altered transcript expression but without FA uptake. The 
importance of these mechanisms in ovarian function and embryo development 
requires further investigation. 
 
Further investigations into the roles of individual PUFA on ovarian steroidogenic 
cells and developing pre-implantation embryos would also help to elucidate the 
mechanisms behind the observations in this thesis. Several groups have investigated 
individual PUFAs on reproductive parameters (Mattos et al., 2003; Sheldrick et al., 
2007; Marei et al., 2009; Meier et al., 2009; Marei et al., 2010), but caution must be 
taken whilst interpreting these data as these FA do not occur in isolation in vivo, but 
as a complex mixture of FA with often opposing actions. In the studies described in 
this thesis, the use of fractionated serum lipoproteins more closely resembles the in 
vivo scenario. Moreover future work may utilise this knowledge of the FA content of 
in vivo derived serum by testing the effects of different combinations of PUFAs on 
granulosa cells and embryos in vitro.   
 
One observation from these studies, which must be taken into account if further work 
is to be carried out, is seasonal differences in quality of abattoir derived material. 
Variations in the expression of transcripts for ELOVL5 and SCD and FA composition 
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in FAF-BSA treated blastocysts highlighted fundamental differences in the oocytes 
obtained from the abattoir over a period of 4 months (November 2009 to March 
2010). Without any knowledge of age, genotype and dietary background of donor 
animals, the fundamental quality of the tissues can vary greatly, potentially affecting 
the outcome of experiments such as the ones described in this thesis. Differences in 
the FA composition of blastocysts in the current thesis and those of others (Reis et 
al., 2002; Wonnacott et al., 2010) could potentially be due to this seasonal effect and 
caution must be taken when interpreting these data. 
 
This thesis also describes a series of experiments designed to optimise a custom-
designed ovine-gonad specific cDNA macro-array gene for the purposes of 
identifying PUFA sensitive genes in granulosa cells. Although this approach was 
applied to both in vivo and in vitro derived granulosa cells, the non-commercial array 
was found to be unsuitable for quantitative gene expression analyses. Nevertheless, 
the use of an alternative array platform would be highly appropriate for the 
identification of novel PUFA sensitive ovarian genes.  
 
In terms of the implications for ruminant reproduction published data suggests that 
supplementing diets with increased n-3 PUFA content could be beneficial. Several 
studies have investigated this hypothesis and have reported improvements in higher 
grade oocytes (Zeron et al., 2002), higher follicular phase oestradiol concentrations 
(Robinson et al., 2002), delayed onset of luteolysis (Mattos et al., 2004) and 
improved oocyte maturation and early embryo development (Marei et al., 2010). As 
cattle fertility is declining worldwide, a relatively cheap and simple option of dietary 
supplementation would be an attractive remedy. Several large-scale feeding studies 
have been completed to date (Armstrong et al., 1990; Carroll et al., 1994; Burke et 
al., 1997) but these studies have had limitations (low sample sizes, inconsistent 
results and undefined energy levels in feed) and therefore no distinct conclusions can 
be drawn.  
 
Although caution must be taken when comparing ruminants to humans, this thesis 
may serve to encourage the consumption of a lower n-6:n-3 PUFA diet. The modern 
western diet comprises an n-6 to n-3 ratio ranging from 15-20 as opposed to a value 
of approximately 1 which several sources suggest is what humans became 
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accustomed to during the course of evolution (Eaton et al., 1998; Simopoulos, 2008). 
Studies have shown that reducing this ratio can have beneficial effects on chronic 
diseases such as rheumatoid arthritis and asthma, and a reduction in the risk of 
developing breast cancer (Broughton et al., 1997; James and Cleland, 1997; Maillard 
et al., 2002). In terms of human reproduction, Several papers suggest a beneficial 
role of n-3 PUFA on human reproduction, for example; increased birth weight 
(Muthayya et al., 2009) longer gestational age (Olsen et al., 1991) and improved 
spermatozoa quality (Safarinejad et al., 2010). However, more in depth studies are 
required to investigate the mechanistic role of PUFAs in the human reproductive 
system. 
 
5.2 General conclusions 
 
This thesis has focused on the effects of offering different sources of PUFA, namely 
the n-3 and n-6 series on FA composition and subsequent effects on gene expression 
in ovine granulosa and theca cells and the pre-implantation embryo. Additional to 
this, the effects of HDL and LDL fractions harvested from sera of ewes offered n-3 
or n-6 PUFA on steroidogenesis were assessed in in vitro cultured granulosa and 
theca cells. The role of LDL and albumin fractions was investigated in the 
development, uptake and gene expression of pre-implantation embryos. 
 
This study has demonstrated that: 
i. Supplementation of culture media with LDL and HDL fractions obtained 
from ewes offered diets high in either n-3 or n-6 PUFA can support ovine 
granulosa and theca cell growth and function. 
ii. The altered follicular-fluid progesterone levels observed in ewes fed n-3 
PUFA diets can be reproduced in vitro and is mediated by actions on the 
theca layer of the follicle. 
iii. Relative to n-6 PUFA, n-3 PUFA increases transcript expression for STAR in 
theca cells. 
iv. HDL, but not LDL, stimulates progesterone output in theca but not granulosa 
cells. 
v. Ovine granulosa and theca cells express transcripts for ELOVL5, FADS1 and 
FADS2 and SCD in theca cells indicating active FA metabolism. 
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vi. Ovine blastocysts utilise albumin but not LDL as a transport molecule for FA 
uptake, but this uptake is associated with poorer morphological grades and a 
heightened stress response. 
vii. Ovine blastocysts are responsive to the presence of serum, albumin and LDL 
in culture in terms of altered transcript expression. 
viii. Ovine blastocysts express transcripts for ELOVL5 and FADS2 indicating 
active FA metabolism in early mammalian embryos. 
 
To conclude, this thesis has confirmed previous reports of HDL stimulated 
progesterone production in ovarian steroidogenic cells. In addition, it has been 
demonstrated that HDL from an n-3 PUFA enriched background can further improve 
progesterone production and that this is associated with an upregulation of the STAR 
transcript in cultured ovine theca cells. Low density lipoprotein was ineffective in 
delivering FA to cultured pre-implantation embryos, however, the albumin fraction 
of serum not only allowed uptake of FA to the embryos but preferentially bound n-3 
over n-6 PUFA. This FA uptake by embryos via albumin however, was associated 
with poorer morphological grades and a heightened stress response manifest by 
increased expression of SOD1 transcript.  
 
This thesis has highlighted the importance of n-3 PUFA in ruminant reproductive 
function in terms of improved steroidogenesis in theca cells both in vitro and in vivo 
and the preferential uptake by embryos via albumin. This taken together with 
published data reporting improved reproductive parameters in ruminants by n-3 
PUFA supplementation may serve to encourage more research in this field to 
investigate the development of a relatively cheap method to begin to improve the 
worldwide decline in dairy cattle fertility. 
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APPENDIX 1 
 
Table A.1.1 Ovine cDNA macroarray gene information 
 
Abbreviation Gene Name 
 
ACTB  Actin, beta 
ALOX12 Arachidonate 12-lipoxygenase 
ALOX5AP Arachidonate 5-lipoxygenase-activating protein 
AMH Anti mullerian hormone 
BMP15 Bone morphogenetic protein 15 
BMP4 Bone morphogenetic protein 4 
BMP7 Bone morphogenetic protein 7 
BMPR1A Bone morphogenetic protein receptor IA 
BMPR1B Bone morphogenetic protein receptor IB 
BMPR2 Bone morphogenetic protein receptor II 
CAV1 Caveolin 1 
CISH Cytokine inducible SH2-containing protein 
c-kit c-kit receptor 
CSF-3 Colony stimulating factor 3 (granulocyte)  
CYP19A1 Cytochrome P450, family 19; aromatase  
DAZL Deleted in azoospermia-like 
DDX4 DEAD box polypeptide 4 
DMRT1 Doublesex and mab-3 related transcription factor 1 
EEF1a1 Eukaryotic translation elongation factor 1 alpha 1 
ESR1 Oestrogen receptor 1 
ESR2 Oestrogen receptor 2 (ER beta) 
FOXL2 Forkhead transcription factor 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GATA4 Gata-binding protien 4 
GDF9 Growth differentiation factor 9 
GJA1 Gap junction protien, alpha 1 
GJB1 Gap junction protien, beta 1 
GJB2 Gap junction protien, beta 2 
GJC1 Gap junction protien, gamma 1 
HPRT1 Hypoxanthine phosphoribosyltransferase 1 
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HSD3B1  3-beta-Hydroxysteroid dehydrogenase 
HSL Hormone sensitive lipase 
IFNA Interferon alpha 
IFNB Interferon beta 
IFNG Interferon gamma 
IGF1 Insulin-like growth factor 1 
IGF2 Insulin-like growth factor 2 
IGF2R Insulin-like growth factor 2 receptor 
IGFBP1 Insulin-like growth factor binding protein 1 
IGFBP2  Insulin-like growth factor binding protein 2 
IL1A Interleukin 1 alpha 
IL1B Interleukin 1 beta 
IL10 Interleukin 10 
IL12A Interleukin 12 alpha 
IL12B Interleukin 12 beta 
IL13 Interleukin 13 
IL16 Interleukin 16 
IL17 Interleukin 17 
IL18 Interleukin 18 
IL2 Interleukin 2 
IL7 Interleukin 7 
IL8 Interleukin 8 
INHA Inhibin alpha 
INHBa Inhibin beta a 
INHBb Inhibin beta b 
INHBc Inhibin beta c 
LHR Luteinizing hormone receptor 
MEL1A Melatonin receptor 
MMP3 Matrix metalloproteinase 3 
MSH4 MutS homolog 4  
MSH5 MutS homolog 5 
NR5A1 Nuclear receptor subfamily 5, group A, member 1 
OSBP2  Oxysterol binding protein 2 
PAPPA Pregnancy-associated plasma protein A 
PGF  Placental growth factor 
PGR Progesterone receptor  
PHB Prohibin 
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POU5F1 POU class 5 homeobox 1  
PTGDS Prostaglandin D2 synthase 
PTGER3 Prostaglandin E receptor 3 (subtype EP3) 
PTGFR Prostaglandin F receptor  
PTGS1 Prostaglandin synthase 1 
PTPRG Protein tyrosine phosphatase, receptor type, G 
SDHA Succinate dehydrogenase complex, subunit A 
SOCS1 Suppressor of cytokine signalling 1 
SOCS2 Suppressor of cytokine signalling 2 
SOCS3 Suppressor of cytokine signalling 3 
SOX14 SRY (sex determining region Y)-box 14 
SOX2 SRY (sex determining region Y)-box 2 
SOX9 SRY (sex determining region Y)-box 9 
SPO11 Meiotic protein covalently bound to DSB homolog 
SRY Sex determining region Y 
STAR Steroidogenic acute regulatory protein 
STC1 Stanniocalcin 1 
TCF21 Transcription factor 21 
TGFb1 Transforming growth factor beta 1 
TGFb2 Transforming growth factor beta 2 
TGFb3 Transforming growth factor beta 3 
TIMP1 Tissue inhibitor of metalloproteinase 1 
TIMP2 Tissue inhibitor of metalloproteinase 2 
TNF Tumor necrosis factor (alpha or member 2)  
VIM Vimentin 
WT1 Wilms tumor 1 
ZFX Zinc finger protein, x-linked 
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APPENDIX 2 
Fatty acid composition of serum, serum fractions and culture media. 
Table A.2.1. Fatty acid (FA) composition of (a) Serum, (b) LDL, (c) HDL and (d) 
Albumin (all fractionated from pooled sera) from ewes offered diets differing in n-3 
and n-6 PUFA (n=2/treatment). 
Diet n-3 n-6 S.E.D. P 
 
g/100g TFA 
  (a) Serum 
    TFA (µg/ml) 1439 1445 
  
Saturated 36.51 36.50 0.189 - 
Unsaturated 59.08 59.13 0.718 - 
MUFA 17.29 18.72 0.618 - 
PUFA 41.79 40.41 0.544 - 
n-6 series 23.51 36.62 0.432 <0.001 
n-3 series 18.28 3.79 0.133 <0.001 
Ratio n-6:n-3 1.29 9.66 0.234 <0.001 
(b) LDL 
        
TFA (µg/ml) 1519 1012 
  
Saturated 36.8 41.5 0.192 0.002 
Unsaturated 58.8 53.9 0.624 0.015 
MUFA 19.5 20.7 0.598 - 
PUFA 39.3 33.1 0.149 <0.001 
n-6 series 24.7 30.5 0.124 <0.001 
n-3 series 14.6 2.63 0.045 <0.001 
Ratio n-6:n-3 1.68 11.6 0.020 <0.001 
(c) HDL 
        
TFA (µg/ml) 3321 3171 
  
Saturated 33.9 30.2 0.612 0.026 
Unsaturated 61.6 64.9 0.521 0.024 
MUFA 18.2 20.1 0.796 - 
PUFA 43.5 44.8 0.276 0.039 
n-6 series 27.7 41.5 0.267 <0.001 
n-3 series 15.7 3.30 0.085 <0.001 
Ratio n-6:n-3 1.76 12.5 0.034 <0.001 
(d) Albumin 
        
TFA (µg/ml) 88.6 89.6 
  
Saturated 38.9 44.0 0.261 0.003 
Unsaturated 57.1 51.4 0.258 0.002 
MUFA 20.8 20.8 0.576 - 
PUFA 36.3 30.6 0.754 0.017 
n-6 series 16.7 25.7 0.298 <0.001 
n-3 series 19.6 4.91 0.460 <0.001 
Ratio n-6:n-3 0.85 5.24 0.073 <0.001 
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Table A.2.2 Fatty acid composition of ovine pooled serum of ewes offered diets 
enriched with either n-3 or n-6 PUFA (n=2/treatment) 
 
Dietary Treatment n-3 n-6 S.E.D. P 
Fatty acids g/100g TFA 
  
   
  C16:0 20.29 14.27 0.193 <0.001 
C17:0 1.47 0.90 0.076 0.017 
C18:0 13.45 20.48 0.167 <0.001 
C20:0 0.22 0.15 0.044 - 
C21:0 0.17 0.05 0.030 - 
C22:0 0.25 0.21 0.007 0.031 
C23:0 0.34 0.27 0.012 0.035 
C24:0 0.33 0.17 0.005 <0.001 
     C16:1 3.99 1.98 0.112 0.003 
C17:1 0.42 0.43 0.080 - 
C18:1n-9t 0.66 0.56 0.026 - 
C18:1n-9c 10.73 15.55 0.802 0.027 
C20:1 1.33 0.14 0.020 <0.001 
C22:1n-9 0.16 0.06 0.007 0.005 
     C18:2n-6t 0.21 0.19 0.091 - 
C18:2n-6c 18.76 32.11 0.347 <0.001 
C18:3n-6 0.20 0.72 0.019 0.002 
C20:2n-6 0.86 0.17 0.061 0.008 
C20:3n-6 0.83 0.42 0.002 <0.001 
C20:4n-6 2.54 2.80 0.072 - 
C22:2n-6 0.10 0.21 0.147 - 
C18:3n-3 2.14 0.57 0.008 <0.001 
C20:3n-3 0.37 0.04 0.037 0.013 
C20:5n-3 11.11 1.43 0.096 <0.001 
C22:6n-3 4.67 1.76 0.041 <0.001 
     Unidentified 4.41 4.37 0.084 - 
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Table A.2.3 Fatty acid composition of LDL fractionated from pooled sera of ewes 
offered diets enriched with either n-3 or n-6 PUFA (n=2/treatment) 
 
Dietary Treatment n-3 n-6 S.E.D. P 
Fatty acids g/100g TFA 
  
C16:0 22.7 15.5 0.124 <0.001 
C17:0 1.26 0.91 0.019 <0.001 
C18:0 11.2 23.4 0.264 <0.001 
C20:0 0.3 0.25 0.005 0.005 
C21:0 0.22 0.18 0.008 0.014 
C22:0 0.29 0.3 0.104 - 
C23:0 0.63 0.62 0.018 - 
C24:0 0.27 0.19 0.004 0.005 
     C16:1 3.79 2.38 0.540 - 
C17:1 0.74 0.59 0.130 - 
C18:1n-9t 0.48 0.72 0.060 0.035 
C18:1n-9c 13.4 16.8 0.100 <0.001 
C20:1 0.95 0.14 0.010 <0.001 
C22:1n-9 0.16 0.05 0.010 0.009 
     C18:2n-6t 0.12 0.3 0.033 0.03 
C18:2n-6c 20.1 26.3 0.141 <0.001 
C18:3n-6 0.27 1.83 0.006 <0.001 
C20:2n-6 0.95 0.14 0.015 <0.001 
C20:3n-6 0.89 0.24 0.019 <0.001 
C20:4n-6 2.23 1.61 0.007 <0.001 
C22:2n-6 0.14 0.06 0.002 <0.001 
C18:3n-3 2.24 0.54 0.008 <0.001 
C20:3n-3 0.34 0.05 0.002 <0.001 
C20:5n-3 8.86 0.96 0.031 <0.001 
C22:6n-3 3.18 1.06 0.004 <0.001 
     Unidentified 3.86 3.72 0.091 - 
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Table A.2.4 Fatty acid composition of HDL fractionated from pooled sera of ewes 
offered diets enriched with either n-3 or n-6 PUFA (n=2/treatment) 
 
Dietary Treatment n-3 n-6 S.E.D. P 
Fatty acids g/100g TFA 
  
   
  C16:0 19.8 12.7 0.311 0.002 
C17:0 1.06 0.63 0.072 0.004 
C18:0 11.9 15.3 0.246 0.003 
C20:0 0.05 0 0.101 - 
C21:0 0 0.27 0.120 - 
C22:0 0.26 0.26 0.004 - 
C23:0 0.52 0.53 0.006 - 
C24:0 0.27 0.21 0.008 - 
     C16:1 3.68 1.11 0.051 <0.001 
C17:1 0 0.50 0.141 - 
C18:1n-9t 0.43 0.31 0.050 - 
C18:1n-9c 13.0 18.2 0.750 0.020 
C20:1 0.92 0 0.022 <0.001 
C22:1n-9 0.14 0 0.135 - 
     C18:2n-6t 0 0 - - 
C18:2n-6c 20.5 37.4 0.206 <0.001 
C18:3n-6 0 0.44 0.021 0.002 
C20:2n-6 0.78 0.40 0.013 0.001 
C20:3n-6 2.46 2.98 0.035 0.004 
C20:4n-6 0.72 0 0.025 0.001 
C22:2n-6 3.25 0.28 0.040 <0.001 
C18:3n-3 1.95 0.52 0.015 <0.001 
C20:3n-3 0.19 0 0.003 <0.001 
C20:5n-3 9.98 1.28 0.069 <0.001 
C22:6n-3 3.61 1.52 0.021 <0.001 
     Unidentified 4.51 4.91 0.245 - 
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Table A.2.5 Fatty acid composition of Albumin fractionated from pooled sera of 
ewes offered diets enriched with either n-3 or n-6 PUFA (n=2/treatment) 
 
Dietary Treatment n-3 n-6 S.E.D. P 
Fatty acids g/100g TFA 
  
   
  C16:0 19.2 17.3 0.101 0.006 
C17:0 1.30 0.91 0.124 0.015 
C18:0 16.2 23.8 0.231 <0.001 
C20:0 0.19 0.15 0.004 0.029 
C21:0 0.36 0.26 0.061 - 
C22:0 0.27 0.25 0.022 - 
C23:0 1.20 1.12 0.114 - 
C24:0 0.21 0.16 0.052 - 
     C16:1 2.21 1.12 0.23 0.042 
C17:1 0.34 0.39 0.011 0.008 
C18:1n-9t 0.68 0.42 0.105 - 
C18:1n-9c 16.1 18.5 0.461 0.035 
C20:1 1.23 0.26 0.034 <0.001 
C22:1n-9 0.35 0.11 0.067 - 
     C18:2n-6t 0.12 0.09 0.005 0.027 
C18:2n-6c 12.8 22.2 0.177 <0.001 
C18:3n-6 0.15 0.12 0.064 - 
C20:2n-6 0.61 0.11 0.036 0.005 
C20:3n-6 0.66 0.34 0.09 - 
C20:4n-6 2.13 2.53 0.034 0.007 
C22:2n-6 0.12 0.31 0.029 0.023 
C18:3n-3 2.13 0.85 0.086 0.004 
C20:3n-3 0.29 0.15 0.021 0.019 
C20:5n-3 10.6 1.72 0.16 <0.001 
C22:6n-3 6.53 2.19 0.199 0.002 
     Unidentified 3.89 4.60 0.265 - 
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Table A.2.6 Fatty acid composition of culture media, basal synthetic oviductal fluid 
medium (SOF), SOF plus 0.1% w/v FA-free (FAF) BSA, basal DMEM and DMEM 
plus n-6 HDL incorporated at a FA level equivalent to that of 5% v/v serum. Values 
are means ± SEM from two technical replicates.  
 
Media SOFM 
SOFM + FAF-
BSA 
DMEM 
DMEM + 
5% 
 
g/100g TFA 
Saturated 52.3±0.40 49.4±1.75 47.5±1.04 32.6±0.10 
Unsaturated 43.6±0.10 45.4±0.88 49.7±0.42 63.1±0.03 
MUFA 25.8±0.62 27.0±0.12 29.2±0.02 22.4±0.46 
PUFA 17.8±0.05 18.4±0.30 20.6±0.27 40.7±0.03 
n-6 15.0±0.28 14.8±0.07 11.8±0.34 35.8±0.92 
n-3 2.8±0.12 3.6±0.29 8.8±0.18 4.9±0.35 
ratio 5.4±0.13 4.2±0.32 1.4±0.01 7.23±0.34 
     C16:0 16.9±1.10 20.8±0.20 16.1±0.80 14.7±0.12 
C18:0 20.6±0.14 11.4±0.14 22.8±0.41 17.3±0.19 
C18:1n9c 20.9±1.05 21.0±0.07 22.0±0.81 19.6±0.48 
C18:2n6c 12.1±0.11 9.7±0.06 7.1±0.04 32.2±0.01 
C20:4n6 2.9±0.51 2.2±0.19 0.9±0.03 2.5±0.20 
C18:3n3 2.2±0.25 0.8±0.01 0.2±0.00 1.1±0.03 
C20:5n3 ND ND ND 1.1±0.03 
C22:6n3  ND ND ND 1.6±0.05 
     TFA (µg/ml) 3.57 3.79 4.20 73.00 
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APPENDIX 3 
 
Media for in vitro embryo culture 
 
All reagents are from Sigma-Aldrich unless otherwise stated. All water used for 
media is tissue culture grade (TCG). All media is sterile filtered after pH and 
osmolarity checks and stored at 4°C.  Note that Stock D can precipitate out of 
solution therefore should be added last and added slowly. Where stocks are used, 
refer to table A.3.1 for details. 
 
A.3.1 Oocyte collection media 
TCM199 with Hepes  19ml 
Glutamine   2.0mg 
Heparin   0.2mg 
Pen/strep soln   100µl 
FCS    1ml 
pH = 7.2-7.3; mOsmo = 283 +/-10 
 
Store for 1 week 
 
A.3.2 Maturation media 
TCM199   9 ml 
Glutamine   1 mg 
Pyruvate   1 mg 
LH    100µl (10µg/ml) 
FSH    1ml (10µg/ml) 
Pen/strep   50µl 
pH = 7.9; mOsmo = 283 +/- 10 
 
Equilibrate at 5% CO2 for at least 1 hour before use. 
Store for 1 week 
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Table A.3.1 List of stock components for embryo culture media. All media made up 
in tissue culture grade water.  All stocks sterile filtered and stored at 4°C. 
 
Stock Component Concentration Amount Volume Storage 
C Na Pyruvate 33mM 36 mg 10ml 1 week 
GLN Glutamine 10mM 73 mg 50ml 1 week 
B NaHCO3 250mM 1.05 g 
50ml 1 week 
 
Phenol red 
 
3 drops 
H Hepes 250mM 5.957 g 100ml 2-4 weeks 
L Na Lactate 330mM 1.41 ml 30ml 2-4 weeks 
S3 NaCl 1.1M 6.294 g 
100ml 3 months 
 
KCl 70mM 0.534 g 
 
KH2PO4 12mM 0.162 g 
D CaCl2.2H2O 171mM 1.26 g 50ml 3 months 
M MgCl2.6H2O 49mM 500 mg 50ml 3 months 
G Glucose 60mM 540 mg 50ml 3 months 
 
A.3.3 Sperm wash media   
Stock S3   10ml   
Stock H   8.4ml   
Stock B   1.6ml   
Stock C   1ml   
Stock GLN   10ml   
Stock M   1ml   
Stock L   1ml   
Stock G    4ml    
Stock D   1ml   
BSA (V/FAF)   300mg   
Pen/strep   0.5ml   
Water    61.5ml   
Made up to 100ml with TCG grade water 
pH = 7.2-7.4; mOsmo = 283+/- 10 
Store for 1 week 
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A.3.4. Percoll medium for sperm separation 
To make up 90% Percoll: 
Percoll    53ml 
Stock S3   5ml 
Stock M   500µl 
Stock D   500µl 
NaHCO3   96mg (22mM) 
Hepes (free acid)  126mg (10.5mM) 
Na Hepes (salt)  137mg (0.5mM) 
pH = 7.2-7.4; mOsmo = 280-300 
Store for 2 months 
 
A.3.5. Fertilisation media      
Stock S3   5ml   
Stock B   5ml   
Stock C   1.5ml   
Stock L   1.5ml   
Stock M   0.5ml   
Stock GLN   5ml   
Stock D   1ml   
Pen/strep   0.25ml   
Water    28.05ml   
pH = 7.9; mOsmo = 283 +/- 10 
Store for 2 weeks 
For IVF ± add 2% sheep serum to Fertilisation medium and equilibrate before use 
 
A.3.6. Hepes SOF (for washing and transporting embryos) 
Stock S3   10ml 
Stock B   2ml 
Stock H   8ml 
Stock C   1ml 
Stock D   1ml 
Stock M   1ml 
Stock L   1ml 
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Stock G   2.5ml 
Stock GLN   10ml 
Water    87.5ml 
Mixed and added 300mg FAF-BSA 
pH = 7.4; mOmol = 270+/-5 
Store for 1-2 weeks 
 
A.3.7. SOFaaBSA (standard embryo culture medium)   
Stock S3   10ml   
Stock B   10ml   
Stock C   3ml   
Stock D   1ml   
Stock L   3ml   
Stock M   1ml   
Stock G   2.5ml   
Stock GLN   10ml   
Pen/strep   0.5ml  
TCG water   50ml     
Non-essential amino acids 0.5ml     
Essential amino acids  1ml     
FAF-BSA*   500mg    
pH = 7.4; mOsmo = 270-280 
Store for 1 week 
 
* Note that SOFaa media containing treatments (i.e LDL, Albumin) included no 
FAF-BSA. Water volume was adjusted to allow for extra volume of LDL and 
Albumin fractions. 
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